chem_id	chebi_id	cas_registry	frac_id(FK)	frac_id	frac_code	moa_code	moa_name	target_code	target_site	group_name	chemical_group	common_name	resistance_risk	comments
1	4	4	221	221	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2	4	4	222	222	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3	4	4	223	223	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4	4	4	224	224	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
5	4	4	225	225	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
232	81936	26530-20-1	452	452	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
6	4	4	226	226	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
7	4	4	227	227	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
8	8	8	228	228	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
9	8	8	229	229	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
10	8	8	230	230	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
11	32	32	231	231	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
12	32	32	232	232	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
13	31	31	233	233	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
14	1	1	234	234	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
15	1	1	235	235	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
16	1	1	236	236	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
17	1	1	237	237	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
18	1	1	238	238	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
19	1	1	239	239	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
20	10	10	240	240	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
21	22	22	241	241	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
22	22	22	242	242	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
23	20	20	243	243	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
24	43	43	244	244	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
25	39	39	245	245	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
26	39	39	246	246	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
27	7	7	247	247	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
28	7	7	248	248	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
29	7	7	249	249	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
47	11	11	267	267	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
30	7	7	250	250	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
31	7	7	251	251	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
32	7	7	252	252	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
33	7	7	253	253	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
34	7	7	254	254	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
35	7	7	255	255	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
36	7	7	256	256	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
37	7	7	257	257	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
38	7	7	258	258	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
39	7	7	259	259	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
40	7	7	260	260	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
41	7	7	261	261	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
42	7	7	262	262	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
43	7	7	263	263	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
44	7	7	264	264	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
45	11	11	265	265	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
46	11	11	266	266	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
48	11	11	268	268	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
49	11	11	269	269	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
50	11	11	270	270	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
51	11	11	271	271	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
52	11	11	272	272	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
53	11	11	273	273	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
54	11	11	274	274	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
55	11	11	275	275	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
56	11	11	276	276	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
57	11	11	277	277	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
58	11	11	278	278	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
59	11	11	279	279	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
60	11	11	280	280	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
61	11	11	281	281	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
62	11	11	282	282	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
63	11	11	283	283	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
64	11	11	284	284	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
65	21	21	285	285	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
66	21	21	286	286	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
67	29	29	287	287	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
68	29	29	288	288	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
69	29	29	289	289	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
70	29	29	290	290	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
71	29	29	291	291	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
72	30	30	292	292	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
73	30	30	293	293	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
74	30	30	294	294	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
75	38	38	295	295	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
76	45	45	296	296	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
77	9	9	297	297	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
78	9	9	298	298	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
79	9	9	299	299	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
80	23	23	300	300	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
81	24	24	301	301	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
82	25	25	302	302	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
83	41	41	303	303	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
84	13	13	304	304	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
85	13	13	305	305	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
86	12	12	306	306	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
87	12	12	307	307	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
88	2	2	308	308	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
89	2	2	309	309	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
90	2	2	310	310	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
91	2	2	311	311	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
92	NA	NA	312	312	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
93	6	6	313	313	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
843		39148-24-8	1063	1063	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
94	6	6	314	314	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
95	6	6	315	315	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
96	6	6	316	316	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
97	14	14	317	317	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
98	14	14	318	318	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
99	14	14	319	319	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
100	14	14	320	320	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
101	14	14	321	321	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
102	14	14	322	322	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
103	14	14	323	323	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
104	28	28	324	324	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
105	28	28	325	325	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
106	28	28	326	326	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
107	NA	NA	327	327	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
108	44	44	328	328	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
109	44	44	329	329	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
110	44	44	330	330	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
111	44	44	331	331	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
112	46	46	332	332	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
113	3	3	333	333	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
114	3	3	334	334	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
115	3	3	335	335	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
116	3	3	336	336	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
117	3	3	337	337	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
118	3	3	338	338	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
119	3	3	339	339	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
120	3	3	340	340	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
121	3	3	341	341	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
122	3	3	342	342	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
123	3	3	343	343	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
124	3	3	344	344	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
199	M1	M1	419	419	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
125	3	3	345	345	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
126	3	3	346	346	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
127	3	3	347	347	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
128	3	3	348	348	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
129	3	3	349	349	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
130	3	3	350	350	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
131	3	3	351	351	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
132	3	3	352	352	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
133	3	3	353	353	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
134	3	3	354	354	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
292	81918	900-95-8	512	512	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
135	3	3	355	355	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
136	3	3	356	356	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
137	3	3	357	357	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
138	3	3	358	358	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
139	3	3	359	359	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
140	3	3	360	360	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
141	3	3	361	361	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
142	3	3	362	362	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
143	3	3	363	363	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
144	3	3	364	364	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
200	M2	M2	420	420	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
145	3	3	365	365	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
146	3	3	366	366	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
147	3	3	367	367	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
148	3	3	368	368	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
149	5	5	369	369	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
150	5	5	370	370	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
151	5	5	371	371	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
152	5	5	372	372	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
153	5	5	373	373	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
154	5	5	374	374	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
155	5	5	375	375	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
156	17	17	376	376	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
157	17	17	377	377	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
158	18	18	378	378	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
159	18	18	379	379	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
160	18	18	380	380	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
161	26	26	381	381	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
162	19	19	382	382	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
163	40	40	383	383	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
164	40	40	384	384	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
165	40	40	385	385	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
166	40	40	386	386	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
167	40	40	387	387	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
168	40	40	388	388	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
169	40	40	389	389	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
170	16.1	16.1	390	390	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
171	16.1	16.1	391	391	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
172	16.1	16.1	392	392	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
173	16.2	16.2	393	393	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
174	16.2	16.2	394	394	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
175	16.2	16.2	395	395	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
176	P1	P1	396	396	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
177	P2	P2	397	397	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
178	P3	P3	398	398	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
179	P3	P3	399	399	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
180	P4	P4	400	400	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
181	P5	P5	401	401	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
182	27	27	402	402	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
183	33	33	403	403	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
184	33	33	404	404	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
185	34	34	405	405	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
186	35	35	406	406	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
187	36	36	407	407	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
188	37	37	408	408	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
189	42	42	409	409	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
190	U6	U6	410	410	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
191	U8	U8	411	411	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
192	U8	U8	412	412	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
193	U12	U12	413	413	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
194	U13	U13	414	414	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
195	U14	U14	415	415	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
196	U15	U15	416	416	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
197	U16	U16	417	417	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
198	NC	NC	418	418	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
231	5827	10004-44-1	451	451	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
201	M3	M3	421	421	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
202	M3	M3	422	422	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
203	M3	M3	423	423	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
204	M3	M3	424	424	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
205	M3	M3	425	425	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
206	M3	M3	426	426	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
207	M3	M3	427	427	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
208	M3	M3	428	428	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
209	M4	M4	429	429	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
210	M4	M4	430	430	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
211	M4	M4	431	431	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
212	M5	M5	432	432	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
213	M6	M6	433	433	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
214	M6	M6	434	434	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
215	M7	M7	435	435	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
216	M7	M7	436	436	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
217	M8	M8	437	437	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
218	M9	M9	438	438	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
219	M10	M10	439	439	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
220	M11	M11	440	440	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
221	3009	71626-11-4	441	441	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
222	82779	98243-83-5	442	442	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
223	5194	57646-30-7	443	443	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
224	6790	57837-19-1	444	444	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
225	60607	70630-17-0	445	445	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
226	81937	77732-09-3	446	446	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
227	81969	58810-48-3	447	447	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
228	81952	41483-43-6	448	448	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
229	81958	5221-53-4	449	449	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
230	81989	23947-60-6	450	450	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
233	138856	14698-29-4	453	453	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
234	3015	17804-35-2	454	454	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
235	3392	10605-21-7	455	455	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
236	81926	3878-19-1	456	456	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
237	45979	148-79-8	457	457	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
238	82060	23564-06-9	458	458	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
239	35014	23564-05-8	459	459	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
240	4520	87130-20-9	460	460	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
241	82048	156052-68-5	461	461	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
242	82856	162650-77-3	462	462	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
243	7957	66063-05-6	463	463	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
244	81764	239110-15-7	464	464	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
245	82860	130339-07-0	465	465	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
246	38628	129558-76-5	466	466	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
247	82052	15310-01-7	467	467	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
248	81792	66332-96-5	468	468	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
249	81823	55814-41-0	469	469	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
250	83065	875915-78-9	470	470	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
251	83070	658066-35-4	471	471	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
252	81994	24691-80-3	472	472	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
253	3405	5234-68-4	473	473	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
293	35036	639-58-7	513	513	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
254	7858	5259-88-1	474	474	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
255	81794	130000-40-7	475	475	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
256	83092	1072957-71-1	476	476	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
257	83106	581809-46-3	477	477	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
258	83113	907204-31-3	478	478	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
259	81793	123572-88-3	479	479	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
260	83126	881685-58-1	480	480	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
261	83134	494793-67-8	481	481	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
262	81777	183675-82-3	482	482	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
263	83173	874967-67-6	483	483	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
264	81822	188425-85-6	484	484	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
265	40909	131860-33-8	485	485	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
266	83185	850881-70-8	486	486	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
267	83187	238410-11-2	487	487	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
268	83194	918162-02-4	488	488	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
269	83197	117428-22-5	489	489	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
270	83202	862588-11-2	490	490	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
271	83205	173662-97-0	491	491	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
272	78780	175013-18-0	492	492	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
273	83212	915410-70-7	493	493	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
274	83213	902760-40-1	494	494	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
275	2962	143390-89-0	495	495	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
276	81833	141517-21-7	496	496	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
277	83218	149961-52-4	497	497	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
278	83220	366815-39-6	498	498	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
279	81831	133408-50-1	499	499	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
280	81832	248593-16-0	500	500	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
281	59340	131807-57-3	501	501	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
282	83253	361377-29-9	502	502	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
283	83258	161326-34-7	503	503	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
284	83261	799247-52-2	504	504	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
285	81841	120116-88-3	505	505	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
286	81846	348635-87-0	506	506	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
287	82153	485-31-4	507	507	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
288	83372	131-72-6	508	508	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
289	83379	39300-45-3	509	509	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
290	81843	79622-59-6	510	510	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
291	81844	89269-64-7	511	511	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
294	30473	76-87-9	514	514	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
295	83393	175217-20-6	515	515	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
296	83398	865318-97-4	516	516	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
297	4045	121552-61-2	517	517	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
298	6751	110235-47-7	518	518	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
299	8674	53112-28-0	519	519	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
300	15353	2079-00-7	520	520	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
301	81419	6980-18-3	521	521	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
302	17076	57-92-1	522	522	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
303	27701	79-57-2	523	523	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
304	82040	124495-18-7	524	524	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
305	83555	189278-12-4	525	525	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
306	34759	74738-17-3	526	526	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
307	81763	131341-86-1	527	527	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
308	3656	84332-86-5	528	528	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
309	28909	36734-19-7	529	529	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
310	8450	32809-16-8	530	530	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
311		50471-44-8	531	531	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
312			532	532	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
313		17109-49-8	533	533	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
314		26087-47-8	534	534	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
315		13457-18-6	535	535	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
316		50512-35-1	536	536	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
317	17097	92-52-4	537	537	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
318	3628	2675-77-6	538	538	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
425	81755	12071-83-9	645	645	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
319	27864	99-30-9	539	539	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
320	34908	82-68-8	540	540	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
321	82044	117-18-0	541	541	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
322	81731	57018-04-9	542	542	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
323	81761	2593-15-9	543	543	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
324	83279	55406-53-6	544	544	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
325	82033	24579-73-5	545	545	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
326	82084	19622-08-3	546	546	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
327			547	547	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
328			548	548	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
329			549	549	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
330			550	550	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
331			551	551	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
332	83629		552	552	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
333		26644-46-2	553	553	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
334		88283-41-4	554	554	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
335		847749-37-5	555	555	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
336	4998	60168-88-9	556	556	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1943		39148-24-8	2163	2163	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
337	7645	63284-71-9	557	557	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
338		35554-44-0	558	558	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
339		134074-64-9	559	559	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
340		101903-30-4	560	560	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
341		67747-09-5	561	561	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
342		68694-11-1	562	562	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
343		60207-31-0	563	563	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
344		55179-31-2	564	564	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
345		116255-48-2	565	565	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
346		94361-06-5	566	566	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
844		13598-36-2	1064	1064	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
347		119446-68-3	567	567	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
348		83657-18-5	568	568	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
349		133855-98-8	569	569	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
350		60207-93-4	570	570	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
351		114369-43-6	571	571	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
352		136426-54-5	572	572	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
353		85509-19-9	573	573	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
354		76674-21-0	574	574	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
355		79983-71-4	575	575	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
356		86598-92-7	576	576	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
845	83341	76280-91-6	1065	1065	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
357		125225-28-7	577	577	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
358		125116-23-6	578	578	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
359		88671-89-0	579	579	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
360		66246-88-6	580	580	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
361		60207-90-1	581	581	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
362		149508-90-7	582	582	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
363		107534-96-3	583	583	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
364		112281-77-3	584	584	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
365		43121-43-3	585	585	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
366		55219-65-3	586	586	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
651	82019	133-07-3	871	871	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
367		131983-72-7	587	587	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
368		178928-70-6	588	588	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
369	83295	91315-15-0	589	589	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
370	81960	1593-77-7	590	590	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
371	50145	67564-91-4	591	591	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
372	9700	81412-43-3	592	592	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
373	81917	67306-00-7	593	593	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
374	83283	3478-94-2	594	594	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
375	9242	118134-30-8	595	595	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
376	81853	126833-17-8	596	596	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
377	83327	473798-59-3	597	597	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
378	81736	88678-67-5	598	598	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
379	7451	65472-88-0	599	599	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
380	9448	91161-71-6	600	600	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
381		37248-47-8	601	601	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
382		11113-80-7	602	602	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
383	81848	110488-70-5	603	603	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
384	83428	211867-47-9	604	604	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
385	83663	868390-90-3	605	605	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
386	83601	413615-35-7	606	606	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
387	82023	140923-17-7	607	607	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
388	83610	283159-90-0	608	608	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
389	81802	374726-62-2	609	609	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
390	47617	27355-22-2	610	610	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
391	45141	57369-32-1	611	611	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
392	81783	41814-78-2	612	612	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
393		104030-54-8	613	613	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
394		139920-32-4	614	614	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
395		115852-48-7	615	615	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
396		135158-54-2	616	616	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
397		27605-76-1	617	617	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
398	81825	223580-51-6	618	618	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
399	83657	224049-04-1	619	619	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
400		9008-22-4	620	620	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
401			621	621	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
402		57966-95-7	622	622	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
403		39148-24-8	623	623	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
404		13598-36-2	624	624	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
405	83341	76280-91-6	625	625	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
406	83335	72459-58-6	626	626	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
407	81801	106917-52-6	627	627	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
408	81759	62865-36-5	628	628	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
409	81933	66952-49-6	629	629	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
410	81797	180409-60-3	630	630	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
411	83345	220899-03-6	631	631	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
412	83346	688046-61-9	632	632	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
413	74889	2439-10-3	633	633	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
414	83277	958647-10-4	634	634	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
415	81844	89269-64-7	635	635	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
416	83268	1003318-67-9	636	636	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
417	83266	376645-78-2	637	637	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
418			638	638	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
419		7440-50-8	639	639	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
420	17909	7704-34-9	640	640	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
421	5015	14484-64-1	641	641	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
422	52492	8018-01-7	642	642	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
423	52497	12427-38-2	643	643	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
424	81539	9006-42-2	644	644	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
426	9495	137-26-8	646	646	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
427	52498	12122-67-7	647	647	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
428	79736	137-30-4	648	648	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
429	34608	133-06-2	649	649	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
430	81938	2425-06-1	650	650	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
431	82019	133-07-3	651	651	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
432	3639	1897-45-6	652	652	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
433	74875	1085-98-9	653	653	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
434	75182	731-27-1	654	654	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
435	82843	108173-90-6	655	655	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
436	5569	13516-27-3	656	656	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
437	82076	101-05-3	657	657	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
438	81842	3347-22-6	658	658	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
439	34620	2439-01-2	659	659	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
440	81826	41205-21-4	660	660	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
441	3009	71626-11-4	661	661	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
442	82779	98243-83-5	662	662	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
443	5194	57646-30-7	663	663	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
444	6790	57837-19-1	664	664	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
445	60607	70630-17-0	665	665	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
446	81937	77732-09-3	666	666	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
447	81969	58810-48-3	667	667	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
448	81952	41483-43-6	668	668	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
449	81958	5221-53-4	669	669	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
450	81989	23947-60-6	670	670	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
451	5827	10004-44-1	671	671	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
452	81936	26530-20-1	672	672	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
453	138856	14698-29-4	673	673	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
454	3015	17804-35-2	674	674	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
541	82044	117-18-0	761	761	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
455	3392	10605-21-7	675	675	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
456	81926	3878-19-1	676	676	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
457	45979	148-79-8	677	677	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
458	82060	23564-06-9	678	678	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
459	35014	23564-05-8	679	679	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
460	4520	87130-20-9	680	680	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
461	82048	156052-68-5	681	681	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
462	82856	162650-77-3	682	682	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
463	7957	66063-05-6	683	683	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
464	81764	239110-15-7	684	684	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
465	82860	130339-07-0	685	685	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
466	38628	129558-76-5	686	686	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
467	82052	15310-01-7	687	687	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
468	81792	66332-96-5	688	688	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
469	81823	55814-41-0	689	689	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
470	83065	875915-78-9	690	690	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
471	83070	658066-35-4	691	691	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
472	81994	24691-80-3	692	692	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
473	3405	5234-68-4	693	693	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
474	7858	5259-88-1	694	694	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
475	81794	130000-40-7	695	695	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
476	83092	1072957-71-1	696	696	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
477	83106	581809-46-3	697	697	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
478	83113	907204-31-3	698	698	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
479	81793	123572-88-3	699	699	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
480	83126	881685-58-1	700	700	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
481	83134	494793-67-8	701	701	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
482	81777	183675-82-3	702	702	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
483	83173	874967-67-6	703	703	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
484	81822	188425-85-6	704	704	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
485	40909	131860-33-8	705	705	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
486	83185	850881-70-8	706	706	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
487	83187	238410-11-2	707	707	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
488	83194	918162-02-4	708	708	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
489	83197	117428-22-5	709	709	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
490	83202	862588-11-2	710	710	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
491	83205	173662-97-0	711	711	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
492	78780	175013-18-0	712	712	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
846	83335	72459-58-6	1066	1066	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
493	83212	915410-70-7	713	713	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
494	83213	902760-40-1	714	714	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
495	2962	143390-89-0	715	715	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
496	81833	141517-21-7	716	716	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
497	83218	149961-52-4	717	717	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
498	83220	366815-39-6	718	718	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
499	81831	133408-50-1	719	719	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
500	81832	248593-16-0	720	720	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
501	59340	131807-57-3	721	721	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
502	83253	361377-29-9	722	722	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
503	83258	161326-34-7	723	723	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
504	83261	799247-52-2	724	724	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
505	81841	120116-88-3	725	725	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
506	81846	348635-87-0	726	726	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
507	82153	485-31-4	727	727	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
508	83372	131-72-6	728	728	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
509	83379	39300-45-3	729	729	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
510	81843	79622-59-6	730	730	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
511	81844	89269-64-7	731	731	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
512	81918	900-95-8	732	732	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
513	35036	639-58-7	733	733	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
514	30473	76-87-9	734	734	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
515	83393	175217-20-6	735	735	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
847	81801	106917-52-6	1067	1067	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
516	83398	865318-97-4	736	736	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
517	4045	121552-61-2	737	737	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
518	6751	110235-47-7	738	738	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
519	8674	53112-28-0	739	739	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
520	15353	2079-00-7	740	740	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
521	81419	6980-18-3	741	741	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
522	17076	57-92-1	742	742	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
523	27701	79-57-2	743	743	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
524	82040	124495-18-7	744	744	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
525	83555	189278-12-4	745	745	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
526	34759	74738-17-3	746	746	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
527	81763	131341-86-1	747	747	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
528	3656	84332-86-5	748	748	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
529	28909	36734-19-7	749	749	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
530	8450	32809-16-8	750	750	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
531		50471-44-8	751	751	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
532			752	752	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
533		17109-49-8	753	753	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
534		26087-47-8	754	754	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
535		13457-18-6	755	755	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
536		50512-35-1	756	756	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
537	17097	92-52-4	757	757	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
538	3628	2675-77-6	758	758	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
539	27864	99-30-9	759	759	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
540	34908	82-68-8	760	760	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
542	81731	57018-04-9	762	762	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
543	81761	2593-15-9	763	763	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
544	83279	55406-53-6	764	764	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
545	82033	24579-73-5	765	765	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
546	82084	19622-08-3	766	766	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
547			767	767	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
548			768	768	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
549			769	769	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
550			770	770	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
551			771	771	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
552	83629		772	772	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
553		26644-46-2	773	773	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
554		88283-41-4	774	774	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
555		847749-37-5	775	775	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
556	4998	60168-88-9	776	776	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
557	7645	63284-71-9	777	777	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
610	47617	27355-22-2	830	830	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
848	81759	62865-36-5	1068	1068	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
558		35554-44-0	778	778	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
559		134074-64-9	779	779	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
560		101903-30-4	780	780	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
561		67747-09-5	781	781	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
562		68694-11-1	782	782	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
563		60207-31-0	783	783	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
564		55179-31-2	784	784	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
565		116255-48-2	785	785	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
566		94361-06-5	786	786	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
567		119446-68-3	787	787	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
611	45141	57369-32-1	831	831	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
568		83657-18-5	788	788	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
569		133855-98-8	789	789	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
570		60207-93-4	790	790	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
571		114369-43-6	791	791	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
572		136426-54-5	792	792	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
573		85509-19-9	793	793	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
574		76674-21-0	794	794	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
575		79983-71-4	795	795	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
576		86598-92-7	796	796	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
577		125225-28-7	797	797	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
612	81783	41814-78-2	832	832	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
578		125116-23-6	798	798	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
579		88671-89-0	799	799	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
580		66246-88-6	800	800	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
581		60207-90-1	801	801	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
582		149508-90-7	802	802	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
583		107534-96-3	803	803	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
584		112281-77-3	804	804	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
585		43121-43-3	805	805	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
586		55219-65-3	806	806	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
587		131983-72-7	807	807	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
650	81938	2425-06-1	870	870	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
588		178928-70-6	808	808	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
589	83295	91315-15-0	809	809	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
590	81960	1593-77-7	810	810	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
591	50145	67564-91-4	811	811	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
592	9700	81412-43-3	812	812	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
593	81917	67306-00-7	813	813	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
594	83283	3478-94-2	814	814	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
595	9242	118134-30-8	815	815	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
596	81853	126833-17-8	816	816	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
597	83327	473798-59-3	817	817	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
598	81736	88678-67-5	818	818	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
599	7451	65472-88-0	819	819	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
600	9448	91161-71-6	820	820	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
601		37248-47-8	821	821	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
602		11113-80-7	822	822	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
603	81848	110488-70-5	823	823	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
604	83428	211867-47-9	824	824	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
605	83663	868390-90-3	825	825	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
606	83601	413615-35-7	826	826	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
607	82023	140923-17-7	827	827	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
608	83610	283159-90-0	828	828	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
609	81802	374726-62-2	829	829	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
849	81933	66952-49-6	1069	1069	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
613		104030-54-8	833	833	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
614		139920-32-4	834	834	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
615		115852-48-7	835	835	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
616		135158-54-2	836	836	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
617		27605-76-1	837	837	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
618	81825	223580-51-6	838	838	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
619	83657	224049-04-1	839	839	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
620		9008-22-4	840	840	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
621			841	841	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
622		57966-95-7	842	842	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
623		39148-24-8	843	843	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
624		13598-36-2	844	844	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
625	83341	76280-91-6	845	845	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
626	83335	72459-58-6	846	846	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
627	81801	106917-52-6	847	847	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
628	81759	62865-36-5	848	848	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
629	81933	66952-49-6	849	849	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
630	81797	180409-60-3	850	850	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
631	83345	220899-03-6	851	851	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
632	83346	688046-61-9	852	852	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
633	74889	2439-10-3	853	853	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
634	83277	958647-10-4	854	854	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
635	81844	89269-64-7	855	855	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
636	83268	1003318-67-9	856	856	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
637	83266	376645-78-2	857	857	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
638			858	858	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
639		7440-50-8	859	859	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
640	17909	7704-34-9	860	860	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
641	5015	14484-64-1	861	861	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
642	52492	8018-01-7	862	862	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
643	52497	12427-38-2	863	863	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
644	81539	9006-42-2	864	864	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
645	81755	12071-83-9	865	865	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
646	9495	137-26-8	866	866	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
647	52498	12122-67-7	867	867	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
648	79736	137-30-4	868	868	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
649	34608	133-06-2	869	869	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
652	3639	1897-45-6	872	872	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
653	74875	1085-98-9	873	873	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
654	75182	731-27-1	874	874	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
655	82843	108173-90-6	875	875	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
656	5569	13516-27-3	876	876	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
657	82076	101-05-3	877	877	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
658	81842	3347-22-6	878	878	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
659	34620	2439-01-2	879	879	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
660	81826	41205-21-4	880	880	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
661	3009	71626-11-4	881	881	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
662	82779	98243-83-5	882	882	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
663	5194	57646-30-7	883	883	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
664	6790	57837-19-1	884	884	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
665	60607	70630-17-0	885	885	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
666	81937	77732-09-3	886	886	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
667	81969	58810-48-3	887	887	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
668	81952	41483-43-6	888	888	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
669	81958	5221-53-4	889	889	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
670	81989	23947-60-6	890	890	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
671	5827	10004-44-1	891	891	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
672	81936	26530-20-1	892	892	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
673	138856	14698-29-4	893	893	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
674	3015	17804-35-2	894	894	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
675	3392	10605-21-7	895	895	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
676	81926	3878-19-1	896	896	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
677	45979	148-79-8	897	897	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
678	82060	23564-06-9	898	898	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
679	35014	23564-05-8	899	899	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
680	4520	87130-20-9	900	900	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
681	82048	156052-68-5	901	901	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
682	82856	162650-77-3	902	902	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
683	7957	66063-05-6	903	903	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
684	81764	239110-15-7	904	904	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
685	82860	130339-07-0	905	905	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
686	38628	129558-76-5	906	906	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
687	82052	15310-01-7	907	907	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
688	81792	66332-96-5	908	908	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
689	81823	55814-41-0	909	909	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
690	83065	875915-78-9	910	910	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
691	83070	658066-35-4	911	911	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
692	81994	24691-80-3	912	912	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
693	3405	5234-68-4	913	913	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
694	7858	5259-88-1	914	914	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
695	81794	130000-40-7	915	915	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
696	83092	1072957-71-1	916	916	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
697	83106	581809-46-3	917	917	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
698	83113	907204-31-3	918	918	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
699	81793	123572-88-3	919	919	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
700	83126	881685-58-1	920	920	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
701	83134	494793-67-8	921	921	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
702	81777	183675-82-3	922	922	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
703	83173	874967-67-6	923	923	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
704	81822	188425-85-6	924	924	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
705	40909	131860-33-8	925	925	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
706	83185	850881-70-8	926	926	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
707	83187	238410-11-2	927	927	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
708	83194	918162-02-4	928	928	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
709	83197	117428-22-5	929	929	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
710	83202	862588-11-2	930	930	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
711	83205	173662-97-0	931	931	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
712	78780	175013-18-0	932	932	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
713	83212	915410-70-7	933	933	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
714	83213	902760-40-1	934	934	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
715	2962	143390-89-0	935	935	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
716	81833	141517-21-7	936	936	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
742	17076	57-92-1	962	962	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
717	83218	149961-52-4	937	937	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
718	83220	366815-39-6	938	938	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
719	81831	133408-50-1	939	939	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
720	81832	248593-16-0	940	940	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
721	59340	131807-57-3	941	941	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
722	83253	361377-29-9	942	942	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
723	83258	161326-34-7	943	943	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
724	83261	799247-52-2	944	944	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
725	81841	120116-88-3	945	945	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
726	81846	348635-87-0	946	946	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
727	82153	485-31-4	947	947	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
728	83372	131-72-6	948	948	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
729	83379	39300-45-3	949	949	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
730	81843	79622-59-6	950	950	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
731	81844	89269-64-7	951	951	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
732	81918	900-95-8	952	952	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
733	35036	639-58-7	953	953	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
734	30473	76-87-9	954	954	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
735	83393	175217-20-6	955	955	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
736	83398	865318-97-4	956	956	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
737	4045	121552-61-2	957	957	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
738	6751	110235-47-7	958	958	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
739	8674	53112-28-0	959	959	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
740	15353	2079-00-7	960	960	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
741	81419	6980-18-3	961	961	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
743	27701	79-57-2	963	963	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
744	82040	124495-18-7	964	964	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
745	83555	189278-12-4	965	965	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
746	34759	74738-17-3	966	966	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
747	81763	131341-86-1	967	967	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
748	3656	84332-86-5	968	968	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
749	28909	36734-19-7	969	969	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
750	8450	32809-16-8	970	970	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
751		50471-44-8	971	971	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
752			972	972	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
753		17109-49-8	973	973	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
754		26087-47-8	974	974	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
755		13457-18-6	975	975	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
756		50512-35-1	976	976	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
757	17097	92-52-4	977	977	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
758	3628	2675-77-6	978	978	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
759	27864	99-30-9	979	979	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
760	34908	82-68-8	980	980	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
761	82044	117-18-0	981	981	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
762	81731	57018-04-9	982	982	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
763	81761	2593-15-9	983	983	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
764	83279	55406-53-6	984	984	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
765	82033	24579-73-5	985	985	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
766	82084	19622-08-3	986	986	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
767			987	987	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
811	50145	67564-91-4	1031	1031	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
768			988	988	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
769			989	989	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
770			990	990	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
771			991	991	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
772	83629		992	992	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
773		26644-46-2	993	993	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
774		88283-41-4	994	994	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
775		847749-37-5	995	995	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
776	4998	60168-88-9	996	996	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
777	7645	63284-71-9	997	997	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
778		35554-44-0	998	998	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
779		134074-64-9	999	999	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
840		9008-22-4	1060	1060	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
3051		39148-24-8	3263	3263	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
780		101903-30-4	1000	1000	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
781		67747-09-5	1001	1001	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
782		68694-11-1	1002	1002	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
783		60207-31-0	1003	1003	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
784		55179-31-2	1004	1004	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
785		116255-48-2	1005	1005	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
786		94361-06-5	1006	1006	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
787		119446-68-3	1007	1007	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
788		83657-18-5	1008	1008	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
789		133855-98-8	1009	1009	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
841			1061	1061	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
790		60207-93-4	1010	1010	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
791		114369-43-6	1011	1011	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
792		136426-54-5	1012	1012	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
793		85509-19-9	1013	1013	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
794		76674-21-0	1014	1014	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
795		79983-71-4	1015	1015	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
796		86598-92-7	1016	1016	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
797		125225-28-7	1017	1017	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
798		125116-23-6	1018	1018	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
799		88671-89-0	1019	1019	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
842		57966-95-7	1062	1062	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
800		66246-88-6	1020	1020	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
801		60207-90-1	1021	1021	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
802		149508-90-7	1022	1022	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
803		107534-96-3	1023	1023	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
804		112281-77-3	1024	1024	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
805		43121-43-3	1025	1025	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
806		55219-65-3	1026	1026	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
807		131983-72-7	1027	1027	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
808		178928-70-6	1028	1028	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
809	83295	91315-15-0	1029	1029	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
810	81960	1593-77-7	1030	1030	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
812	9700	81412-43-3	1032	1032	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
813	81917	67306-00-7	1033	1033	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
814	83283	3478-94-2	1034	1034	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
815	9242	118134-30-8	1035	1035	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
816	81853	126833-17-8	1036	1036	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
817	83327	473798-59-3	1037	1037	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
818	81736	88678-67-5	1038	1038	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
819	7451	65472-88-0	1039	1039	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
820	9448	91161-71-6	1040	1040	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
821		37248-47-8	1041	1041	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
822		11113-80-7	1042	1042	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
823	81848	110488-70-5	1043	1043	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
824	83428	211867-47-9	1044	1044	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
825	83663	868390-90-3	1045	1045	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
826	83601	413615-35-7	1046	1046	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
827	82023	140923-17-7	1047	1047	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
828	83610	283159-90-0	1048	1048	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
829	81802	374726-62-2	1049	1049	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
830	47617	27355-22-2	1050	1050	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
831	45141	57369-32-1	1051	1051	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
832	81783	41814-78-2	1052	1052	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
833		104030-54-8	1053	1053	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
834		139920-32-4	1054	1054	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
835		115852-48-7	1055	1055	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
836		135158-54-2	1056	1056	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
837		27605-76-1	1057	1057	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
838	81825	223580-51-6	1058	1058	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
839	83657	224049-04-1	1059	1059	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
850	81797	180409-60-3	1070	1070	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
851	83345	220899-03-6	1071	1071	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
852	83346	688046-61-9	1072	1072	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
853	74889	2439-10-3	1073	1073	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
854	83277	958647-10-4	1074	1074	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
855	81844	89269-64-7	1075	1075	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
856	83268	1003318-67-9	1076	1076	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
857	83266	376645-78-2	1077	1077	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
858			1078	1078	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
859		7440-50-8	1079	1079	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
860	17909	7704-34-9	1080	1080	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
861	5015	14484-64-1	1081	1081	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
862	52492	8018-01-7	1082	1082	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
863	52497	12427-38-2	1083	1083	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
864	81539	9006-42-2	1084	1084	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
865	81755	12071-83-9	1085	1085	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
866	9495	137-26-8	1086	1086	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
867	52498	12122-67-7	1087	1087	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
868	79736	137-30-4	1088	1088	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
869	34608	133-06-2	1089	1089	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
870	81938	2425-06-1	1090	1090	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
871	82019	133-07-3	1091	1091	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
872	3639	1897-45-6	1092	1092	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
873	74875	1085-98-9	1093	1093	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
874	75182	731-27-1	1094	1094	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
875	82843	108173-90-6	1095	1095	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
876	5569	13516-27-3	1096	1096	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
877	82076	101-05-3	1097	1097	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
878	81842	3347-22-6	1098	1098	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
879	34620	2439-01-2	1099	1099	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
880	81826	41205-21-4	1100	1100	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
881	3009	71626-11-4	1101	1101	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1041		37248-47-8	1261	1261	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
882	82779	98243-83-5	1102	1102	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
883	5194	57646-30-7	1103	1103	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
884	6790	57837-19-1	1104	1104	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
885	60607	70630-17-0	1105	1105	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
886	81937	77732-09-3	1106	1106	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
887	81969	58810-48-3	1107	1107	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
888	81952	41483-43-6	1108	1108	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
889	81958	5221-53-4	1109	1109	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
890	81989	23947-60-6	1110	1110	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
891	5827	10004-44-1	1111	1111	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
892	81936	26530-20-1	1112	1112	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
893	138856	14698-29-4	1113	1113	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
894	3015	17804-35-2	1114	1114	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
895	3392	10605-21-7	1115	1115	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
896	81926	3878-19-1	1116	1116	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
897	45979	148-79-8	1117	1117	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
898	82060	23564-06-9	1118	1118	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
899	35014	23564-05-8	1119	1119	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
900	4520	87130-20-9	1120	1120	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
901	82048	156052-68-5	1121	1121	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
902	82856	162650-77-3	1122	1122	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
903	7957	66063-05-6	1123	1123	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
904	81764	239110-15-7	1124	1124	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
905	82860	130339-07-0	1125	1125	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
906	38628	129558-76-5	1126	1126	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
907	82052	15310-01-7	1127	1127	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1944		13598-36-2	2164	2164	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
908	81792	66332-96-5	1128	1128	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
909	81823	55814-41-0	1129	1129	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
910	83065	875915-78-9	1130	1130	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
911	83070	658066-35-4	1131	1131	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
912	81994	24691-80-3	1132	1132	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
913	3405	5234-68-4	1133	1133	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
914	7858	5259-88-1	1134	1134	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
915	81794	130000-40-7	1135	1135	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
916	83092	1072957-71-1	1136	1136	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
917	83106	581809-46-3	1137	1137	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
918	83113	907204-31-3	1138	1138	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
919	81793	123572-88-3	1139	1139	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
920	83126	881685-58-1	1140	1140	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
921	83134	494793-67-8	1141	1141	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
922	81777	183675-82-3	1142	1142	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
923	83173	874967-67-6	1143	1143	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
941	59340	131807-57-3	1161	1161	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
924	81822	188425-85-6	1144	1144	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
925	40909	131860-33-8	1145	1145	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
926	83185	850881-70-8	1146	1146	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
927	83187	238410-11-2	1147	1147	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
928	83194	918162-02-4	1148	1148	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
929	83197	117428-22-5	1149	1149	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
930	83202	862588-11-2	1150	1150	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
931	83205	173662-97-0	1151	1151	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
932	78780	175013-18-0	1152	1152	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
933	83212	915410-70-7	1153	1153	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
934	83213	902760-40-1	1154	1154	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
935	2962	143390-89-0	1155	1155	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
936	81833	141517-21-7	1156	1156	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
937	83218	149961-52-4	1157	1157	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
938	83220	366815-39-6	1158	1158	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
939	81831	133408-50-1	1159	1159	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
940	81832	248593-16-0	1160	1160	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1037	83327	473798-59-3	1257	1257	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
942	83253	361377-29-9	1162	1162	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
943	83258	161326-34-7	1163	1163	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
944	83261	799247-52-2	1164	1164	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
945	81841	120116-88-3	1165	1165	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
946	81846	348635-87-0	1166	1166	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
947	82153	485-31-4	1167	1167	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
948	83372	131-72-6	1168	1168	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
949	83379	39300-45-3	1169	1169	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
950	81843	79622-59-6	1170	1170	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
951	81844	89269-64-7	1171	1171	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
952	81918	900-95-8	1172	1172	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
953	35036	639-58-7	1173	1173	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
954	30473	76-87-9	1174	1174	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
955	83393	175217-20-6	1175	1175	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
956	83398	865318-97-4	1176	1176	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
957	4045	121552-61-2	1177	1177	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
958	6751	110235-47-7	1178	1178	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
959	8674	53112-28-0	1179	1179	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
960	15353	2079-00-7	1180	1180	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
961	81419	6980-18-3	1181	1181	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
962	17076	57-92-1	1182	1182	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
963	27701	79-57-2	1183	1183	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
964	82040	124495-18-7	1184	1184	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
965	83555	189278-12-4	1185	1185	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
966	34759	74738-17-3	1186	1186	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
967	81763	131341-86-1	1187	1187	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
968	3656	84332-86-5	1188	1188	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1945	83341	76280-91-6	2165	2165	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
969	28909	36734-19-7	1189	1189	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
970	8450	32809-16-8	1190	1190	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
971		50471-44-8	1191	1191	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
972			1192	1192	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
973		17109-49-8	1193	1193	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
974		26087-47-8	1194	1194	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
975		13457-18-6	1195	1195	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
976		50512-35-1	1196	1196	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
977	17097	92-52-4	1197	1197	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
978	3628	2675-77-6	1198	1198	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
979	27864	99-30-9	1199	1199	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
980	34908	82-68-8	1200	1200	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
981	82044	117-18-0	1201	1201	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
982	81731	57018-04-9	1202	1202	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
983	81761	2593-15-9	1203	1203	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
984	83279	55406-53-6	1204	1204	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
985	82033	24579-73-5	1205	1205	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
986	82084	19622-08-3	1206	1206	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
987			1207	1207	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
988			1208	1208	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
989			1209	1209	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
990			1210	1210	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
991			1211	1211	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
992	83629		1212	1212	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
993		26644-46-2	1213	1213	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
994		88283-41-4	1214	1214	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
995		847749-37-5	1215	1215	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
996	4998	60168-88-9	1216	1216	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
997	7645	63284-71-9	1217	1217	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
998		35554-44-0	1218	1218	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
999		134074-64-9	1219	1219	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1000		101903-30-4	1220	1220	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1001		67747-09-5	1221	1221	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1002		68694-11-1	1222	1222	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1038	81736	88678-67-5	1258	1258	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
1003		60207-31-0	1223	1223	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1004		55179-31-2	1224	1224	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1005		116255-48-2	1225	1225	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1006		94361-06-5	1226	1226	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1007		119446-68-3	1227	1227	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1008		83657-18-5	1228	1228	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1009		133855-98-8	1229	1229	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1010		60207-93-4	1230	1230	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1011		114369-43-6	1231	1231	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1012		136426-54-5	1232	1232	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1039	7451	65472-88-0	1259	1259	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
1013		85509-19-9	1233	1233	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1014		76674-21-0	1234	1234	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1015		79983-71-4	1235	1235	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1016		86598-92-7	1236	1236	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1017		125225-28-7	1237	1237	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1018		125116-23-6	1238	1238	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1019		88671-89-0	1239	1239	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1020		66246-88-6	1240	1240	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1021		60207-90-1	1241	1241	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1022		149508-90-7	1242	1242	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1040	9448	91161-71-6	1260	1260	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
1023		107534-96-3	1243	1243	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1024		112281-77-3	1244	1244	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1025		43121-43-3	1245	1245	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1026		55219-65-3	1246	1246	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1027		131983-72-7	1247	1247	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1028		178928-70-6	1248	1248	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1029	83295	91315-15-0	1249	1249	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1030	81960	1593-77-7	1250	1250	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1031	50145	67564-91-4	1251	1251	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1032	9700	81412-43-3	1252	1252	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1033	81917	67306-00-7	1253	1253	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1034	83283	3478-94-2	1254	1254	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1035	9242	118134-30-8	1255	1255	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1036	81853	126833-17-8	1256	1256	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
1042		11113-80-7	1262	1262	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
1043	81848	110488-70-5	1263	1263	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1044	83428	211867-47-9	1264	1264	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1045	83663	868390-90-3	1265	1265	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1046	83601	413615-35-7	1266	1266	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1047	82023	140923-17-7	1267	1267	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1048	83610	283159-90-0	1268	1268	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1049	81802	374726-62-2	1269	1269	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1050	47617	27355-22-2	1270	1270	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
1051	45141	57369-32-1	1271	1271	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
1052	81783	41814-78-2	1272	1272	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
1053		104030-54-8	1273	1273	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
1054		139920-32-4	1274	1274	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
1055		115852-48-7	1275	1275	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
1056		135158-54-2	1276	1276	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
1057		27605-76-1	1277	1277	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
1058	81825	223580-51-6	1278	1278	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
1059	83657	224049-04-1	1279	1279	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
1060		9008-22-4	1280	1280	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
1061			1281	1281	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
1062		57966-95-7	1282	1282	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
1063		39148-24-8	1283	1283	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
1064		13598-36-2	1284	1284	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
1065	83341	76280-91-6	1285	1285	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
1066	83335	72459-58-6	1286	1286	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
1067	81801	106917-52-6	1287	1287	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
1068	81759	62865-36-5	1288	1288	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
1069	81933	66952-49-6	1289	1289	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
1070	81797	180409-60-3	1290	1290	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
1071	83345	220899-03-6	1291	1291	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1072	83346	688046-61-9	1292	1292	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1073	74889	2439-10-3	1293	1293	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
1074	83277	958647-10-4	1294	1294	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
1075	81844	89269-64-7	1295	1295	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
1076	83268	1003318-67-9	1296	1296	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
1077	83266	376645-78-2	1297	1297	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
1078			1298	1298	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
1079		7440-50-8	1299	1299	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1080	17909	7704-34-9	1300	1300	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1081	5015	14484-64-1	1301	1301	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1082	52492	8018-01-7	1302	1302	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1083	52497	12427-38-2	1303	1303	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1084	81539	9006-42-2	1304	1304	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1085	81755	12071-83-9	1305	1305	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1086	9495	137-26-8	1306	1306	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1087	52498	12122-67-7	1307	1307	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1088	79736	137-30-4	1308	1308	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1089	34608	133-06-2	1309	1309	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1090	81938	2425-06-1	1310	1310	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1091	82019	133-07-3	1311	1311	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1092	3639	1897-45-6	1312	1312	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1093	74875	1085-98-9	1313	1313	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1094	75182	731-27-1	1314	1314	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1095	82843	108173-90-6	1315	1315	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1096	5569	13516-27-3	1316	1316	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1097	82076	101-05-3	1317	1317	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1098	81842	3347-22-6	1318	1318	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1099	34620	2439-01-2	1319	1319	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1100	81826	41205-21-4	1320	1320	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1101	3009	71626-11-4	1321	1321	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1102	82779	98243-83-5	1322	1322	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1103	5194	57646-30-7	1323	1323	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1104	6790	57837-19-1	1324	1324	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1105	60607	70630-17-0	1325	1325	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1106	81937	77732-09-3	1326	1326	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1946	83335	72459-58-6	2166	2166	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
1107	81969	58810-48-3	1327	1327	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1108	81952	41483-43-6	1328	1328	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1109	81958	5221-53-4	1329	1329	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1110	81989	23947-60-6	1330	1330	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1111	5827	10004-44-1	1331	1331	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
1112	81936	26530-20-1	1332	1332	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
1113	138856	14698-29-4	1333	1333	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
1114	3015	17804-35-2	1334	1334	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1115	3392	10605-21-7	1335	1335	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1116	81926	3878-19-1	1336	1336	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1117	45979	148-79-8	1337	1337	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1118	82060	23564-06-9	1338	1338	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1119	35014	23564-05-8	1339	1339	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1120	4520	87130-20-9	1340	1340	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
1121	82048	156052-68-5	1341	1341	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
1122	82856	162650-77-3	1342	1342	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
1123	7957	66063-05-6	1343	1343	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
1124	81764	239110-15-7	1344	1344	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
1125	82860	130339-07-0	1345	1345	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
1126	38628	129558-76-5	1346	1346	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
1127	82052	15310-01-7	1347	1347	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1128	81792	66332-96-5	1348	1348	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1129	81823	55814-41-0	1349	1349	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1130	83065	875915-78-9	1350	1350	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1299		7440-50-8	1519	1519	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1131	83070	658066-35-4	1351	1351	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1132	81994	24691-80-3	1352	1352	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1133	3405	5234-68-4	1353	1353	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1134	7858	5259-88-1	1354	1354	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1135	81794	130000-40-7	1355	1355	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1136	83092	1072957-71-1	1356	1356	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1137	83106	581809-46-3	1357	1357	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1138	83113	907204-31-3	1358	1358	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1139	81793	123572-88-3	1359	1359	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1140	83126	881685-58-1	1360	1360	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1141	83134	494793-67-8	1361	1361	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1142	81777	183675-82-3	1362	1362	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1143	83173	874967-67-6	1363	1363	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1144	81822	188425-85-6	1364	1364	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1145	40909	131860-33-8	1365	1365	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1146	83185	850881-70-8	1366	1366	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1147	83187	238410-11-2	1367	1367	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1148	83194	918162-02-4	1368	1368	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1149	83197	117428-22-5	1369	1369	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1150	83202	862588-11-2	1370	1370	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1151	83205	173662-97-0	1371	1371	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1152	78780	175013-18-0	1372	1372	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1153	83212	915410-70-7	1373	1373	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1154	83213	902760-40-1	1374	1374	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1155	2962	143390-89-0	1375	1375	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1156	81833	141517-21-7	1376	1376	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1157	83218	149961-52-4	1377	1377	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1158	83220	366815-39-6	1378	1378	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1159	81831	133408-50-1	1379	1379	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1160	81832	248593-16-0	1380	1380	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1161	59340	131807-57-3	1381	1381	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1162	83253	361377-29-9	1382	1382	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1163	83258	161326-34-7	1383	1383	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1164	83261	799247-52-2	1384	1384	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1165	81841	120116-88-3	1385	1385	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
1166	81846	348635-87-0	1386	1386	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
1167	82153	485-31-4	1387	1387	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
1168	83372	131-72-6	1388	1388	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
1169	83379	39300-45-3	1389	1389	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
1170	81843	79622-59-6	1390	1390	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
1171	81844	89269-64-7	1391	1391	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
1172	81918	900-95-8	1392	1392	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
1173	35036	639-58-7	1393	1393	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
1174	30473	76-87-9	1394	1394	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
1175	83393	175217-20-6	1395	1395	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
1176	83398	865318-97-4	1396	1396	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
1177	4045	121552-61-2	1397	1397	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1178	6751	110235-47-7	1398	1398	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1179	8674	53112-28-0	1399	1399	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1180	15353	2079-00-7	1400	1400	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
1181	81419	6980-18-3	1401	1401	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
1182	17076	57-92-1	1402	1402	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
1183	27701	79-57-2	1403	1403	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
1184	82040	124495-18-7	1404	1404	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
1185	83555	189278-12-4	1405	1405	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
1186	34759	74738-17-3	1406	1406	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
1187	81763	131341-86-1	1407	1407	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
1188	3656	84332-86-5	1408	1408	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1189	28909	36734-19-7	1409	1409	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1190	8450	32809-16-8	1410	1410	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1191		50471-44-8	1411	1411	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1192			1412	1412	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
1193		17109-49-8	1413	1413	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1947	81801	106917-52-6	2167	2167	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
1194		26087-47-8	1414	1414	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1195		13457-18-6	1415	1415	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1196		50512-35-1	1416	1416	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1197	17097	92-52-4	1417	1417	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1198	3628	2675-77-6	1418	1418	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1199	27864	99-30-9	1419	1419	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1200	34908	82-68-8	1420	1420	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1201	82044	117-18-0	1421	1421	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1202	81731	57018-04-9	1422	1422	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1203	81761	2593-15-9	1423	1423	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1204	83279	55406-53-6	1424	1424	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
1205	82033	24579-73-5	1425	1425	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
1206	82084	19622-08-3	1426	1426	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
1207			1427	1427	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
1208			1428	1428	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1209			1429	1429	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1210			1430	1430	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1211			1431	1431	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1212	83629		1432	1432	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
1213		26644-46-2	1433	1433	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1214		88283-41-4	1434	1434	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1948	81759	62865-36-5	2168	2168	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
1215		847749-37-5	1435	1435	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1216	4998	60168-88-9	1436	1436	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1217	7645	63284-71-9	1437	1437	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1218		35554-44-0	1438	1438	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1219		134074-64-9	1439	1439	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1220		101903-30-4	1440	1440	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1221		67747-09-5	1441	1441	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1222		68694-11-1	1442	1442	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1223		60207-31-0	1443	1443	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1224		55179-31-2	1444	1444	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1300	17909	7704-34-9	1520	1520	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1225		116255-48-2	1445	1445	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1226		94361-06-5	1446	1446	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1227		119446-68-3	1447	1447	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1228		83657-18-5	1448	1448	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1229		133855-98-8	1449	1449	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1230		60207-93-4	1450	1450	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1231		114369-43-6	1451	1451	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1232		136426-54-5	1452	1452	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1233		85509-19-9	1453	1453	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1234		76674-21-0	1454	1454	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1331	5827	10004-44-1	1551	1551	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
1235		79983-71-4	1455	1455	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1236		86598-92-7	1456	1456	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1237		125225-28-7	1457	1457	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1238		125116-23-6	1458	1458	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1239		88671-89-0	1459	1459	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1240		66246-88-6	1460	1460	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1241		60207-90-1	1461	1461	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1242		149508-90-7	1462	1462	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1243		107534-96-3	1463	1463	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1244		112281-77-3	1464	1464	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1332	81936	26530-20-1	1552	1552	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
1245		43121-43-3	1465	1465	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1246		55219-65-3	1466	1466	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1247		131983-72-7	1467	1467	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1248		178928-70-6	1468	1468	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1249	83295	91315-15-0	1469	1469	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1250	81960	1593-77-7	1470	1470	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1251	50145	67564-91-4	1471	1471	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1252	9700	81412-43-3	1472	1472	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1253	81917	67306-00-7	1473	1473	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1254	83283	3478-94-2	1474	1474	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1255	9242	118134-30-8	1475	1475	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1256	81853	126833-17-8	1476	1476	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
1257	83327	473798-59-3	1477	1477	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
1258	81736	88678-67-5	1478	1478	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
1259	7451	65472-88-0	1479	1479	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
1260	9448	91161-71-6	1480	1480	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
1261		37248-47-8	1481	1481	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
1262		11113-80-7	1482	1482	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
1263	81848	110488-70-5	1483	1483	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1264	83428	211867-47-9	1484	1484	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1265	83663	868390-90-3	1485	1485	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1266	83601	413615-35-7	1486	1486	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1267	82023	140923-17-7	1487	1487	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1268	83610	283159-90-0	1488	1488	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1269	81802	374726-62-2	1489	1489	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1270	47617	27355-22-2	1490	1490	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
1271	45141	57369-32-1	1491	1491	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
1272	81783	41814-78-2	1492	1492	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
1273		104030-54-8	1493	1493	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
1274		139920-32-4	1494	1494	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
1275		115852-48-7	1495	1495	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
1276		135158-54-2	1496	1496	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
1277		27605-76-1	1497	1497	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
1278	81825	223580-51-6	1498	1498	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
1279	83657	224049-04-1	1499	1499	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
1280		9008-22-4	1500	1500	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
1281			1501	1501	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
1282		57966-95-7	1502	1502	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
1283		39148-24-8	1503	1503	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
1284		13598-36-2	1504	1504	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
1285	83341	76280-91-6	1505	1505	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
1286	83335	72459-58-6	1506	1506	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
1287	81801	106917-52-6	1507	1507	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
1288	81759	62865-36-5	1508	1508	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
1289	81933	66952-49-6	1509	1509	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
1290	81797	180409-60-3	1510	1510	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
1291	83345	220899-03-6	1511	1511	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1292	83346	688046-61-9	1512	1512	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1293	74889	2439-10-3	1513	1513	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
1294	83277	958647-10-4	1514	1514	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
1295	81844	89269-64-7	1515	1515	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
1296	83268	1003318-67-9	1516	1516	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
1297	83266	376645-78-2	1517	1517	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
1298			1518	1518	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
1949	81933	66952-49-6	2169	2169	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
1301	5015	14484-64-1	1521	1521	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1302	52492	8018-01-7	1522	1522	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1303	52497	12427-38-2	1523	1523	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1304	81539	9006-42-2	1524	1524	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1305	81755	12071-83-9	1525	1525	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1306	9495	137-26-8	1526	1526	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1307	52498	12122-67-7	1527	1527	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1308	79736	137-30-4	1528	1528	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1309	34608	133-06-2	1529	1529	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1310	81938	2425-06-1	1530	1530	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1311	82019	133-07-3	1531	1531	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1312	3639	1897-45-6	1532	1532	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1313	74875	1085-98-9	1533	1533	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1314	75182	731-27-1	1534	1534	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1315	82843	108173-90-6	1535	1535	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1316	5569	13516-27-3	1536	1536	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1317	82076	101-05-3	1537	1537	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1318	81842	3347-22-6	1538	1538	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1319	34620	2439-01-2	1539	1539	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1320	81826	41205-21-4	1540	1540	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1321	3009	71626-11-4	1541	1541	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1322	82779	98243-83-5	1542	1542	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1323	5194	57646-30-7	1543	1543	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1324	6790	57837-19-1	1544	1544	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1325	60607	70630-17-0	1545	1545	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1326	81937	77732-09-3	1546	1546	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1327	81969	58810-48-3	1547	1547	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1328	81952	41483-43-6	1548	1548	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1329	81958	5221-53-4	1549	1549	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1330	81989	23947-60-6	1550	1550	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1333	138856	14698-29-4	1553	1553	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
1334	3015	17804-35-2	1554	Systemic	1554	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1335	3392	10605-21-7	1555	Systemic	1555	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1336	81926	3878-19-1	1556	1556	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1337	45979	148-79-8	1557	1557	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1338	82060	23564-06-9	1558	1558	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1339	35014	23564-05-8	1559	Systemic	1559	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1340	4520	87130-20-9	1560	Systemic	1560	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
1341	82048	156052-68-5	1561	1561	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
1342	82856	162650-77-3	1562	1562	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
1343	7957	66063-05-6	1563	1563	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
1344	81764	239110-15-7	1564	1564	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
1345	82860	130339-07-0	1565	1565	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
1346	38628	129558-76-5	1566	1566	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
1347	82052	15310-01-7	1567	1567	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1348	81792	66332-96-5	1568	1568	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1349	81823	55814-41-0	1569	1569	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1350	83065	875915-78-9	1570	1570	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1351	83070	658066-35-4	1571	1571	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1352	81994	24691-80-3	1572	1572	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1353	3405	5234-68-4	1573	Systemic	1573	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1392	81918	900-95-8	1612	1612	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
1354	7858	5259-88-1	1574	1574	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1355	81794	130000-40-7	1575	1575	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1356	83092	1072957-71-1	1576	1576	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1357	83106	581809-46-3	1577	1577	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1358	83113	907204-31-3	1578	1578	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1359	81793	123572-88-3	1579	1579	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1360	83126	881685-58-1	1580	1580	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1361	83134	494793-67-8	1581	1581	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1362	81777	183675-82-3	1582	1582	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1363	83173	874967-67-6	1583	1583	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1364	81822	188425-85-6	1584	1584	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1365	40909	131860-33-8	1585	Preventive, curative, and systemic	1585	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1366	83185	850881-70-8	1586	1586	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1367	83187	238410-11-2	1587	1587	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1368	83194	918162-02-4	1588	1588	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1369	83197	117428-22-5	1589	1589	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1370	83202	862588-11-2	1590	1590	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1371	83205	173662-97-0	1591	1591	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1372	78780	175013-18-0	1592	1592	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1373	83212	915410-70-7	1593	1593	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1374	83213	902760-40-1	1594	1594	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1375	2962	143390-89-0	1595	1595	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1376	81833	141517-21-7	1596	1596	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1377	83218	149961-52-4	1597	1597	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1378	83220	366815-39-6	1598	1598	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1379	81831	133408-50-1	1599	1599	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1380	81832	248593-16-0	1600	1600	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1381	59340	131807-57-3	1601	1601	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1382	83253	361377-29-9	1602	1602	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1383	83258	161326-34-7	1603	1603	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1384	83261	799247-52-2	1604	1604	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1385	81841	120116-88-3	1605	1605	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
1386	81846	348635-87-0	1606	1606	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
1387	82153	485-31-4	1607	1607	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
1388	83372	131-72-6	1608	1608	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
1389	83379	39300-45-3	1609	1609	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
1390	81843	79622-59-6	1610	1610	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
1391	81844	89269-64-7	1611	1611	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
1393	35036	639-58-7	1613	1613	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
1394	30473	76-87-9	1614	1614	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
1395	83393	175217-20-6	1615	1615	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
1396	83398	865318-97-4	1616	1616	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
1397	4045	121552-61-2	1617	1617	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1398	6751	110235-47-7	1618	1618	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1399	8674	53112-28-0	1619	1619	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1400	15353	2079-00-7	1620	1620	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
1401	81419	6980-18-3	1621	1621	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
1402	17076	57-92-1	1622	1622	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
1403	27701	79-57-2	1623	1623	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
1404	82040	124495-18-7	1624	1624	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
1405	83555	189278-12-4	1625	1625	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
1406	34759	74738-17-3	1626	1626	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
1407	81763	131341-86-1	1627	1627	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
1408	3656	84332-86-5	1628	1628	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1409	28909	36734-19-7	1629	Preventive, early curative, and systemic	1629	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1410	8450	32809-16-8	1630	1630	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1411		50471-44-8	1631	1631	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1412			1632	1632	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
1413		17109-49-8	1633	1633	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1414		26087-47-8	1634	1634	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1415		13457-18-6	1635	1635	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1416		50512-35-1	1636	1636	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1417	17097	92-52-4	1637	1637	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1418	3628	2675-77-6	1638	1638	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1419	27864	99-30-9	1639	1639	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1420	34908	82-68-8	1640	1640	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1421	82044	117-18-0	1641	1641	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1422	81731	57018-04-9	1642	1642	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1423	81761	2593-15-9	1643	1643	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1424	83279	55406-53-6	1644	1644	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
1425	82033	24579-73-5	1645	1645	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
1426	82084	19622-08-3	1646	1646	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
1427			1647	1647	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
1428			1648	1648	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1429			1649	1649	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1430			1650	1650	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1431			1651	1651	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1432	83629		1652	1652	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
1433		26644-46-2	1653	1653	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1434		88283-41-4	1654	1654	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1435		847749-37-5	1655	1655	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1436	4998	60168-88-9	1656	1656	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4161		39148-24-8	4363	4363	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
1437	7645	63284-71-9	1657	1657	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1438		35554-44-0	1658	1658	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1439		134074-64-9	1659	1659	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1440		101903-30-4	1660	1660	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1441		67747-09-5	1661	1661	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1442		68694-11-1	1662	1662	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1443		60207-31-0	1663	1663	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1444		55179-31-2	1664	1664	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1445		116255-48-2	1665	1665	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1446		94361-06-5	1666	1666	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1710	47617	27355-22-2	1930	1930	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
1447		119446-68-3	1667	1667	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1448		83657-18-5	1668	1668	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1449		133855-98-8	1669	1669	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1450		60207-93-4	1670	1670	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1451		114369-43-6	1671	1671	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1452		136426-54-5	1672	1672	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1453		85509-19-9	1673	1673	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1454		76674-21-0	1674	1674	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1455		79983-71-4	1675	1675	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1456		86598-92-7	1676	1676	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1711	45141	57369-32-1	1931	1931	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
1457		125225-28-7	1677	1677	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1458		125116-23-6	1678	1678	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1459		88671-89-0	1679	1679	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1460		66246-88-6	1680	1680	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1461		60207-90-1	1681	1681	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1462		149508-90-7	1682	1682	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1463		107534-96-3	1683	1683	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1464		112281-77-3	1684	1684	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1465		43121-43-3	1685	1685	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1466		55219-65-3	1686	1686	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1712	81783	41814-78-2	1932	1932	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
1467		131983-72-7	1687	1687	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1468		178928-70-6	1688	1688	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1469	83295	91315-15-0	1689	Systemic	1689	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1470	81960	1593-77-7	1690	Systemic	1690	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1471	50145	67564-91-4	1691	Systemic	1691	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1472	9700	81412-43-3	1692	Systemic	1692	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1473	81917	67306-00-7	1693	Systemic	1693	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1474	83283	3478-94-2	1694	1694	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1475	9242	118134-30-8	1695	Systemic	1695	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1476	81853	126833-17-8	1696	Locally systemic	1696	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
1477	83327	473798-59-3	1697	1697	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
1478	81736	88678-67-5	1698	Systemic	1698	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
1479	7451	65472-88-0	1699	Various	1699	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
1480	9448	91161-71-6	1700	Various	1700	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
1481		37248-47-8	1701	1701	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
1482		11113-80-7	1702	1702	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
1483	81848	110488-70-5	1703	1703	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1484	83428	211867-47-9	1704	1704	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1485	83663	868390-90-3	1705	1705	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1486	83601	413615-35-7	1706	1706	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1487	82023	140923-17-7	1707	1707	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1488	83610	283159-90-0	1708	1708	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1489	81802	374726-62-2	1709	1709	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1490	47617	27355-22-2	1710	1710	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
1491	45141	57369-32-1	1711	1711	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
1492	81783	41814-78-2	1712	1712	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
1493		104030-54-8	1713	1713	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
1494		139920-32-4	1714	1714	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
1495		115852-48-7	1715	1715	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
1496		135158-54-2	1716	1716	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
1497		27605-76-1	1717	1717	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
1498	81825	223580-51-6	1718	1718	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
1499	83657	224049-04-1	1719	1719	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
1500		9008-22-4	1720	1720	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
1501			1721	1721	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
1502		57966-95-7	1722	1722	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
1503		39148-24-8	1723	1723	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
1504		13598-36-2	1724	1724	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
1505	83341	76280-91-6	1725	1725	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
1506	83335	72459-58-6	1726	1726	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
1507	81801	106917-52-6	1727	1727	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
1508	81759	62865-36-5	1728	1728	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
1509	81933	66952-49-6	1729	1729	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
1510	81797	180409-60-3	1730	1730	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
1511	83345	220899-03-6	1731	1731	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1512	83346	688046-61-9	1732	1732	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1513	74889	2439-10-3	1733	1733	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
1514	83277	958647-10-4	1734	1734	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
1515	81844	89269-64-7	1735	1735	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
1516	83268	1003318-67-9	1736	1736	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
1517	83266	376645-78-2	1737	1737	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
1518			1738	1738	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
1519		7440-50-8	1739	1739	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1520	17909	7704-34-9	1740	1740	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1521	5015	14484-64-1	1741	1741	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1522	52492	8018-01-7	1742	1742	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1523	52497	12427-38-2	1743	1743	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1524	81539	9006-42-2	1744	1744	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1525	81755	12071-83-9	1745	1745	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1526	9495	137-26-8	1746	1746	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1527	52498	12122-67-7	1747	1747	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1528	79736	137-30-4	1748	1748	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1529	34608	133-06-2	1749	1749	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1530	81938	2425-06-1	1750	1750	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1531	82019	133-07-3	1751	1751	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1532	3639	1897-45-6	1752	1752	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1533	74875	1085-98-9	1753	1753	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1534	75182	731-27-1	1754	1754	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1535	82843	108173-90-6	1755	1755	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1536	5569	13516-27-3	1756	1756	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1537	82076	101-05-3	1757	1757	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1538	81842	3347-22-6	1758	1758	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1539	34620	2439-01-2	1759	1759	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1540	81826	41205-21-4	1760	1760	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1541	3009	71626-11-4	1761	1761	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1542	82779	98243-83-5	1762	1762	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1543	5194	57646-30-7	1763	1763	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1544	6790	57837-19-1	1764	1764	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1545	60607	70630-17-0	1765	1765	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1546	81937	77732-09-3	1766	1766	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1547	81969	58810-48-3	1767	1767	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1548	81952	41483-43-6	1768	1768	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1549	81958	5221-53-4	1769	1769	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1550	81989	23947-60-6	1770	1770	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1551	5827	10004-44-1	1771	1771	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
1552	81936	26530-20-1	1772	1772	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
1553	138856	14698-29-4	1773	1773	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
1554	3015	17804-35-2	1774	Systemic	1774	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1555	3392	10605-21-7	1775	Systemic	1775	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1556	81926	3878-19-1	1776	1776	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1557	45979	148-79-8	1777	1777	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1558	82060	23564-06-9	1778	1778	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1559	35014	23564-05-8	1779	Systemic	1779	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1560	4520	87130-20-9	1780	Systemic	1780	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
1561	82048	156052-68-5	1781	1781	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
1562	82856	162650-77-3	1782	1782	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
1563	7957	66063-05-6	1783	1783	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
1564	81764	239110-15-7	1784	1784	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
1565	82860	130339-07-0	1785	1785	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
1566	38628	129558-76-5	1786	1786	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
1567	82052	15310-01-7	1787	1787	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1568	81792	66332-96-5	1788	1788	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1569	81823	55814-41-0	1789	1789	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1570	83065	875915-78-9	1790	1790	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1571	83070	658066-35-4	1791	1791	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1572	81994	24691-80-3	1792	1792	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1573	3405	5234-68-4	1793	Systemic	1793	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1574	7858	5259-88-1	1794	1794	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1575	81794	130000-40-7	1795	1795	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1576	83092	1072957-71-1	1796	1796	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1577	83106	581809-46-3	1797	1797	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1578	83113	907204-31-3	1798	1798	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1579	81793	123572-88-3	1799	1799	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1580	83126	881685-58-1	1800	1800	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1581	83134	494793-67-8	1801	1801	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1582	81777	183675-82-3	1802	1802	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1583	83173	874967-67-6	1803	1803	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1584	81822	188425-85-6	1804	1804	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1585	40909	131860-33-8	1805	Preventive, curative, and systemic	1805	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1586	83185	850881-70-8	1806	1806	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1587	83187	238410-11-2	1807	1807	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1588	83194	918162-02-4	1808	1808	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1589	83197	117428-22-5	1809	1809	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1590	83202	862588-11-2	1810	1810	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1591	83205	173662-97-0	1811	1811	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1592	78780	175013-18-0	1812	1812	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1593	83212	915410-70-7	1813	1813	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1594	83213	902760-40-1	1814	1814	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1595	2962	143390-89-0	1815	1815	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1596	81833	141517-21-7	1816	1816	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1597	83218	149961-52-4	1817	1817	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1598	83220	366815-39-6	1818	1818	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1599	81831	133408-50-1	1819	1819	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1600	81832	248593-16-0	1820	1820	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1601	59340	131807-57-3	1821	1821	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1602	83253	361377-29-9	1822	1822	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1603	83258	161326-34-7	1823	1823	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1604	83261	799247-52-2	1824	1824	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1605	81841	120116-88-3	1825	1825	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
1606	81846	348635-87-0	1826	1826	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
1607	82153	485-31-4	1827	1827	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
1608	83372	131-72-6	1828	1828	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
1609	83379	39300-45-3	1829	1829	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
1610	81843	79622-59-6	1830	1830	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
1611	81844	89269-64-7	1831	1831	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
1612	81918	900-95-8	1832	1832	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
1613	35036	639-58-7	1833	1833	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
1614	30473	76-87-9	1834	1834	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
1615	83393	175217-20-6	1835	1835	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
1616	83398	865318-97-4	1836	1836	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
1617	4045	121552-61-2	1837	1837	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1618	6751	110235-47-7	1838	1838	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1619	8674	53112-28-0	1839	1839	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1620	15353	2079-00-7	1840	1840	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
1621	81419	6980-18-3	1841	1841	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
1622	17076	57-92-1	1842	1842	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
1623	27701	79-57-2	1843	1843	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
1624	82040	124495-18-7	1844	1844	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
1625	83555	189278-12-4	1845	1845	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
1626	34759	74738-17-3	1846	1846	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
1627	81763	131341-86-1	1847	1847	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
1628	3656	84332-86-5	1848	1848	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1629	28909	36734-19-7	1849	Preventive, early curative, and systemic	1849	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1630	8450	32809-16-8	1850	1850	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1631		50471-44-8	1851	1851	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1632			1852	1852	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
1633		17109-49-8	1853	1853	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1634		26087-47-8	1854	1854	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1635		13457-18-6	1855	1855	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1636		50512-35-1	1856	1856	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1637	17097	92-52-4	1857	1857	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1638	3628	2675-77-6	1858	1858	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1639	27864	99-30-9	1859	1859	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1640	34908	82-68-8	1860	1860	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1641	82044	117-18-0	1861	1861	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1642	81731	57018-04-9	1862	1862	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1643	81761	2593-15-9	1863	1863	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1644	83279	55406-53-6	1864	1864	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
1645	82033	24579-73-5	1865	1865	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
1646	82084	19622-08-3	1866	1866	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
1647			1867	1867	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
1648			1868	1868	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1649			1869	1869	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1650			1870	1870	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1651			1871	1871	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1652	83629		1872	1872	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
1653		26644-46-2	1873	1873	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1654		88283-41-4	1874	1874	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1655		847749-37-5	1875	1875	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1656	4998	60168-88-9	1876	1876	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1657	7645	63284-71-9	1877	1877	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1658		35554-44-0	1878	1878	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1659		134074-64-9	1879	1879	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1660		101903-30-4	1880	1880	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1661		67747-09-5	1881	1881	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1662		68694-11-1	1882	1882	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1663		60207-31-0	1883	1883	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1664		55179-31-2	1884	1884	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1665		116255-48-2	1885	1885	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1666		94361-06-5	1886	1886	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1667		119446-68-3	1887	1887	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1941			2161	2161	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
1668		83657-18-5	1888	1888	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1669		133855-98-8	1889	1889	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1670		60207-93-4	1890	1890	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1671		114369-43-6	1891	1891	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1672		136426-54-5	1892	1892	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1673		85509-19-9	1893	1893	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1674		76674-21-0	1894	1894	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1675		79983-71-4	1895	1895	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1676		86598-92-7	1896	1896	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1677		125225-28-7	1897	1897	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1942		57966-95-7	2162	2162	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
1678		125116-23-6	1898	1898	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1679		88671-89-0	1899	1899	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1680		66246-88-6	1900	1900	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1681		60207-90-1	1901	1901	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1682		149508-90-7	1902	1902	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1683		107534-96-3	1903	1903	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1684		112281-77-3	1904	1904	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1685		43121-43-3	1905	1905	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1686		55219-65-3	1906	1906	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1687		131983-72-7	1907	1907	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1750	81938	2425-06-1	1970	1970	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1688		178928-70-6	1908	1908	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1689	83295	91315-15-0	1909	Systemic	1909	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1690	81960	1593-77-7	1910	Systemic	1910	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1691	50145	67564-91-4	1911	Systemic	1911	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1692	9700	81412-43-3	1912	Systemic	1912	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1693	81917	67306-00-7	1913	Systemic	1913	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1694	83283	3478-94-2	1914	1914	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1695	9242	118134-30-8	1915	Systemic	1915	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1696	81853	126833-17-8	1916	Locally systemic	1916	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
1697	83327	473798-59-3	1917	1917	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
1698	81736	88678-67-5	1918	Systemic	1918	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
1699	7451	65472-88-0	1919	Various	1919	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
1700	9448	91161-71-6	1920	Various	1920	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
1701		37248-47-8	1921	1921	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
1702		11113-80-7	1922	1922	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
1703	81848	110488-70-5	1923	1923	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1704	83428	211867-47-9	1924	1924	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1705	83663	868390-90-3	1925	1925	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1706	83601	413615-35-7	1926	1926	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1707	82023	140923-17-7	1927	1927	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1708	83610	283159-90-0	1928	1928	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1709	81802	374726-62-2	1929	1929	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1713		104030-54-8	1933	1933	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
1714		139920-32-4	1934	1934	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
1715		115852-48-7	1935	1935	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
1716		135158-54-2	1936	1936	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
1717		27605-76-1	1937	1937	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
1718	81825	223580-51-6	1938	1938	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
1719	83657	224049-04-1	1939	1939	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
1720		9008-22-4	1940	1940	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
1721			1941	1941	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
1722		57966-95-7	1942	1942	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
1723		39148-24-8	1943	1943	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
1724		13598-36-2	1944	1944	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
1725	83341	76280-91-6	1945	1945	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
1726	83335	72459-58-6	1946	1946	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
1727	81801	106917-52-6	1947	1947	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
1728	81759	62865-36-5	1948	1948	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
1729	81933	66952-49-6	1949	1949	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
1730	81797	180409-60-3	1950	1950	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
1731	83345	220899-03-6	1951	1951	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1732	83346	688046-61-9	1952	1952	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1733	74889	2439-10-3	1953	1953	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
1734	83277	958647-10-4	1954	1954	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
1735	81844	89269-64-7	1955	1955	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
1736	83268	1003318-67-9	1956	1956	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
1737	83266	376645-78-2	1957	1957	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
1738			1958	1958	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
1739		7440-50-8	1959	1959	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1740	17909	7704-34-9	1960	1960	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1741	5015	14484-64-1	1961	1961	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1742	52492	8018-01-7	1962	1962	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1743	52497	12427-38-2	1963	1963	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1744	81539	9006-42-2	1964	1964	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1745	81755	12071-83-9	1965	1965	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1746	9495	137-26-8	1966	1966	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1747	52498	12122-67-7	1967	1967	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1748	79736	137-30-4	1968	1968	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1749	34608	133-06-2	1969	1969	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1751	82019	133-07-3	1971	1971	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1752	3639	1897-45-6	1972	1972	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1753	74875	1085-98-9	1973	1973	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1754	75182	731-27-1	1974	1974	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1755	82843	108173-90-6	1975	1975	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1756	5569	13516-27-3	1976	1976	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1757	82076	101-05-3	1977	1977	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1758	81842	3347-22-6	1978	1978	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1759	34620	2439-01-2	1979	1979	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1760	81826	41205-21-4	1980	1980	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1761	3009	71626-11-4	1981	1981	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1762	82779	98243-83-5	1982	1982	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1763	5194	57646-30-7	1983	1983	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1764	6790	57837-19-1	1984	1984	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1765	60607	70630-17-0	1985	1985	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1766	81937	77732-09-3	1986	1986	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1767	81969	58810-48-3	1987	1987	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1768	81952	41483-43-6	1988	1988	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1769	81958	5221-53-4	1989	1989	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1770	81989	23947-60-6	1990	1990	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1771	5827	10004-44-1	1991	1991	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
1772	81936	26530-20-1	1992	1992	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
1773	138856	14698-29-4	1993	1993	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
1774	3015	17804-35-2	1994	Systemic	1994	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1775	3392	10605-21-7	1995	Systemic	1995	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1776	81926	3878-19-1	1996	1996	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1777	45979	148-79-8	1997	1997	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1866	82084	19622-08-3	2086	2086	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
1778	82060	23564-06-9	1998	1998	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1779	35014	23564-05-8	1999	Systemic	1999	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1780	4520	87130-20-9	2000	Systemic	2000	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
1781	82048	156052-68-5	2001	2001	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
1782	82856	162650-77-3	2002	2002	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
1783	7957	66063-05-6	2003	2003	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
1784	81764	239110-15-7	2004	2004	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
1785	82860	130339-07-0	2005	2005	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
1786	38628	129558-76-5	2006	2006	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
1787	82052	15310-01-7	2007	2007	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1788	81792	66332-96-5	2008	2008	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1789	81823	55814-41-0	2009	2009	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1790	83065	875915-78-9	2010	2010	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1791	83070	658066-35-4	2011	2011	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1792	81994	24691-80-3	2012	2012	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1793	3405	5234-68-4	2013	Systemic	2013	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1794	7858	5259-88-1	2014	2014	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1795	81794	130000-40-7	2015	2015	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1796	83092	1072957-71-1	2016	2016	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1797	83106	581809-46-3	2017	2017	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1798	83113	907204-31-3	2018	2018	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1799	81793	123572-88-3	2019	2019	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1800	83126	881685-58-1	2020	2020	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1801	83134	494793-67-8	2021	2021	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1802	81777	183675-82-3	2022	2022	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1803	83173	874967-67-6	2023	2023	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1804	81822	188425-85-6	2024	2024	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
1805	40909	131860-33-8	2025	Preventive, curative, and systemic	2025	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1806	83185	850881-70-8	2026	2026	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1807	83187	238410-11-2	2027	2027	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1808	83194	918162-02-4	2028	2028	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1809	83197	117428-22-5	2029	2029	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1810	83202	862588-11-2	2030	2030	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1811	83205	173662-97-0	2031	2031	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1812	78780	175013-18-0	2032	2032	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1813	83212	915410-70-7	2033	2033	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1814	83213	902760-40-1	2034	2034	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1815	2962	143390-89-0	2035	2035	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1867			2087	2087	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
1816	81833	141517-21-7	2036	2036	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1817	83218	149961-52-4	2037	2037	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1818	83220	366815-39-6	2038	2038	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1819	81831	133408-50-1	2039	2039	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1820	81832	248593-16-0	2040	2040	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1821	59340	131807-57-3	2041	2041	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1822	83253	361377-29-9	2042	2042	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1823	83258	161326-34-7	2043	2043	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1824	83261	799247-52-2	2044	2044	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
1825	81841	120116-88-3	2045	2045	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
1826	81846	348635-87-0	2046	2046	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
1827	82153	485-31-4	2047	2047	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
1828	83372	131-72-6	2048	2048	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
1829	83379	39300-45-3	2049	2049	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
1830	81843	79622-59-6	2050	2050	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
1831	81844	89269-64-7	2051	2051	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
1832	81918	900-95-8	2052	2052	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
1833	35036	639-58-7	2053	2053	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
1834	30473	76-87-9	2054	2054	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
1835	83393	175217-20-6	2055	2055	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
1836	83398	865318-97-4	2056	2056	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
1837	4045	121552-61-2	2057	2057	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1838	6751	110235-47-7	2058	2058	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1839	8674	53112-28-0	2059	2059	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
1840	15353	2079-00-7	2060	2060	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
1841	81419	6980-18-3	2061	2061	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
1842	17076	57-92-1	2062	2062	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
1843	27701	79-57-2	2063	2063	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
1844	82040	124495-18-7	2064	2064	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
1845	83555	189278-12-4	2065	2065	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
1846	34759	74738-17-3	2066	2066	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
1847	81763	131341-86-1	2067	2067	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
1848	3656	84332-86-5	2068	2068	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1849	28909	36734-19-7	2069	Preventive, early curative, and systemic	2069	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1850	8450	32809-16-8	2070	2070	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1851		50471-44-8	2071	2071	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
1852			2072	2072	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
1853		17109-49-8	2073	2073	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1854		26087-47-8	2074	2074	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1855		13457-18-6	2075	2075	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1856		50512-35-1	2076	2076	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
1857	17097	92-52-4	2077	2077	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1858	3628	2675-77-6	2078	2078	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1859	27864	99-30-9	2079	2079	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1860	34908	82-68-8	2080	2080	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1861	82044	117-18-0	2081	2081	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1862	81731	57018-04-9	2082	2082	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1863	81761	2593-15-9	2083	2083	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
1864	83279	55406-53-6	2084	2084	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
1865	82033	24579-73-5	2085	2085	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
1868			2088	2088	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1869			2089	2089	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1870			2090	2090	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1871			2091	2091	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
1872	83629		2092	2092	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
1873		26644-46-2	2093	2093	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1874		88283-41-4	2094	2094	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1875		847749-37-5	2095	2095	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1876	4998	60168-88-9	2096	2096	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1877	7645	63284-71-9	2097	2097	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1878		35554-44-0	2098	2098	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1879		134074-64-9	2099	2099	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1937		27605-76-1	2157	2157	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
1880		101903-30-4	2100	2100	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1881		67747-09-5	2101	2101	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1882		68694-11-1	2102	2102	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1883		60207-31-0	2103	2103	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1884		55179-31-2	2104	2104	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1885		116255-48-2	2105	2105	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1886		94361-06-5	2106	2106	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1887		119446-68-3	2107	2107	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1888		83657-18-5	2108	2108	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1889		133855-98-8	2109	2109	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1938	81825	223580-51-6	2158	2158	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
1890		60207-93-4	2110	2110	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1891		114369-43-6	2111	2111	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1892		136426-54-5	2112	2112	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1893		85509-19-9	2113	2113	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1894		76674-21-0	2114	2114	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1895		79983-71-4	2115	2115	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1896		86598-92-7	2116	2116	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1897		125225-28-7	2117	2117	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1898		125116-23-6	2118	2118	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1899		88671-89-0	2119	2119	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1939	83657	224049-04-1	2159	2159	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
1900		66246-88-6	2120	2120	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1901		60207-90-1	2121	2121	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1902		149508-90-7	2122	2122	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1903		107534-96-3	2123	2123	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1904		112281-77-3	2124	2124	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1905		43121-43-3	2125	2125	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1906		55219-65-3	2126	2126	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1907		131983-72-7	2127	2127	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1908		178928-70-6	2128	2128	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
1909	83295	91315-15-0	2129	Systemic	2129	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1910	81960	1593-77-7	2130	Systemic	2130	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1911	50145	67564-91-4	2131	Systemic	2131	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1912	9700	81412-43-3	2132	Systemic	2132	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1913	81917	67306-00-7	2133	Systemic	2133	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1914	83283	3478-94-2	2134	2134	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1915	9242	118134-30-8	2135	Systemic	2135	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
1916	81853	126833-17-8	2136	Locally systemic	2136	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
1917	83327	473798-59-3	2137	2137	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
1918	81736	88678-67-5	2138	Systemic	2138	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
1919	7451	65472-88-0	2139	Various	2139	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
1920	9448	91161-71-6	2140	Various	2140	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
1921		37248-47-8	2141	2141	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
1922		11113-80-7	2142	2142	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
1923	81848	110488-70-5	2143	2143	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1924	83428	211867-47-9	2144	2144	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1925	83663	868390-90-3	2145	2145	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1926	83601	413615-35-7	2146	2146	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1927	82023	140923-17-7	2147	2147	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1928	83610	283159-90-0	2148	2148	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1929	81802	374726-62-2	2149	2149	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
1930	47617	27355-22-2	2150	2150	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
1931	45141	57369-32-1	2151	2151	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
1932	81783	41814-78-2	2152	2152	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
1933		104030-54-8	2153	2153	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
1934		139920-32-4	2154	2154	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
1935		115852-48-7	2155	2155	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
1936		135158-54-2	2156	2156	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
1940		9008-22-4	2160	2160	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
1950	81797	180409-60-3	2170	2170	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
1951	83345	220899-03-6	2171	2171	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1952	83346	688046-61-9	2172	2172	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
1953	74889	2439-10-3	2173	2173	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
1954	83277	958647-10-4	2174	2174	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
1955	81844	89269-64-7	2175	2175	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
1956	83268	1003318-67-9	2176	2176	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
1957	83266	376645-78-2	2177	2177	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
1958			2178	2178	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
1959		7440-50-8	2179	2179	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1960	17909	7704-34-9	2180	2180	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1961	5015	14484-64-1	2181	2181	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1962	52492	8018-01-7	2182	2182	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1963	52497	12427-38-2	2183	2183	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1964	81539	9006-42-2	2184	2184	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1965	81755	12071-83-9	2185	2185	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1966	9495	137-26-8	2186	2186	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1967	52498	12122-67-7	2187	2187	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1968	79736	137-30-4	2188	2188	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1969	34608	133-06-2	2189	2189	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1970	81938	2425-06-1	2190	2190	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1971	82019	133-07-3	2191	2191	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1972	3639	1897-45-6	2192	2192	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1973	74875	1085-98-9	2193	2193	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1974	75182	731-27-1	2194	2194	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1975	82843	108173-90-6	2195	2195	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1976	5569	13516-27-3	2196	2196	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1977	82076	101-05-3	2197	2197	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1978	81842	3347-22-6	2198	2198	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1979	34620	2439-01-2	2199	2199	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1980	81826	41205-21-4	2200	2200	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
1981	3009	71626-11-4	2201	2201	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2141		37248-47-8	2361	2361	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
1982	82779	98243-83-5	2202	2202	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1983	5194	57646-30-7	2203	2203	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1984	6790	57837-19-1	2204	2204	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1985	60607	70630-17-0	2205	2205	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1986	81937	77732-09-3	2206	2206	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1987	81969	58810-48-3	2207	2207	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
1988	81952	41483-43-6	2208	2208	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1989	81958	5221-53-4	2209	2209	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1990	81989	23947-60-6	2210	2210	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
1991	5827	10004-44-1	2211	2211	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
1992	81936	26530-20-1	2212	2212	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
1993	138856	14698-29-4	2213	2213	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
1994	3015	17804-35-2	2214	Systemic	2214	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1995	3392	10605-21-7	2215	Systemic	2215	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1996	81926	3878-19-1	2216	2216	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1997	45979	148-79-8	2217	2217	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1998	82060	23564-06-9	2218	2218	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
1999	35014	23564-05-8	2219	Systemic	2219	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2000	4520	87130-20-9	2220	Systemic	2220	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
2001	82048	156052-68-5	2221	2221	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
2002	82856	162650-77-3	2222	2222	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
2003	7957	66063-05-6	2223	2223	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
2004	81764	239110-15-7	2224	2224	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
2005	82860	130339-07-0	2225	2225	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
2006	38628	129558-76-5	2226	2226	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
2007	82052	15310-01-7	2227	2227	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3052		13598-36-2	3264	3264	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
2008	81792	66332-96-5	2228	2228	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2009	81823	55814-41-0	2229	2229	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2010	83065	875915-78-9	2230	2230	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2011	83070	658066-35-4	2231	2231	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2012	81994	24691-80-3	2232	2232	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2013	3405	5234-68-4	2233	Systemic	2233	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2014	7858	5259-88-1	2234	2234	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2015	81794	130000-40-7	2235	2235	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2016	83092	1072957-71-1	2236	2236	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2017	83106	581809-46-3	2237	2237	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2018	83113	907204-31-3	2238	2238	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2019	81793	123572-88-3	2239	2239	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2020	83126	881685-58-1	2240	2240	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2021	83134	494793-67-8	2241	2241	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2022	81777	183675-82-3	2242	2242	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2023	83173	874967-67-6	2243	2243	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2041	59340	131807-57-3	2261	2261	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2024	81822	188425-85-6	2244	2244	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2025	40909	131860-33-8	2245	Preventive, curative, and systemic	2245	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2026	83185	850881-70-8	2246	2246	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2027	83187	238410-11-2	2247	2247	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2028	83194	918162-02-4	2248	2248	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2029	83197	117428-22-5	2249	2249	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2030	83202	862588-11-2	2250	2250	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2031	83205	173662-97-0	2251	2251	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2032	78780	175013-18-0	2252	2252	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2033	83212	915410-70-7	2253	2253	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2034	83213	902760-40-1	2254	2254	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2035	2962	143390-89-0	2255	2255	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2036	81833	141517-21-7	2256	2256	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2037	83218	149961-52-4	2257	2257	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2038	83220	366815-39-6	2258	2258	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2039	81831	133408-50-1	2259	2259	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2040	81832	248593-16-0	2260	2260	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2137	83327	473798-59-3	2357	2357	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
2042	83253	361377-29-9	2262	2262	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2043	83258	161326-34-7	2263	2263	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2044	83261	799247-52-2	2264	2264	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2045	81841	120116-88-3	2265	2265	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
2046	81846	348635-87-0	2266	2266	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
2047	82153	485-31-4	2267	2267	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
2048	83372	131-72-6	2268	2268	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
2049	83379	39300-45-3	2269	2269	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
2050	81843	79622-59-6	2270	2270	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
2051	81844	89269-64-7	2271	2271	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
2052	81918	900-95-8	2272	2272	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
2053	35036	639-58-7	2273	2273	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
2054	30473	76-87-9	2274	2274	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
2055	83393	175217-20-6	2275	2275	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
2056	83398	865318-97-4	2276	2276	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
2057	4045	121552-61-2	2277	2277	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2058	6751	110235-47-7	2278	2278	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2059	8674	53112-28-0	2279	2279	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2060	15353	2079-00-7	2280	2280	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
2061	81419	6980-18-3	2281	2281	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
2062	17076	57-92-1	2282	2282	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
2063	27701	79-57-2	2283	2283	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
2064	82040	124495-18-7	2284	2284	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
2065	83555	189278-12-4	2285	2285	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
2066	34759	74738-17-3	2286	2286	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
2067	81763	131341-86-1	2287	2287	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
2068	3656	84332-86-5	2288	2288	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3053	83341	76280-91-6	3265	3265	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
2069	28909	36734-19-7	2289	Preventive, early curative, and systemic	2289	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2070	8450	32809-16-8	2290	2290	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2071		50471-44-8	2291	2291	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2072			2292	2292	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
2073		17109-49-8	2293	2293	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2074		26087-47-8	2294	2294	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2075		13457-18-6	2295	2295	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2076		50512-35-1	2296	2296	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2077	17097	92-52-4	2297	2297	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2078	3628	2675-77-6	2298	2298	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2079	27864	99-30-9	2299	2299	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2080	34908	82-68-8	2300	2300	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2081	82044	117-18-0	2301	2301	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2082	81731	57018-04-9	2302	2302	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2083	81761	2593-15-9	2303	2303	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2084	83279	55406-53-6	2304	2304	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
2085	82033	24579-73-5	2305	2305	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
2086	82084	19622-08-3	2306	2306	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
2087			2307	2307	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
2088			2308	2308	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2089			2309	2309	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2090			2310	2310	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2091			2311	2311	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2092	83629		2312	2312	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
2093		26644-46-2	2313	2313	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2094		88283-41-4	2314	2314	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2095		847749-37-5	2315	2315	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2096	4998	60168-88-9	2316	2316	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2097	7645	63284-71-9	2317	2317	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2098		35554-44-0	2318	2318	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2099		134074-64-9	2319	2319	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2100		101903-30-4	2320	2320	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2101		67747-09-5	2321	2321	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2102		68694-11-1	2322	2322	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2138	81736	88678-67-5	2358	Systemic	2358	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
2103		60207-31-0	2323	2323	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2104		55179-31-2	2324	2324	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2105		116255-48-2	2325	2325	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2106		94361-06-5	2326	2326	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2107		119446-68-3	2327	2327	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2108		83657-18-5	2328	2328	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2109		133855-98-8	2329	2329	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2110		60207-93-4	2330	2330	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2111		114369-43-6	2331	2331	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2112		136426-54-5	2332	2332	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2139	7451	65472-88-0	2359	Various	2359	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
2113		85509-19-9	2333	2333	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2114		76674-21-0	2334	2334	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2115		79983-71-4	2335	2335	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2116		86598-92-7	2336	2336	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2117		125225-28-7	2337	2337	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2118		125116-23-6	2338	2338	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2119		88671-89-0	2339	2339	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2120		66246-88-6	2340	2340	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2121		60207-90-1	2341	2341	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2122		149508-90-7	2342	2342	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2140	9448	91161-71-6	2360	Various	2360	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
2123		107534-96-3	2343	2343	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2124		112281-77-3	2344	2344	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2125		43121-43-3	2345	2345	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2126		55219-65-3	2346	2346	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2127		131983-72-7	2347	2347	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2128		178928-70-6	2348	2348	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2129	83295	91315-15-0	2349	Systemic	2349	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2130	81960	1593-77-7	2350	Systemic	2350	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2131	50145	67564-91-4	2351	Systemic	2351	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2132	9700	81412-43-3	2352	Systemic	2352	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2133	81917	67306-00-7	2353	Systemic	2353	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2134	83283	3478-94-2	2354	2354	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2135	9242	118134-30-8	2355	Systemic	2355	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2136	81853	126833-17-8	2356	Locally systemic	2356	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
2142		11113-80-7	2362	2362	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
2143	81848	110488-70-5	2363	2363	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2144	83428	211867-47-9	2364	2364	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2145	83663	868390-90-3	2365	2365	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2146	83601	413615-35-7	2366	2366	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2147	82023	140923-17-7	2367	2367	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2148	83610	283159-90-0	2368	2368	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2149	81802	374726-62-2	2369	2369	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2150	47617	27355-22-2	2370	2370	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
2151	45141	57369-32-1	2371	2371	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
2152	81783	41814-78-2	2372	2372	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
2153		104030-54-8	2373	2373	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
2154		139920-32-4	2374	2374	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
2155		115852-48-7	2375	2375	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
2156		135158-54-2	2376	2376	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
2157		27605-76-1	2377	2377	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
2158	81825	223580-51-6	2378	2378	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
2159	83657	224049-04-1	2379	2379	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
2160		9008-22-4	2380	2380	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
2161			2381	2381	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
2162		57966-95-7	2382	2382	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
2163		39148-24-8	2383	2383	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
2164		13598-36-2	2384	2384	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
2165	83341	76280-91-6	2385	2385	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
2166	83335	72459-58-6	2386	2386	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
2167	81801	106917-52-6	2387	2387	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
2168	81759	62865-36-5	2388	2388	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
2169	81933	66952-49-6	2389	2389	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
2170	81797	180409-60-3	2390	2390	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
2171	83345	220899-03-6	2391	2391	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
2172	83346	688046-61-9	2392	2392	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
2173	74889	2439-10-3	2393	2393	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
2174	83277	958647-10-4	2394	2394	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
2175	81844	89269-64-7	2395	2395	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
2176	83268	1003318-67-9	2396	2396	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
2177	83266	376645-78-2	2397	2397	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
2178			2398	2398	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
2179		7440-50-8	2399	2399	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2180	17909	7704-34-9	2400	2400	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2181	5015	14484-64-1	2401	2401	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2182	52492	8018-01-7	2402	2402	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2183	52497	12427-38-2	2403	2403	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2184	81539	9006-42-2	2404	2404	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2185	81755	12071-83-9	2405	2405	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2186	9495	137-26-8	2406	2406	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2187	52498	12122-67-7	2407	2407	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2188	79736	137-30-4	2408	2408	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2189	34608	133-06-2	2409	2409	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2190	81938	2425-06-1	2410	2410	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2191	82019	133-07-3	2411	2411	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2192	3639	1897-45-6	2412	2412	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2193	74875	1085-98-9	2413	2413	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2194	75182	731-27-1	2414	2414	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2195	82843	108173-90-6	2415	2415	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2196	5569	13516-27-3	2416	2416	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2197	82076	101-05-3	2417	2417	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2198	81842	3347-22-6	2418	2418	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2199	34620	2439-01-2	2419	2419	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2200	81826	41205-21-4	2420	2420	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2203	3009	71626-11-4	2421	2421	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2204	82779	98243-83-5	2422	2422	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2205	5194	57646-30-7	2423	2423	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2206	6790	57837-19-1	2424	2424	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2207	60607	70630-17-0	2425	2425	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2208	81937	77732-09-3	2426	2426	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3054	83335	72459-58-6	3266	3266	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
2209	81969	58810-48-3	2427	2427	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2210	81952	41483-43-6	2428	2428	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
2211	81958	5221-53-4	2429	2429	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
2212	81989	23947-60-6	2430	2430	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
2213	5827	10004-44-1	2431	2431	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
2214	81936	26530-20-1	2432	2432	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
2215	138856	14698-29-4	2433	2433	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
2216	3015	17804-35-2	2434	Systemic	2434	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2217	3392	10605-21-7	2435	Systemic	2435	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2218	81926	3878-19-1	2436	2436	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2219	45979	148-79-8	2437	2437	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2220	82060	23564-06-9	2438	2438	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2221	35014	23564-05-8	2439	Systemic	2439	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2222	4520	87130-20-9	2440	Systemic	2440	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
2223	82048	156052-68-5	2441	2441	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
2224	82856	162650-77-3	2442	2442	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
2225	7957	66063-05-6	2443	2443	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
2226	81764	239110-15-7	2444	2444	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
2227	82860	130339-07-0	2445	2445	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
2228	38628	129558-76-5	2446	2446	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
2229	82052	15310-01-7	2447	2447	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2230	81792	66332-96-5	2448	2448	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2231	81823	55814-41-0	2449	2449	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2232	83065	875915-78-9	2450	2450	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2401		7440-50-8	2619	2619	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2233	83070	658066-35-4	2451	2451	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2234	81994	24691-80-3	2452	2452	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2235	3405	5234-68-4	2453	Systemic	2453	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2236	7858	5259-88-1	2454	2454	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2237	81794	130000-40-7	2455	2455	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2238	83092	1072957-71-1	2456	2456	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2239	83106	581809-46-3	2457	2457	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2240	83113	907204-31-3	2458	2458	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2241	81793	123572-88-3	2459	2459	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2242	83126	881685-58-1	2460	2460	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2243	83134	494793-67-8	2461	2461	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2244	81777	183675-82-3	2462	2462	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2245	83173	874967-67-6	2463	2463	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2246	81822	188425-85-6	2464	2464	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2247	40909	131860-33-8	2465	Preventive, curative, and systemic	2465	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2248	83185	850881-70-8	2466	2466	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2249	83187	238410-11-2	2467	2467	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2250	83194	918162-02-4	2468	2468	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2251	83197	117428-22-5	2469	2469	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2252	83202	862588-11-2	2470	2470	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2253	83205	173662-97-0	2471	2471	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2254	78780	175013-18-0	2472	2472	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2255	83212	915410-70-7	2473	2473	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2256	83213	902760-40-1	2474	2474	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2257	2962	143390-89-0	2475	2475	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2258	81833	141517-21-7	2476	2476	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2259	83218	149961-52-4	2477	2477	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2260	83220	366815-39-6	2478	2478	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2261	81831	133408-50-1	2479	2479	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2262	81832	248593-16-0	2480	2480	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2263	59340	131807-57-3	2481	2481	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2264	83253	361377-29-9	2482	2482	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2265	83258	161326-34-7	2483	2483	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2266	83261	799247-52-2	2484	2484	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2267	81841	120116-88-3	2485	2485	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
2268	81846	348635-87-0	2486	2486	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
2269	82153	485-31-4	2487	2487	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
2270	83372	131-72-6	2488	2488	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
2271	83379	39300-45-3	2489	2489	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
2272	81843	79622-59-6	2490	2490	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
2273	81844	89269-64-7	2491	2491	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
2274	81918	900-95-8	2492	2492	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
2275	35036	639-58-7	2493	2493	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
2276	30473	76-87-9	2494	2494	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
2277	83393	175217-20-6	2495	2495	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
2278	83398	865318-97-4	2496	2496	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
2279	4045	121552-61-2	2497	2497	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2280	6751	110235-47-7	2498	2498	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2281	8674	53112-28-0	2499	2499	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2282	15353	2079-00-7	2500	2500	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
2283	81419	6980-18-3	2501	2501	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
2284	17076	57-92-1	2502	2502	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
2285	27701	79-57-2	2503	2503	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
2286	82040	124495-18-7	2504	2504	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
2287	83555	189278-12-4	2505	2505	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
2288	34759	74738-17-3	2506	2506	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
2289	81763	131341-86-1	2507	2507	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
2290	3656	84332-86-5	2508	2508	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2291	28909	36734-19-7	2509	Preventive, early curative, and systemic	2509	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2292	8450	32809-16-8	2510	2510	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2293		50471-44-8	2511	2511	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2294			2512	2512	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
2295		17109-49-8	2513	2513	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3055	81801	106917-52-6	3267	3267	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
2296		26087-47-8	2514	2514	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2297		13457-18-6	2515	2515	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2298		50512-35-1	2516	2516	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2299	17097	92-52-4	2517	2517	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2300	3628	2675-77-6	2518	2518	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2301	27864	99-30-9	2519	2519	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2302	34908	82-68-8	2520	2520	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2303	82044	117-18-0	2521	2521	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2304	81731	57018-04-9	2522	2522	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2305	81761	2593-15-9	2523	2523	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2306	83279	55406-53-6	2524	2524	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
2307	82033	24579-73-5	2525	2525	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
2308	82084	19622-08-3	2526	2526	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
2309			2527	2527	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
2310			2528	2528	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2311			2529	2529	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2312			2530	2530	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2313			2531	2531	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2314	83629		2532	2532	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
2315		26644-46-2	2533	2533	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2316		88283-41-4	2534	2534	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3056	81759	62865-36-5	3268	3268	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
2317		847749-37-5	2535	2535	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2318	4998	60168-88-9	2536	2536	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2319	7645	63284-71-9	2537	2537	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2320		35554-44-0	2538	2538	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2321		134074-64-9	2539	2539	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2322		101903-30-4	2540	2540	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2323		67747-09-5	2541	2541	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2324		68694-11-1	2542	2542	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2325		60207-31-0	2543	2543	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2326		55179-31-2	2544	2544	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2402	17909	7704-34-9	2620	2620	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2327		116255-48-2	2545	2545	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2328		94361-06-5	2546	2546	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2329		119446-68-3	2547	2547	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2330		83657-18-5	2548	2548	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2331		133855-98-8	2549	2549	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2332		60207-93-4	2550	2550	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2333		114369-43-6	2551	2551	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2334		136426-54-5	2552	2552	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2335		85509-19-9	2553	2553	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2336		76674-21-0	2554	2554	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2435	5827	10004-44-1	2651	2651	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
2337		79983-71-4	2555	2555	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2338		86598-92-7	2556	2556	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2339		125225-28-7	2557	2557	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2340		125116-23-6	2558	2558	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2341		88671-89-0	2559	2559	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2342		66246-88-6	2560	2560	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2343		60207-90-1	2561	2561	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2344		149508-90-7	2562	2562	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2345		107534-96-3	2563	2563	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2346		112281-77-3	2564	2564	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2436	81936	26530-20-1	2652	2652	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
2347		43121-43-3	2565	2565	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2348		55219-65-3	2566	2566	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2349		131983-72-7	2567	2567	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2350		178928-70-6	2568	2568	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2351	83295	91315-15-0	2569	Systemic	2569	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2352	81960	1593-77-7	2570	Systemic	2570	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2353	50145	67564-91-4	2571	Systemic	2571	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2354	9700	81412-43-3	2572	Systemic	2572	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2355	81917	67306-00-7	2573	Systemic	2573	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2356	83283	3478-94-2	2574	2574	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2357	9242	118134-30-8	2575	Systemic	2575	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2358	81853	126833-17-8	2576	Locally systemic	2576	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
2359	83327	473798-59-3	2577	2577	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
2360	81736	88678-67-5	2578	Systemic	2578	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
2361	7451	65472-88-0	2579	Various	2579	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
2362	9448	91161-71-6	2580	Various	2580	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
2363		37248-47-8	2581	2581	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
2364		11113-80-7	2582	2582	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
2365	81848	110488-70-5	2583	2583	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2366	83428	211867-47-9	2584	2584	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2367	83663	868390-90-3	2585	2585	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2368	83601	413615-35-7	2586	2586	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2369	82023	140923-17-7	2587	2587	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2370	83610	283159-90-0	2588	2588	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2371	81802	374726-62-2	2589	2589	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2372	47617	27355-22-2	2590	2590	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
2373	45141	57369-32-1	2591	2591	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
2374	81783	41814-78-2	2592	2592	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
2375		104030-54-8	2593	2593	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
2376		139920-32-4	2594	2594	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
2377		115852-48-7	2595	2595	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
2378		135158-54-2	2596	2596	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
2379		27605-76-1	2597	2597	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
2380	81825	223580-51-6	2598	2598	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
2381	83657	224049-04-1	2599	2599	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
2382		9008-22-4	2600	2600	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
2383			2601	2601	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
2384		57966-95-7	2602	2602	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
2385		39148-24-8	2603	2603	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
2386		13598-36-2	2604	2604	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
2387	83341	76280-91-6	2605	2605	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
2388	83335	72459-58-6	2606	2606	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
2389	81801	106917-52-6	2607	2607	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
2390	81759	62865-36-5	2608	2608	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
2391	81933	66952-49-6	2609	2609	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
2392	81797	180409-60-3	2610	2610	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
2393	83345	220899-03-6	2611	2611	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
2394	83346	688046-61-9	2612	2612	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
2395	74889	2439-10-3	2613	2613	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
2396	83277	958647-10-4	2614	2614	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
2397	81844	89269-64-7	2615	2615	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
2398	83268	1003318-67-9	2616	2616	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
2399	83266	376645-78-2	2617	2617	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
2400			2618	2618	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
3057	81933	66952-49-6	3269	3269	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
2403	5015	14484-64-1	2621	2621	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2404	52492	8018-01-7	2622	2622	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2405	52497	12427-38-2	2623	2623	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2406	81539	9006-42-2	2624	2624	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2407	81755	12071-83-9	2625	2625	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2408	9495	137-26-8	2626	2626	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2409	52498	12122-67-7	2627	2627	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2410	79736	137-30-4	2628	2628	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2411	34608	133-06-2	2629	2629	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2412	81938	2425-06-1	2630	2630	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2413	82019	133-07-3	2631	2631	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2414	3639	1897-45-6	2632	2632	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2415	74875	1085-98-9	2633	2633	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2416	75182	731-27-1	2634	2634	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2417	82843	108173-90-6	2635	2635	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2418	5569	13516-27-3	2636	2636	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2419	82076	101-05-3	2637	2637	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2420	81842	3347-22-6	2638	2638	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2421	34620	2439-01-2	2639	2639	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2422	81826	41205-21-4	2640	2640	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2425	3009	71626-11-4	2641	2641	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2426	82779	98243-83-5	2642	2642	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2427	5194	57646-30-7	2643	2643	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2428	6790	57837-19-1	2644	2644	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2429	60607	70630-17-0	2645	2645	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2430	81937	77732-09-3	2646	2646	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2431	81969	58810-48-3	2647	2647	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2432	81952	41483-43-6	2648	2648	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
2433	81958	5221-53-4	2649	2649	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
2434	81989	23947-60-6	2650	2650	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
2437	138856	14698-29-4	2653	2653	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
2438	3015	17804-35-2	2654	Systemic	2654	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2439	3392	10605-21-7	2655	Systemic	2655	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2440	81926	3878-19-1	2656	2656	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2441	45979	148-79-8	2657	2657	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2442	82060	23564-06-9	2658	2658	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2443	35014	23564-05-8	2659	Systemic	2659	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2444	4520	87130-20-9	2660	Systemic	2660	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
2445	82048	156052-68-5	2661	2661	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
2446	82856	162650-77-3	2662	2662	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
2447	7957	66063-05-6	2663	2663	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
2448	81764	239110-15-7	2664	2664	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
2449	82860	130339-07-0	2665	2665	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
2450	38628	129558-76-5	2666	2666	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
2451	82052	15310-01-7	2667	2667	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2452	81792	66332-96-5	2668	2668	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2453	81823	55814-41-0	2669	2669	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2454	83065	875915-78-9	2670	2670	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2455	83070	658066-35-4	2671	2671	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2456	81994	24691-80-3	2672	2672	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2457	3405	5234-68-4	2673	Systemic	2673	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2496	81918	900-95-8	2712	2712	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
2458	7858	5259-88-1	2674	2674	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2459	81794	130000-40-7	2675	2675	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2460	83092	1072957-71-1	2676	2676	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2461	83106	581809-46-3	2677	2677	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2462	83113	907204-31-3	2678	2678	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2463	81793	123572-88-3	2679	2679	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2464	83126	881685-58-1	2680	2680	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2465	83134	494793-67-8	2681	2681	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2466	81777	183675-82-3	2682	2682	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2467	83173	874967-67-6	2683	2683	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2468	81822	188425-85-6	2684	2684	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2469	40909	131860-33-8	2685	Preventive, curative, and systemic	2685	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2470	83185	850881-70-8	2686	2686	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2471	83187	238410-11-2	2687	2687	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2472	83194	918162-02-4	2688	2688	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2473	83197	117428-22-5	2689	2689	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2474	83202	862588-11-2	2690	2690	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2475	83205	173662-97-0	2691	2691	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2476	78780	175013-18-0	2692	2692	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2477	83212	915410-70-7	2693	2693	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2478	83213	902760-40-1	2694	2694	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2479	2962	143390-89-0	2695	2695	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2480	81833	141517-21-7	2696	2696	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2481	83218	149961-52-4	2697	2697	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2482	83220	366815-39-6	2698	2698	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2483	81831	133408-50-1	2699	2699	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2484	81832	248593-16-0	2700	2700	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2485	59340	131807-57-3	2701	2701	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2486	83253	361377-29-9	2702	2702	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2487	83258	161326-34-7	2703	2703	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2488	83261	799247-52-2	2704	2704	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2489	81841	120116-88-3	2705	2705	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
2490	81846	348635-87-0	2706	2706	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
2491	82153	485-31-4	2707	2707	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
2492	83372	131-72-6	2708	2708	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
2493	83379	39300-45-3	2709	2709	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
2494	81843	79622-59-6	2710	2710	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
2495	81844	89269-64-7	2711	2711	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
2497	35036	639-58-7	2713	2713	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
2498	30473	76-87-9	2714	2714	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
2499	83393	175217-20-6	2715	2715	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
2500	83398	865318-97-4	2716	2716	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
2501	4045	121552-61-2	2717	2717	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2502	6751	110235-47-7	2718	2718	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2503	8674	53112-28-0	2719	2719	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2504	15353	2079-00-7	2720	2720	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
2505	81419	6980-18-3	2721	2721	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
2506	17076	57-92-1	2722	2722	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
2507	27701	79-57-2	2723	2723	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
2508	82040	124495-18-7	2724	2724	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
2509	83555	189278-12-4	2725	2725	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
2510	34759	74738-17-3	2726	2726	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
2511	81763	131341-86-1	2727	2727	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
2512	3656	84332-86-5	2728	2728	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2513	28909	36734-19-7	2729	Preventive, early curative, and systemic	2729	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2514	8450	32809-16-8	2730	2730	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2515		50471-44-8	2731	2731	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2516			2732	2732	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
2517		17109-49-8	2733	2733	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2518		26087-47-8	2734	2734	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2519		13457-18-6	2735	2735	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2520		50512-35-1	2736	2736	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2521	17097	92-52-4	2737	2737	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2522	3628	2675-77-6	2738	2738	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2523	27864	99-30-9	2739	2739	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2524	34908	82-68-8	2740	2740	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2525	82044	117-18-0	2741	2741	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2526	81731	57018-04-9	2742	2742	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2527	81761	2593-15-9	2743	2743	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2528	83279	55406-53-6	2744	2744	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
2529	82033	24579-73-5	2745	2745	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
2530	82084	19622-08-3	2746	2746	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
2531			2747	2747	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
2532			2748	2748	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2533			2749	2749	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2534			2750	2750	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2535			2751	2751	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2536	83629		2752	2752	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
2537		26644-46-2	2753	2753	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2538		88283-41-4	2754	2754	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2539		847749-37-5	2755	2755	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2540	4998	60168-88-9	2756	2756	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2541	7645	63284-71-9	2757	2757	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2542		35554-44-0	2758	2758	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2543		134074-64-9	2759	2759	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2544		101903-30-4	2760	2760	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2545		67747-09-5	2761	2761	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2546		68694-11-1	2762	2762	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2547		60207-31-0	2763	2763	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2548		55179-31-2	2764	2764	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2549		116255-48-2	2765	2765	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2550		94361-06-5	2766	2766	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2816	47617	27355-22-2	3030	3030	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
2551		119446-68-3	2767	2767	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2552		83657-18-5	2768	2768	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2553		133855-98-8	2769	2769	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2554		60207-93-4	2770	2770	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2555		114369-43-6	2771	2771	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2556		136426-54-5	2772	2772	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2557		85509-19-9	2773	2773	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2558		76674-21-0	2774	2774	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2559		79983-71-4	2775	2775	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2560		86598-92-7	2776	2776	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2817	45141	57369-32-1	3031	3031	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
2561		125225-28-7	2777	2777	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2562		125116-23-6	2778	2778	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2563		88671-89-0	2779	2779	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2564		66246-88-6	2780	2780	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2565		60207-90-1	2781	2781	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2566		149508-90-7	2782	2782	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2567		107534-96-3	2783	2783	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2568		112281-77-3	2784	2784	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2569		43121-43-3	2785	2785	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2570		55219-65-3	2786	2786	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2818	81783	41814-78-2	3032	3032	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
2571		131983-72-7	2787	2787	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2572		178928-70-6	2788	2788	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2573	83295	91315-15-0	2789	Systemic	2789	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2574	81960	1593-77-7	2790	Systemic	2790	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2575	50145	67564-91-4	2791	Systemic	2791	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2576	9700	81412-43-3	2792	Systemic	2792	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2577	81917	67306-00-7	2793	Systemic	2793	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2578	83283	3478-94-2	2794	2794	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2579	9242	118134-30-8	2795	Systemic	2795	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2580	81853	126833-17-8	2796	Locally systemic	2796	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
2581	83327	473798-59-3	2797	2797	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
2582	81736	88678-67-5	2798	Systemic	2798	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
2583	7451	65472-88-0	2799	Various	2799	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
2584	9448	91161-71-6	2800	Various	2800	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
2585		37248-47-8	2801	2801	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
2586		11113-80-7	2802	2802	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
2587	81848	110488-70-5	2803	2803	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2588	83428	211867-47-9	2804	2804	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2589	83663	868390-90-3	2805	2805	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2590	83601	413615-35-7	2806	2806	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2591	82023	140923-17-7	2807	2807	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2592	83610	283159-90-0	2808	2808	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2593	81802	374726-62-2	2809	2809	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2594	47617	27355-22-2	2810	2810	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
2595	45141	57369-32-1	2811	2811	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
2596	81783	41814-78-2	2812	2812	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
2597		104030-54-8	2813	2813	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
2598		139920-32-4	2814	2814	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
2599		115852-48-7	2815	2815	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
2600		135158-54-2	2816	2816	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
2601		27605-76-1	2817	2817	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
2602	81825	223580-51-6	2818	2818	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
2603	83657	224049-04-1	2819	2819	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
2604		9008-22-4	2820	2820	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
2605			2821	2821	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
2606		57966-95-7	2822	2822	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
2607		39148-24-8	2823	2823	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
2608		13598-36-2	2824	2824	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
2609	83341	76280-91-6	2825	2825	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
2610	83335	72459-58-6	2826	2826	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
2611	81801	106917-52-6	2827	2827	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
2612	81759	62865-36-5	2828	2828	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
2613	81933	66952-49-6	2829	2829	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
2614	81797	180409-60-3	2830	2830	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
2615	83345	220899-03-6	2831	2831	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
2616	83346	688046-61-9	2832	2832	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
2617	74889	2439-10-3	2833	2833	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
2618	83277	958647-10-4	2834	2834	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
2619	81844	89269-64-7	2835	2835	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
2620	83268	1003318-67-9	2836	2836	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
2621	83266	376645-78-2	2837	2837	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
2622			2838	2838	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
2623		7440-50-8	2839	2839	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2624	17909	7704-34-9	2840	2840	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2625	5015	14484-64-1	2841	2841	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2626	52492	8018-01-7	2842	2842	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2627	52497	12427-38-2	2843	2843	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2628	81539	9006-42-2	2844	2844	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2629	81755	12071-83-9	2845	2845	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2630	9495	137-26-8	2846	2846	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2631	52498	12122-67-7	2847	2847	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2632	79736	137-30-4	2848	2848	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2633	34608	133-06-2	2849	2849	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2634	81938	2425-06-1	2850	2850	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2635	82019	133-07-3	2851	2851	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2636	3639	1897-45-6	2852	2852	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2637	74875	1085-98-9	2853	2853	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2638	75182	731-27-1	2854	2854	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2639	82843	108173-90-6	2855	2855	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2640	5569	13516-27-3	2856	2856	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2641	82076	101-05-3	2857	2857	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2642	81842	3347-22-6	2858	2858	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2643	34620	2439-01-2	2859	2859	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2644	81826	41205-21-4	2860	2860	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2647	3009	71626-11-4	2861	2861	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2648	82779	98243-83-5	2862	2862	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2649	5194	57646-30-7	2863	2863	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2650	6790	57837-19-1	2864	2864	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2651	60607	70630-17-0	2865	2865	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2652	81937	77732-09-3	2866	2866	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2653	81969	58810-48-3	2867	2867	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2654	81952	41483-43-6	2868	2868	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
2655	81958	5221-53-4	2869	2869	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
2656	81989	23947-60-6	2870	2870	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
2657	5827	10004-44-1	2871	2871	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
2658	81936	26530-20-1	2872	2872	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
2659	138856	14698-29-4	2873	2873	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
2660	3015	17804-35-2	2874	Systemic	2874	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2661	3392	10605-21-7	2875	Systemic	2875	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2662	81926	3878-19-1	2876	2876	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2663	45979	148-79-8	2877	2877	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2664	82060	23564-06-9	2878	2878	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2665	35014	23564-05-8	2879	Systemic	2879	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2666	4520	87130-20-9	2880	Systemic	2880	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
2667	82048	156052-68-5	2881	2881	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
2668	82856	162650-77-3	2882	2882	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
2669	7957	66063-05-6	2883	2883	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
2670	81764	239110-15-7	2884	2884	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
2671	82860	130339-07-0	2885	2885	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
2672	38628	129558-76-5	2886	2886	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
2673	82052	15310-01-7	2887	2887	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2674	81792	66332-96-5	2888	2888	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2675	81823	55814-41-0	2889	2889	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2676	83065	875915-78-9	2890	2890	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2677	83070	658066-35-4	2891	2891	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2678	81994	24691-80-3	2892	2892	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2679	3405	5234-68-4	2893	Systemic	2893	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2680	7858	5259-88-1	2894	2894	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2681	81794	130000-40-7	2895	2895	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2682	83092	1072957-71-1	2896	2896	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2683	83106	581809-46-3	2897	2897	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2684	83113	907204-31-3	2898	2898	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2685	81793	123572-88-3	2899	2899	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2686	83126	881685-58-1	2900	2900	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2687	83134	494793-67-8	2901	2901	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2688	81777	183675-82-3	2902	2902	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2689	83173	874967-67-6	2903	2903	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2690	81822	188425-85-6	2904	2904	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2691	40909	131860-33-8	2905	Preventive, curative, and systemic	2905	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2692	83185	850881-70-8	2906	2906	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2693	83187	238410-11-2	2907	2907	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2694	83194	918162-02-4	2908	2908	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2695	83197	117428-22-5	2909	2909	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2696	83202	862588-11-2	2910	2910	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2697	83205	173662-97-0	2911	2911	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2698	78780	175013-18-0	2912	2912	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2699	83212	915410-70-7	2913	2913	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2700	83213	902760-40-1	2914	2914	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2701	2962	143390-89-0	2915	2915	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2702	81833	141517-21-7	2916	2916	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2703	83218	149961-52-4	2917	2917	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2704	83220	366815-39-6	2918	2918	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2705	81831	133408-50-1	2919	2919	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2706	81832	248593-16-0	2920	2920	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2707	59340	131807-57-3	2921	2921	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2708	83253	361377-29-9	2922	2922	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2709	83258	161326-34-7	2923	2923	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2710	83261	799247-52-2	2924	2924	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2711	81841	120116-88-3	2925	2925	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
2712	81846	348635-87-0	2926	2926	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
2713	82153	485-31-4	2927	2927	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
2714	83372	131-72-6	2928	2928	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
2715	83379	39300-45-3	2929	2929	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
2716	81843	79622-59-6	2930	2930	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
2717	81844	89269-64-7	2931	2931	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
2718	81918	900-95-8	2932	2932	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
2719	35036	639-58-7	2933	2933	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
2720	30473	76-87-9	2934	2934	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
2721	83393	175217-20-6	2935	2935	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
2722	83398	865318-97-4	2936	2936	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
2723	4045	121552-61-2	2937	2937	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2724	6751	110235-47-7	2938	2938	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2725	8674	53112-28-0	2939	2939	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2726	15353	2079-00-7	2940	2940	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
2727	81419	6980-18-3	2941	2941	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
2728	17076	57-92-1	2942	2942	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
2729	27701	79-57-2	2943	2943	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
2730	82040	124495-18-7	2944	2944	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
2731	83555	189278-12-4	2945	2945	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
2732	34759	74738-17-3	2946	2946	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
2733	81763	131341-86-1	2947	2947	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
2734	3656	84332-86-5	2948	2948	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2735	28909	36734-19-7	2949	Preventive, early curative, and systemic	2949	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2736	8450	32809-16-8	2950	2950	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2737		50471-44-8	2951	2951	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2738			2952	2952	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
2739		17109-49-8	2953	2953	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2740		26087-47-8	2954	2954	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2741		13457-18-6	2955	2955	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2742		50512-35-1	2956	2956	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2743	17097	92-52-4	2957	2957	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2744	3628	2675-77-6	2958	2958	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2745	27864	99-30-9	2959	2959	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2746	34908	82-68-8	2960	2960	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2747	82044	117-18-0	2961	2961	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2748	81731	57018-04-9	2962	2962	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2749	81761	2593-15-9	2963	2963	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2750	83279	55406-53-6	2964	2964	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
2751	82033	24579-73-5	2965	2965	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
2752	82084	19622-08-3	2966	2966	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
2753			2967	2967	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
2754			2968	2968	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2755			2969	2969	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2756			2970	2970	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2757			2971	2971	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2758	83629		2972	2972	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
2759		26644-46-2	2973	2973	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2760		88283-41-4	2974	2974	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2761		847749-37-5	2975	2975	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2762	4998	60168-88-9	2976	2976	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2763	7645	63284-71-9	2977	2977	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2764		35554-44-0	2978	2978	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2765		134074-64-9	2979	2979	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2766		101903-30-4	2980	2980	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2767		67747-09-5	2981	2981	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2768		68694-11-1	2982	2982	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2769		60207-31-0	2983	2983	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2770		55179-31-2	2984	2984	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2771		116255-48-2	2985	2985	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2772		94361-06-5	2986	2986	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2773		119446-68-3	2987	2987	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3049			3261	3261	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
2774		83657-18-5	2988	2988	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2775		133855-98-8	2989	2989	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2776		60207-93-4	2990	2990	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2777		114369-43-6	2991	2991	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2778		136426-54-5	2992	2992	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2779		85509-19-9	2993	2993	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2780		76674-21-0	2994	2994	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2781		79983-71-4	2995	2995	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2782		86598-92-7	2996	2996	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2783		125225-28-7	2997	2997	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3050		57966-95-7	3262	3262	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
2784		125116-23-6	2998	2998	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2785		88671-89-0	2999	2999	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2786		66246-88-6	3000	3000	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2787		60207-90-1	3001	3001	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2788		149508-90-7	3002	3002	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2789		107534-96-3	3003	3003	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2790		112281-77-3	3004	3004	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2791		43121-43-3	3005	3005	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2792		55219-65-3	3006	3006	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2793		131983-72-7	3007	3007	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2856	81938	2425-06-1	3070	3070	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2794		178928-70-6	3008	3008	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2795	83295	91315-15-0	3009	Systemic	3009	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2796	81960	1593-77-7	3010	Systemic	3010	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2797	50145	67564-91-4	3011	Systemic	3011	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2798	9700	81412-43-3	3012	Systemic	3012	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2799	81917	67306-00-7	3013	Systemic	3013	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2800	83283	3478-94-2	3014	3014	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2801	9242	118134-30-8	3015	Systemic	3015	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
2802	81853	126833-17-8	3016	Locally systemic	3016	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
2803	83327	473798-59-3	3017	3017	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
2804	81736	88678-67-5	3018	Systemic	3018	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
2805	7451	65472-88-0	3019	Various	3019	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
2806	9448	91161-71-6	3020	Various	3020	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
2807		37248-47-8	3021	3021	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
2808		11113-80-7	3022	3022	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
2809	81848	110488-70-5	3023	3023	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2810	83428	211867-47-9	3024	3024	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2811	83663	868390-90-3	3025	3025	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2812	83601	413615-35-7	3026	3026	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2813	82023	140923-17-7	3027	3027	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2814	83610	283159-90-0	3028	3028	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2815	81802	374726-62-2	3029	3029	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
2819		104030-54-8	3033	3033	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
2820		139920-32-4	3034	3034	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
2821		115852-48-7	3035	3035	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
2822		135158-54-2	3036	3036	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
2823		27605-76-1	3037	3037	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
2824	81825	223580-51-6	3038	3038	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
2825	83657	224049-04-1	3039	3039	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
2826		9008-22-4	3040	3040	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
2827			3041	3041	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
2828		57966-95-7	3042	3042	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
2829		39148-24-8	3043	3043	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
2830		13598-36-2	3044	3044	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
2831	83341	76280-91-6	3045	3045	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
2832	83335	72459-58-6	3046	3046	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
2833	81801	106917-52-6	3047	3047	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
2834	81759	62865-36-5	3048	3048	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
2835	81933	66952-49-6	3049	3049	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
2836	81797	180409-60-3	3050	3050	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
2837	83345	220899-03-6	3051	3051	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
2838	83346	688046-61-9	3052	3052	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
2839	74889	2439-10-3	3053	3053	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
2840	83277	958647-10-4	3054	3054	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
2841	81844	89269-64-7	3055	3055	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
2842	83268	1003318-67-9	3056	3056	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
2843	83266	376645-78-2	3057	3057	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
2844			3058	3058	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
2845		7440-50-8	3059	3059	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2846	17909	7704-34-9	3060	3060	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2847	5015	14484-64-1	3061	3061	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2848	52492	8018-01-7	3062	3062	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2849	52497	12427-38-2	3063	3063	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2850	81539	9006-42-2	3064	3064	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2851	81755	12071-83-9	3065	3065	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2852	9495	137-26-8	3066	3066	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2853	52498	12122-67-7	3067	3067	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2854	79736	137-30-4	3068	3068	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2855	34608	133-06-2	3069	3069	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2857	82019	133-07-3	3071	3071	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2858	3639	1897-45-6	3072	3072	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2859	74875	1085-98-9	3073	3073	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2860	75182	731-27-1	3074	3074	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2861	82843	108173-90-6	3075	3075	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2862	5569	13516-27-3	3076	3076	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2863	82076	101-05-3	3077	3077	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2864	81842	3347-22-6	3078	3078	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2865	34620	2439-01-2	3079	3079	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2866	81826	41205-21-4	3080	3080	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
2869	3009	71626-11-4	3081	3081	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2870	82779	98243-83-5	3082	3082	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2871	5194	57646-30-7	3083	3083	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2872	6790	57837-19-1	3084	3084	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2873	60607	70630-17-0	3085	3085	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2874	81937	77732-09-3	3086	3086	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2875	81969	58810-48-3	3087	3087	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2876	81952	41483-43-6	3088	3088	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
2877	81958	5221-53-4	3089	3089	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
2878	81989	23947-60-6	3090	3090	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
2879	5827	10004-44-1	3091	3091	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
2880	81936	26530-20-1	3092	3092	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
2881	138856	14698-29-4	3093	3093	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
2882	3015	17804-35-2	3094	Systemic	3094	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2883	3392	10605-21-7	3095	Systemic	3095	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2884	81926	3878-19-1	3096	3096	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2885	45979	148-79-8	3097	3097	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2974	82084	19622-08-3	3186	3186	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
2886	82060	23564-06-9	3098	3098	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2887	35014	23564-05-8	3099	Systemic	3099	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
2888	4520	87130-20-9	3100	Systemic	3100	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
2889	82048	156052-68-5	3101	3101	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
2890	82856	162650-77-3	3102	3102	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
2891	7957	66063-05-6	3103	3103	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
2892	81764	239110-15-7	3104	3104	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
2893	82860	130339-07-0	3105	3105	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
2894	38628	129558-76-5	3106	3106	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
2895	82052	15310-01-7	3107	3107	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2896	81792	66332-96-5	3108	3108	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2897	81823	55814-41-0	3109	3109	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2898	83065	875915-78-9	3110	3110	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2899	83070	658066-35-4	3111	3111	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2900	81994	24691-80-3	3112	3112	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2901	3405	5234-68-4	3113	Systemic	3113	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2902	7858	5259-88-1	3114	3114	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2903	81794	130000-40-7	3115	3115	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2904	83092	1072957-71-1	3116	3116	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2905	83106	581809-46-3	3117	3117	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2906	83113	907204-31-3	3118	3118	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2907	81793	123572-88-3	3119	3119	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2908	83126	881685-58-1	3120	3120	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2909	83134	494793-67-8	3121	3121	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2910	81777	183675-82-3	3122	3122	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2911	83173	874967-67-6	3123	3123	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2912	81822	188425-85-6	3124	3124	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
2913	40909	131860-33-8	3125	Preventive, curative, and systemic	3125	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2914	83185	850881-70-8	3126	3126	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2915	83187	238410-11-2	3127	3127	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2916	83194	918162-02-4	3128	3128	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2917	83197	117428-22-5	3129	3129	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2918	83202	862588-11-2	3130	3130	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2919	83205	173662-97-0	3131	3131	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2920	78780	175013-18-0	3132	3132	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2921	83212	915410-70-7	3133	3133	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2922	83213	902760-40-1	3134	3134	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2923	2962	143390-89-0	3135	3135	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2975			3187	3187	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
2924	81833	141517-21-7	3136	3136	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2925	83218	149961-52-4	3137	3137	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2926	83220	366815-39-6	3138	3138	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2927	81831	133408-50-1	3139	3139	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2928	81832	248593-16-0	3140	3140	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2929	59340	131807-57-3	3141	3141	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2930	83253	361377-29-9	3142	3142	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2931	83258	161326-34-7	3143	3143	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2932	83261	799247-52-2	3144	3144	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
2933	81841	120116-88-3	3145	3145	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
2934	81846	348635-87-0	3146	3146	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
2935	82153	485-31-4	3147	3147	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
2936	83372	131-72-6	3148	3148	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
2937	83379	39300-45-3	3149	3149	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
2938	81843	79622-59-6	3150	3150	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
2939	81844	89269-64-7	3151	3151	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
2940	81918	900-95-8	3152	3152	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
2941	35036	639-58-7	3153	3153	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
2942	30473	76-87-9	3154	3154	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
2943	83393	175217-20-6	3155	3155	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
2944	83398	865318-97-4	3156	3156	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
2945	4045	121552-61-2	3157	3157	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2946	6751	110235-47-7	3158	3158	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2947	8674	53112-28-0	3159	3159	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
2948	15353	2079-00-7	3160	3160	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
2949	81419	6980-18-3	3161	3161	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
2950	17076	57-92-1	3162	3162	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
2951	27701	79-57-2	3163	3163	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
2952	82040	124495-18-7	3164	3164	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
2953	83555	189278-12-4	3165	3165	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
2954	34759	74738-17-3	3166	3166	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
2955	81763	131341-86-1	3167	3167	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
2956	3656	84332-86-5	3168	3168	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2957	28909	36734-19-7	3169	Preventive, early curative, and systemic	3169	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2958	8450	32809-16-8	3170	3170	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2959		50471-44-8	3171	3171	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
2960			3172	3172	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
2961		17109-49-8	3173	3173	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2962		26087-47-8	3174	3174	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2963		13457-18-6	3175	3175	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2964		50512-35-1	3176	3176	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
2965	17097	92-52-4	3177	3177	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2966	3628	2675-77-6	3178	3178	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2967	27864	99-30-9	3179	3179	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2968	34908	82-68-8	3180	3180	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2969	82044	117-18-0	3181	3181	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2970	81731	57018-04-9	3182	3182	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2971	81761	2593-15-9	3183	3183	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
2972	83279	55406-53-6	3184	3184	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
2973	82033	24579-73-5	3185	3185	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
2976			3188	3188	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2977			3189	3189	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2978			3190	3190	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2979			3191	3191	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
2980	83629		3192	3192	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
2981		26644-46-2	3193	3193	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2982		88283-41-4	3194	3194	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2983		847749-37-5	3195	3195	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2984	4998	60168-88-9	3196	3196	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2985	7645	63284-71-9	3197	3197	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2986		35554-44-0	3198	3198	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2987		134074-64-9	3199	3199	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3045		27605-76-1	3257	3257	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
2988		101903-30-4	3200	3200	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2989		67747-09-5	3201	3201	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2990		68694-11-1	3202	3202	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2991		60207-31-0	3203	3203	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2992		55179-31-2	3204	3204	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2993		116255-48-2	3205	3205	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2994		94361-06-5	3206	3206	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2995		119446-68-3	3207	3207	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2996		83657-18-5	3208	3208	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2997		133855-98-8	3209	3209	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3046	81825	223580-51-6	3258	3258	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
2998		60207-93-4	3210	3210	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
2999		114369-43-6	3211	3211	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3000		136426-54-5	3212	3212	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3001		85509-19-9	3213	3213	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3002		76674-21-0	3214	3214	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3003		79983-71-4	3215	3215	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3004		86598-92-7	3216	3216	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3005		125225-28-7	3217	3217	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3006		125116-23-6	3218	3218	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3007		88671-89-0	3219	3219	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3047	83657	224049-04-1	3259	3259	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
3008		66246-88-6	3220	3220	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3009		60207-90-1	3221	3221	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3010		149508-90-7	3222	3222	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3011		107534-96-3	3223	3223	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3012		112281-77-3	3224	3224	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3013		43121-43-3	3225	3225	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3014		55219-65-3	3226	3226	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3015		131983-72-7	3227	3227	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3016		178928-70-6	3228	3228	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3017	83295	91315-15-0	3229	Systemic	3229	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3018	81960	1593-77-7	3230	Systemic	3230	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3019	50145	67564-91-4	3231	Systemic	3231	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3020	9700	81412-43-3	3232	Systemic	3232	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3021	81917	67306-00-7	3233	Systemic	3233	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3022	83283	3478-94-2	3234	3234	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3023	9242	118134-30-8	3235	Systemic	3235	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3024	81853	126833-17-8	3236	Locally systemic	3236	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
3025	83327	473798-59-3	3237	3237	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
3026	81736	88678-67-5	3238	Systemic	3238	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
3027	7451	65472-88-0	3239	Various	3239	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
3028	9448	91161-71-6	3240	Various	3240	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
3029		37248-47-8	3241	3241	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
3030		11113-80-7	3242	3242	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
3031	81848	110488-70-5	3243	3243	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3032	83428	211867-47-9	3244	3244	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3033	83663	868390-90-3	3245	3245	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3034	83601	413615-35-7	3246	3246	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3035	82023	140923-17-7	3247	3247	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3036	83610	283159-90-0	3248	3248	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3037	81802	374726-62-2	3249	3249	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3038	47617	27355-22-2	3250	3250	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
3039	45141	57369-32-1	3251	3251	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
3040	81783	41814-78-2	3252	3252	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
3041		104030-54-8	3253	3253	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
3042		139920-32-4	3254	3254	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
3043		115852-48-7	3255	3255	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
3044		135158-54-2	3256	3256	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
3048		9008-22-4	3260	3260	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
3058	81797	180409-60-3	3270	3270	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
3059	83345	220899-03-6	3271	3271	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
3060	83346	688046-61-9	3272	3272	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
3061	74889	2439-10-3	3273	3273	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
3062	83277	958647-10-4	3274	3274	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
3063	81844	89269-64-7	3275	3275	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
3064	83268	1003318-67-9	3276	3276	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
3065	83266	376645-78-2	3277	3277	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
3066			3278	3278	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
3067		7440-50-8	3279	3279	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3068	17909	7704-34-9	3280	3280	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3069	5015	14484-64-1	3281	3281	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3070	52492	8018-01-7	3282	3282	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3071	52497	12427-38-2	3283	3283	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3072	81539	9006-42-2	3284	3284	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3073	81755	12071-83-9	3285	3285	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3074	9495	137-26-8	3286	3286	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3075	52498	12122-67-7	3287	3287	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3076	79736	137-30-4	3288	3288	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3077	34608	133-06-2	3289	3289	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3078	81938	2425-06-1	3290	3290	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3079	82019	133-07-3	3291	3291	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3080	3639	1897-45-6	3292	3292	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3081	74875	1085-98-9	3293	3293	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3082	75182	731-27-1	3294	3294	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3083	82843	108173-90-6	3295	3295	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3084	5569	13516-27-3	3296	3296	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3085	82076	101-05-3	3297	3297	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3086	81842	3347-22-6	3298	3298	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3087	34620	2439-01-2	3299	3299	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3088	81826	41205-21-4	3300	3300	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3091	3009	71626-11-4	3301	3301	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3251		37248-47-8	3461	3461	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
3092	82779	98243-83-5	3302	3302	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3093	5194	57646-30-7	3303	3303	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3094	6790	57837-19-1	3304	3304	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3095	60607	70630-17-0	3305	3305	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3096	81937	77732-09-3	3306	3306	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3097	81969	58810-48-3	3307	3307	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3098	81952	41483-43-6	3308	3308	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3099	81958	5221-53-4	3309	3309	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3100	81989	23947-60-6	3310	3310	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3101	5827	10004-44-1	3311	3311	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
3102	81936	26530-20-1	3312	3312	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
3103	138856	14698-29-4	3313	3313	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
3104	3015	17804-35-2	3314	Systemic	3314	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3105	3392	10605-21-7	3315	Systemic	3315	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3106	81926	3878-19-1	3316	3316	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3107	45979	148-79-8	3317	3317	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3108	82060	23564-06-9	3318	3318	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3109	35014	23564-05-8	3319	Systemic	3319	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3110	4520	87130-20-9	3320	Systemic	3320	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
3111	82048	156052-68-5	3321	3321	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
3112	82856	162650-77-3	3322	3322	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
3113	7957	66063-05-6	3323	3323	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
3114	81764	239110-15-7	3324	3324	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
3115	82860	130339-07-0	3325	3325	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
3116	38628	129558-76-5	3326	3326	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
3117	82052	15310-01-7	3327	3327	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4162		13598-36-2	4364	4364	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
3118	81792	66332-96-5	3328	3328	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3119	81823	55814-41-0	3329	3329	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3120	83065	875915-78-9	3330	3330	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3121	83070	658066-35-4	3331	3331	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3122	81994	24691-80-3	3332	3332	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3123	3405	5234-68-4	3333	Systemic	3333	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3124	7858	5259-88-1	3334	3334	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3125	81794	130000-40-7	3335	3335	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3126	83092	1072957-71-1	3336	3336	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3127	83106	581809-46-3	3337	3337	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3128	83113	907204-31-3	3338	3338	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3129	81793	123572-88-3	3339	3339	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3130	83126	881685-58-1	3340	3340	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3131	83134	494793-67-8	3341	3341	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3132	81777	183675-82-3	3342	3342	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3133	83173	874967-67-6	3343	3343	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3151	59340	131807-57-3	3361	3361	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3134	81822	188425-85-6	3344	3344	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3135	40909	131860-33-8	3345	Preventive, curative, and systemic	3345	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3136	83185	850881-70-8	3346	3346	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3137	83187	238410-11-2	3347	3347	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3138	83194	918162-02-4	3348	3348	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3139	83197	117428-22-5	3349	3349	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3140	83202	862588-11-2	3350	3350	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3141	83205	173662-97-0	3351	3351	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3142	78780	175013-18-0	3352	3352	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3143	83212	915410-70-7	3353	3353	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3144	83213	902760-40-1	3354	3354	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3145	2962	143390-89-0	3355	3355	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3146	81833	141517-21-7	3356	3356	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3147	83218	149961-52-4	3357	3357	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3148	83220	366815-39-6	3358	3358	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3149	81831	133408-50-1	3359	3359	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3150	81832	248593-16-0	3360	3360	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3247	83327	473798-59-3	3457	3457	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
3152	83253	361377-29-9	3362	3362	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3153	83258	161326-34-7	3363	3363	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3154	83261	799247-52-2	3364	3364	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3155	81841	120116-88-3	3365	3365	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
3156	81846	348635-87-0	3366	3366	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
3157	82153	485-31-4	3367	3367	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
3158	83372	131-72-6	3368	3368	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
3159	83379	39300-45-3	3369	3369	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
3160	81843	79622-59-6	3370	3370	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
3161	81844	89269-64-7	3371	3371	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
3162	81918	900-95-8	3372	3372	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
3163	35036	639-58-7	3373	3373	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
3164	30473	76-87-9	3374	3374	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
3165	83393	175217-20-6	3375	3375	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
3166	83398	865318-97-4	3376	3376	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
3167	4045	121552-61-2	3377	3377	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
3168	6751	110235-47-7	3378	3378	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
3169	8674	53112-28-0	3379	3379	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
3170	15353	2079-00-7	3380	3380	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
3171	81419	6980-18-3	3381	3381	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
3172	17076	57-92-1	3382	3382	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
3173	27701	79-57-2	3383	3383	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
3174	82040	124495-18-7	3384	3384	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
3175	83555	189278-12-4	3385	3385	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
3176	34759	74738-17-3	3386	3386	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
3177	81763	131341-86-1	3387	3387	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
3178	3656	84332-86-5	3388	3388	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4163	83341	76280-91-6	4365	4365	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
3179	28909	36734-19-7	3389	Preventive, early curative, and systemic	3389	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3180	8450	32809-16-8	3390	3390	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3181		50471-44-8	3391	3391	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3182			3392	3392	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
3183		17109-49-8	3393	3393	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3184		26087-47-8	3394	3394	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3185		13457-18-6	3395	3395	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3186		50512-35-1	3396	3396	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3187	17097	92-52-4	3397	3397	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3188	3628	2675-77-6	3398	3398	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3189	27864	99-30-9	3399	3399	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3190	34908	82-68-8	3400	3400	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3191	82044	117-18-0	3401	3401	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3192	81731	57018-04-9	3402	3402	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3193	81761	2593-15-9	3403	3403	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3194	83279	55406-53-6	3404	3404	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
3195	82033	24579-73-5	3405	3405	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
3196	82084	19622-08-3	3406	3406	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
3197			3407	3407	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
3198			3408	3408	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3199			3409	3409	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3200			3410	3410	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3201			3411	3411	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3202	83629		3412	3412	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
3203		26644-46-2	3413	3413	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3204		88283-41-4	3414	3414	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3205		847749-37-5	3415	3415	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3206	4998	60168-88-9	3416	3416	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3207	7645	63284-71-9	3417	3417	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3208		35554-44-0	3418	3418	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3209		134074-64-9	3419	3419	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3210		101903-30-4	3420	3420	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3211		67747-09-5	3421	3421	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3212		68694-11-1	3422	3422	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3248	81736	88678-67-5	3458	Systemic	3458	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
3213		60207-31-0	3423	3423	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3214		55179-31-2	3424	3424	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3215		116255-48-2	3425	3425	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3216		94361-06-5	3426	3426	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3217		119446-68-3	3427	3427	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3218		83657-18-5	3428	3428	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3219		133855-98-8	3429	3429	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3220		60207-93-4	3430	3430	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3221		114369-43-6	3431	3431	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3222		136426-54-5	3432	3432	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3249	7451	65472-88-0	3459	Various	3459	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
3223		85509-19-9	3433	3433	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3224		76674-21-0	3434	3434	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3225		79983-71-4	3435	3435	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3226		86598-92-7	3436	3436	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3227		125225-28-7	3437	3437	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3228		125116-23-6	3438	3438	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3229		88671-89-0	3439	3439	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3230		66246-88-6	3440	3440	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3231		60207-90-1	3441	3441	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3232		149508-90-7	3442	3442	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3250	9448	91161-71-6	3460	Various	3460	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
3233		107534-96-3	3443	3443	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3234		112281-77-3	3444	3444	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3235		43121-43-3	3445	3445	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3236		55219-65-3	3446	3446	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3237		131983-72-7	3447	3447	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3238		178928-70-6	3448	3448	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3239	83295	91315-15-0	3449	Systemic	3449	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3240	81960	1593-77-7	3450	Systemic	3450	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3241	50145	67564-91-4	3451	Systemic	3451	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3242	9700	81412-43-3	3452	Systemic	3452	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3243	81917	67306-00-7	3453	Systemic	3453	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3244	83283	3478-94-2	3454	3454	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3245	9242	118134-30-8	3455	Systemic	3455	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3246	81853	126833-17-8	3456	Locally systemic	3456	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
3252		11113-80-7	3462	3462	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
3253	81848	110488-70-5	3463	3463	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3254	83428	211867-47-9	3464	3464	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3255	83663	868390-90-3	3465	3465	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3256	83601	413615-35-7	3466	3466	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3257	82023	140923-17-7	3467	3467	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3258	83610	283159-90-0	3468	3468	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3259	81802	374726-62-2	3469	3469	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3260	47617	27355-22-2	3470	3470	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
3261	45141	57369-32-1	3471	3471	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
3262	81783	41814-78-2	3472	3472	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
3263		104030-54-8	3473	3473	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
3264		139920-32-4	3474	3474	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
3265		115852-48-7	3475	3475	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
3266		135158-54-2	3476	3476	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
3267		27605-76-1	3477	3477	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
3268	81825	223580-51-6	3478	3478	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
3269	83657	224049-04-1	3479	3479	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
3270		9008-22-4	3480	3480	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
3271			3481	3481	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
3272		57966-95-7	3482	3482	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
3273		39148-24-8	3483	3483	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
3274		13598-36-2	3484	3484	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
3275	83341	76280-91-6	3485	3485	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
3276	83335	72459-58-6	3486	3486	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
3277	81801	106917-52-6	3487	3487	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
3278	81759	62865-36-5	3488	3488	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
3279	81933	66952-49-6	3489	3489	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
3280	81797	180409-60-3	3490	3490	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
3281	83345	220899-03-6	3491	3491	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
3282	83346	688046-61-9	3492	3492	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
3283	74889	2439-10-3	3493	3493	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
3284	83277	958647-10-4	3494	3494	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
3285	81844	89269-64-7	3495	3495	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
3286	83268	1003318-67-9	3496	3496	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
3287	83266	376645-78-2	3497	3497	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
3288			3498	3498	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
3289		7440-50-8	3499	3499	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3290	17909	7704-34-9	3500	3500	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3291	5015	14484-64-1	3501	3501	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3292	52492	8018-01-7	3502	3502	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3293	52497	12427-38-2	3503	3503	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3294	81539	9006-42-2	3504	3504	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3295	81755	12071-83-9	3505	3505	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3296	9495	137-26-8	3506	3506	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3297	52498	12122-67-7	3507	3507	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3298	79736	137-30-4	3508	3508	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3299	34608	133-06-2	3509	3509	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3300	81938	2425-06-1	3510	3510	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3301	82019	133-07-3	3511	3511	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3302	3639	1897-45-6	3512	3512	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3303	74875	1085-98-9	3513	3513	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3304	75182	731-27-1	3514	3514	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3305	82843	108173-90-6	3515	3515	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3306	5569	13516-27-3	3516	3516	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3307	82076	101-05-3	3517	3517	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3308	81842	3347-22-6	3518	3518	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3309	34620	2439-01-2	3519	3519	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3310	81826	41205-21-4	3520	3520	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3313	3009	71626-11-4	3521	3521	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3314	82779	98243-83-5	3522	3522	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3315	5194	57646-30-7	3523	3523	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3316	6790	57837-19-1	3524	3524	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3317	60607	70630-17-0	3525	3525	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3318	81937	77732-09-3	3526	3526	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4164	83335	72459-58-6	4366	4366	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
3319	81969	58810-48-3	3527	3527	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3320	81952	41483-43-6	3528	3528	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3321	81958	5221-53-4	3529	3529	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3322	81989	23947-60-6	3530	3530	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3323	5827	10004-44-1	3531	3531	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
3324	81936	26530-20-1	3532	3532	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
3325	138856	14698-29-4	3533	3533	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
3326	3015	17804-35-2	3534	Systemic	3534	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3327	3392	10605-21-7	3535	Systemic	3535	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3328	81926	3878-19-1	3536	3536	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3329	45979	148-79-8	3537	3537	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3330	82060	23564-06-9	3538	3538	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3331	35014	23564-05-8	3539	Systemic	3539	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3332	4520	87130-20-9	3540	Systemic	3540	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
3333	82048	156052-68-5	3541	3541	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
3334	82856	162650-77-3	3542	3542	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
3335	7957	66063-05-6	3543	3543	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
3336	81764	239110-15-7	3544	3544	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
3337	82860	130339-07-0	3545	3545	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
3338	38628	129558-76-5	3546	3546	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
3339	82052	15310-01-7	3547	3547	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3340	81792	66332-96-5	3548	3548	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3341	81823	55814-41-0	3549	3549	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3342	83065	875915-78-9	3550	3550	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3511		7440-50-8	3719	3719	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3343	83070	658066-35-4	3551	3551	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3344	81994	24691-80-3	3552	3552	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3345	3405	5234-68-4	3553	Systemic	3553	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3346	7858	5259-88-1	3554	3554	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3347	81794	130000-40-7	3555	3555	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3348	83092	1072957-71-1	3556	3556	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3349	83106	581809-46-3	3557	3557	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3350	83113	907204-31-3	3558	3558	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3351	81793	123572-88-3	3559	3559	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3352	83126	881685-58-1	3560	3560	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3353	83134	494793-67-8	3561	3561	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3354	81777	183675-82-3	3562	3562	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3355	83173	874967-67-6	3563	3563	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3356	81822	188425-85-6	3564	3564	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3357	40909	131860-33-8	3565	Preventive, curative, and systemic	3565	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3358	83185	850881-70-8	3566	3566	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3359	83187	238410-11-2	3567	3567	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3360	83194	918162-02-4	3568	3568	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3361	83197	117428-22-5	3569	3569	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3362	83202	862588-11-2	3570	3570	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3363	83205	173662-97-0	3571	3571	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3364	78780	175013-18-0	3572	3572	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3365	83212	915410-70-7	3573	3573	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3366	83213	902760-40-1	3574	3574	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3367	2962	143390-89-0	3575	3575	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3368	81833	141517-21-7	3576	3576	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3369	83218	149961-52-4	3577	3577	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3370	83220	366815-39-6	3578	3578	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3371	81831	133408-50-1	3579	3579	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3372	81832	248593-16-0	3580	3580	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3373	59340	131807-57-3	3581	3581	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3374	83253	361377-29-9	3582	3582	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3375	83258	161326-34-7	3583	3583	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3376	83261	799247-52-2	3584	3584	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3377	81841	120116-88-3	3585	3585	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
3378	81846	348635-87-0	3586	3586	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
3379	82153	485-31-4	3587	3587	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
3380	83372	131-72-6	3588	3588	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
3381	83379	39300-45-3	3589	3589	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
3382	81843	79622-59-6	3590	3590	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
3383	81844	89269-64-7	3591	3591	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
3384	81918	900-95-8	3592	3592	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
3385	35036	639-58-7	3593	3593	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
3386	30473	76-87-9	3594	3594	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
3387	83393	175217-20-6	3595	3595	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
3388	83398	865318-97-4	3596	3596	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
3389	4045	121552-61-2	3597	3597	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
3390	6751	110235-47-7	3598	3598	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
3391	8674	53112-28-0	3599	3599	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
3392	15353	2079-00-7	3600	3600	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
3393	81419	6980-18-3	3601	3601	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
3394	17076	57-92-1	3602	3602	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
3395	27701	79-57-2	3603	3603	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
3396	82040	124495-18-7	3604	3604	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
3397	83555	189278-12-4	3605	3605	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
3398	34759	74738-17-3	3606	3606	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
3399	81763	131341-86-1	3607	3607	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
3400	3656	84332-86-5	3608	3608	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3401	28909	36734-19-7	3609	Preventive, early curative, and systemic	3609	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3402	8450	32809-16-8	3610	3610	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3403		50471-44-8	3611	3611	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3404			3612	3612	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
3405		17109-49-8	3613	3613	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4165	81801	106917-52-6	4367	4367	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
3406		26087-47-8	3614	3614	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3407		13457-18-6	3615	3615	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3408		50512-35-1	3616	3616	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3409	17097	92-52-4	3617	3617	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3410	3628	2675-77-6	3618	3618	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3411	27864	99-30-9	3619	3619	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3412	34908	82-68-8	3620	3620	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3413	82044	117-18-0	3621	3621	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3414	81731	57018-04-9	3622	3622	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3415	81761	2593-15-9	3623	3623	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3416	83279	55406-53-6	3624	3624	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
3417	82033	24579-73-5	3625	3625	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
3418	82084	19622-08-3	3626	3626	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
3419			3627	3627	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
3420			3628	3628	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3421			3629	3629	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3422			3630	3630	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3423			3631	3631	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3424	83629		3632	3632	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
3425		26644-46-2	3633	3633	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3426		88283-41-4	3634	3634	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4166	81759	62865-36-5	4368	4368	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
3427		847749-37-5	3635	3635	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3428	4998	60168-88-9	3636	3636	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3429	7645	63284-71-9	3637	3637	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3430		35554-44-0	3638	3638	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3431		134074-64-9	3639	3639	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3432		101903-30-4	3640	3640	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3433		67747-09-5	3641	3641	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3434		68694-11-1	3642	3642	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3435		60207-31-0	3643	3643	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3436		55179-31-2	3644	3644	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3512	17909	7704-34-9	3720	3720	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3437		116255-48-2	3645	3645	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3438		94361-06-5	3646	3646	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3439		119446-68-3	3647	3647	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3440		83657-18-5	3648	3648	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3441		133855-98-8	3649	3649	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3442		60207-93-4	3650	3650	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3443		114369-43-6	3651	3651	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3444		136426-54-5	3652	3652	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3445		85509-19-9	3653	3653	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3446		76674-21-0	3654	3654	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3545	5827	10004-44-1	3751	3751	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
3447		79983-71-4	3655	3655	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3448		86598-92-7	3656	3656	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3449		125225-28-7	3657	3657	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3450		125116-23-6	3658	3658	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3451		88671-89-0	3659	3659	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3452		66246-88-6	3660	3660	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3453		60207-90-1	3661	3661	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3454		149508-90-7	3662	3662	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3455		107534-96-3	3663	3663	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3456		112281-77-3	3664	3664	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3546	81936	26530-20-1	3752	3752	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
3457		43121-43-3	3665	3665	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3458		55219-65-3	3666	3666	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3459		131983-72-7	3667	3667	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3460		178928-70-6	3668	3668	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3461	83295	91315-15-0	3669	Systemic	3669	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3462	81960	1593-77-7	3670	Systemic	3670	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3463	50145	67564-91-4	3671	Systemic	3671	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3464	9700	81412-43-3	3672	Systemic	3672	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3465	81917	67306-00-7	3673	Systemic	3673	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3466	83283	3478-94-2	3674	3674	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3467	9242	118134-30-8	3675	Systemic	3675	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3468	81853	126833-17-8	3676	Locally systemic	3676	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
3469	83327	473798-59-3	3677	3677	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
3470	81736	88678-67-5	3678	Systemic	3678	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
3471	7451	65472-88-0	3679	Various	3679	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
3472	9448	91161-71-6	3680	Various	3680	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
3473		37248-47-8	3681	3681	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
3474		11113-80-7	3682	3682	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
3475	81848	110488-70-5	3683	3683	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3476	83428	211867-47-9	3684	3684	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3477	83663	868390-90-3	3685	3685	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3478	83601	413615-35-7	3686	3686	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3479	82023	140923-17-7	3687	3687	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3480	83610	283159-90-0	3688	3688	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3481	81802	374726-62-2	3689	3689	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3482	47617	27355-22-2	3690	3690	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
3483	45141	57369-32-1	3691	3691	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
3484	81783	41814-78-2	3692	3692	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
3485		104030-54-8	3693	3693	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
3486		139920-32-4	3694	3694	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
3487		115852-48-7	3695	3695	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
3488		135158-54-2	3696	3696	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
3489		27605-76-1	3697	3697	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
3490	81825	223580-51-6	3698	3698	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
3491	83657	224049-04-1	3699	3699	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
3492		9008-22-4	3700	3700	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
3493			3701	3701	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
3494		57966-95-7	3702	3702	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
3495		39148-24-8	3703	3703	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
3496		13598-36-2	3704	3704	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
3497	83341	76280-91-6	3705	3705	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
3498	83335	72459-58-6	3706	3706	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
3499	81801	106917-52-6	3707	3707	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
3500	81759	62865-36-5	3708	3708	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
3501	81933	66952-49-6	3709	3709	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
3502	81797	180409-60-3	3710	3710	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
3503	83345	220899-03-6	3711	3711	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
3504	83346	688046-61-9	3712	3712	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
3505	74889	2439-10-3	3713	3713	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
3506	83277	958647-10-4	3714	3714	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
3507	81844	89269-64-7	3715	3715	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
3508	83268	1003318-67-9	3716	3716	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
3509	83266	376645-78-2	3717	3717	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
3510			3718	3718	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
4167	81933	66952-49-6	4369	4369	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
3513	5015	14484-64-1	3721	3721	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3514	52492	8018-01-7	3722	3722	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3515	52497	12427-38-2	3723	3723	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3516	81539	9006-42-2	3724	3724	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3517	81755	12071-83-9	3725	3725	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3518	9495	137-26-8	3726	3726	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3519	52498	12122-67-7	3727	3727	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3520	79736	137-30-4	3728	3728	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3521	34608	133-06-2	3729	3729	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3522	81938	2425-06-1	3730	3730	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3523	82019	133-07-3	3731	3731	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3524	3639	1897-45-6	3732	3732	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3525	74875	1085-98-9	3733	3733	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3526	75182	731-27-1	3734	3734	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3527	82843	108173-90-6	3735	3735	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3528	5569	13516-27-3	3736	3736	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3529	82076	101-05-3	3737	3737	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3530	81842	3347-22-6	3738	3738	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3531	34620	2439-01-2	3739	3739	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3532	81826	41205-21-4	3740	3740	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3535	3009	71626-11-4	3741	3741	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3536	82779	98243-83-5	3742	3742	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3537	5194	57646-30-7	3743	3743	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3538	6790	57837-19-1	3744	3744	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3539	60607	70630-17-0	3745	3745	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3540	81937	77732-09-3	3746	3746	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3541	81969	58810-48-3	3747	3747	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3542	81952	41483-43-6	3748	3748	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3543	81958	5221-53-4	3749	3749	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3544	81989	23947-60-6	3750	3750	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3547	138856	14698-29-4	3753	3753	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
3548	3015	17804-35-2	3754	Systemic	3754	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3549	3392	10605-21-7	3755	Systemic	3755	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3550	81926	3878-19-1	3756	3756	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3551	45979	148-79-8	3757	3757	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3552	82060	23564-06-9	3758	3758	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3553	35014	23564-05-8	3759	Systemic	3759	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3554	4520	87130-20-9	3760	Systemic	3760	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
3555	82048	156052-68-5	3761	3761	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
3556	82856	162650-77-3	3762	3762	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
3557	7957	66063-05-6	3763	3763	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
3558	81764	239110-15-7	3764	3764	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
3559	82860	130339-07-0	3765	3765	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
3560	38628	129558-76-5	3766	3766	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
3561	82052	15310-01-7	3767	3767	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3562	81792	66332-96-5	3768	3768	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3563	81823	55814-41-0	3769	3769	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3564	83065	875915-78-9	3770	3770	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3565	83070	658066-35-4	3771	3771	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3566	81994	24691-80-3	3772	3772	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3567	3405	5234-68-4	3773	Systemic	3773	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3606	81918	900-95-8	3812	3812	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
3568	7858	5259-88-1	3774	3774	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3569	81794	130000-40-7	3775	3775	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3570	83092	1072957-71-1	3776	3776	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3571	83106	581809-46-3	3777	3777	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3572	83113	907204-31-3	3778	3778	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3573	81793	123572-88-3	3779	3779	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3574	83126	881685-58-1	3780	3780	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3575	83134	494793-67-8	3781	3781	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3576	81777	183675-82-3	3782	3782	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3577	83173	874967-67-6	3783	3783	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3578	81822	188425-85-6	3784	3784	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3579	40909	131860-33-8	3785	Preventive, curative, and systemic	3785	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3580	83185	850881-70-8	3786	3786	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3581	83187	238410-11-2	3787	3787	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3582	83194	918162-02-4	3788	3788	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3583	83197	117428-22-5	3789	3789	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3584	83202	862588-11-2	3790	3790	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3585	83205	173662-97-0	3791	3791	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3586	78780	175013-18-0	3792	3792	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3587	83212	915410-70-7	3793	3793	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3588	83213	902760-40-1	3794	3794	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3589	2962	143390-89-0	3795	3795	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3590	81833	141517-21-7	3796	3796	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3591	83218	149961-52-4	3797	3797	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3592	83220	366815-39-6	3798	3798	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3593	81831	133408-50-1	3799	3799	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3594	81832	248593-16-0	3800	3800	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3595	59340	131807-57-3	3801	3801	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3596	83253	361377-29-9	3802	3802	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3597	83258	161326-34-7	3803	3803	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3598	83261	799247-52-2	3804	3804	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3599	81841	120116-88-3	3805	3805	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
3600	81846	348635-87-0	3806	3806	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
3601	82153	485-31-4	3807	3807	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
3602	83372	131-72-6	3808	3808	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
3603	83379	39300-45-3	3809	3809	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
3604	81843	79622-59-6	3810	3810	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
3605	81844	89269-64-7	3811	3811	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
3607	35036	639-58-7	3813	3813	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
3608	30473	76-87-9	3814	3814	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
3609	83393	175217-20-6	3815	3815	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
3610	83398	865318-97-4	3816	3816	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
3611	4045	121552-61-2	3817	3817	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
3612	6751	110235-47-7	3818	3818	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
3613	8674	53112-28-0	3819	3819	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
3614	15353	2079-00-7	3820	3820	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
3615	81419	6980-18-3	3821	3821	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
3616	17076	57-92-1	3822	3822	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
3617	27701	79-57-2	3823	3823	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
3618	82040	124495-18-7	3824	3824	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
3619	83555	189278-12-4	3825	3825	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
3620	34759	74738-17-3	3826	3826	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
3621	81763	131341-86-1	3827	3827	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
3622	3656	84332-86-5	3828	3828	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3623	28909	36734-19-7	3829	Preventive, early curative, and systemic	3829	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3624	8450	32809-16-8	3830	3830	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3625		50471-44-8	3831	3831	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3626			3832	3832	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
3627		17109-49-8	3833	3833	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3628		26087-47-8	3834	3834	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3629		13457-18-6	3835	3835	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3630		50512-35-1	3836	3836	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3631	17097	92-52-4	3837	3837	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3632	3628	2675-77-6	3838	3838	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3633	27864	99-30-9	3839	3839	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3634	34908	82-68-8	3840	3840	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3635	82044	117-18-0	3841	3841	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3636	81731	57018-04-9	3842	3842	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3637	81761	2593-15-9	3843	3843	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3638	83279	55406-53-6	3844	3844	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
3639	82033	24579-73-5	3845	3845	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
3640	82084	19622-08-3	3846	3846	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
3641			3847	3847	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
3642			3848	3848	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3643			3849	3849	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3644			3850	3850	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3645			3851	3851	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3646	83629		3852	3852	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
3647		26644-46-2	3853	3853	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3648		88283-41-4	3854	3854	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3649		847749-37-5	3855	3855	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3650	4998	60168-88-9	3856	3856	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3651	7645	63284-71-9	3857	3857	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3652		35554-44-0	3858	3858	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3653		134074-64-9	3859	3859	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3654		101903-30-4	3860	3860	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3655		67747-09-5	3861	3861	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3656		68694-11-1	3862	3862	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3657		60207-31-0	3863	3863	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3658		55179-31-2	3864	3864	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3659		116255-48-2	3865	3865	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3660		94361-06-5	3866	3866	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3926	47617	27355-22-2	4130	4130	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
3661		119446-68-3	3867	3867	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3662		83657-18-5	3868	3868	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3663		133855-98-8	3869	3869	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3664		60207-93-4	3870	3870	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3665		114369-43-6	3871	3871	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3666		136426-54-5	3872	3872	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3667		85509-19-9	3873	3873	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3668		76674-21-0	3874	3874	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3669		79983-71-4	3875	3875	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3670		86598-92-7	3876	3876	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3927	45141	57369-32-1	4131	4131	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
3671		125225-28-7	3877	3877	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3672		125116-23-6	3878	3878	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3673		88671-89-0	3879	3879	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3674		66246-88-6	3880	3880	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3675		60207-90-1	3881	3881	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3676		149508-90-7	3882	3882	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3677		107534-96-3	3883	3883	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3678		112281-77-3	3884	3884	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3679		43121-43-3	3885	3885	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3680		55219-65-3	3886	3886	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3928	81783	41814-78-2	4132	4132	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
3681		131983-72-7	3887	3887	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3682		178928-70-6	3888	3888	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3683	83295	91315-15-0	3889	Systemic	3889	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3684	81960	1593-77-7	3890	Systemic	3890	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3685	50145	67564-91-4	3891	Systemic	3891	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3686	9700	81412-43-3	3892	Systemic	3892	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3687	81917	67306-00-7	3893	Systemic	3893	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3688	83283	3478-94-2	3894	3894	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3689	9242	118134-30-8	3895	Systemic	3895	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3690	81853	126833-17-8	3896	Locally systemic	3896	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
3691	83327	473798-59-3	3897	3897	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
3692	81736	88678-67-5	3898	Systemic	3898	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
3693	7451	65472-88-0	3899	Various	3899	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
3694	9448	91161-71-6	3900	Various	3900	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
3695		37248-47-8	3901	3901	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
3696		11113-80-7	3902	3902	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
3697	81848	110488-70-5	3903	3903	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3698	83428	211867-47-9	3904	3904	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3699	83663	868390-90-3	3905	3905	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3700	83601	413615-35-7	3906	3906	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3701	82023	140923-17-7	3907	3907	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3702	83610	283159-90-0	3908	3908	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3703	81802	374726-62-2	3909	3909	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3704	47617	27355-22-2	3910	3910	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
3705	45141	57369-32-1	3911	3911	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
3706	81783	41814-78-2	3912	3912	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
3707		104030-54-8	3913	3913	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
3708		139920-32-4	3914	3914	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
3709		115852-48-7	3915	3915	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
3710		135158-54-2	3916	3916	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
3711		27605-76-1	3917	3917	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
3712	81825	223580-51-6	3918	3918	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
3713	83657	224049-04-1	3919	3919	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
3714		9008-22-4	3920	3920	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
3715			3921	3921	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
3716		57966-95-7	3922	3922	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
3717		39148-24-8	3923	3923	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
3718		13598-36-2	3924	3924	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
3719	83341	76280-91-6	3925	3925	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
3720	83335	72459-58-6	3926	3926	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
3721	81801	106917-52-6	3927	3927	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
3722	81759	62865-36-5	3928	3928	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
3723	81933	66952-49-6	3929	3929	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
3724	81797	180409-60-3	3930	3930	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
3725	83345	220899-03-6	3931	3931	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
3726	83346	688046-61-9	3932	3932	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
3727	74889	2439-10-3	3933	3933	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
3728	83277	958647-10-4	3934	3934	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
3729	81844	89269-64-7	3935	3935	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
3730	83268	1003318-67-9	3936	3936	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
3731	83266	376645-78-2	3937	3937	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
3732			3938	3938	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
3733		7440-50-8	3939	3939	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3734	17909	7704-34-9	3940	3940	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3735	5015	14484-64-1	3941	3941	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3736	52492	8018-01-7	3942	3942	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3737	52497	12427-38-2	3943	3943	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3738	81539	9006-42-2	3944	3944	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3739	81755	12071-83-9	3945	3945	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3740	9495	137-26-8	3946	3946	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3741	52498	12122-67-7	3947	3947	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3742	79736	137-30-4	3948	3948	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3743	34608	133-06-2	3949	3949	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3744	81938	2425-06-1	3950	3950	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3745	82019	133-07-3	3951	3951	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3746	3639	1897-45-6	3952	3952	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3747	74875	1085-98-9	3953	3953	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3748	75182	731-27-1	3954	3954	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3749	82843	108173-90-6	3955	3955	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3750	5569	13516-27-3	3956	3956	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3751	82076	101-05-3	3957	3957	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3752	81842	3347-22-6	3958	3958	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3753	34620	2439-01-2	3959	3959	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3754	81826	41205-21-4	3960	3960	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3757	3009	71626-11-4	3961	3961	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3758	82779	98243-83-5	3962	3962	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3759	5194	57646-30-7	3963	3963	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3760	6790	57837-19-1	3964	3964	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3761	60607	70630-17-0	3965	3965	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3762	81937	77732-09-3	3966	3966	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3763	81969	58810-48-3	3967	3967	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3764	81952	41483-43-6	3968	3968	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3765	81958	5221-53-4	3969	3969	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3766	81989	23947-60-6	3970	3970	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3767	5827	10004-44-1	3971	3971	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
3768	81936	26530-20-1	3972	3972	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
3769	138856	14698-29-4	3973	3973	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
3770	3015	17804-35-2	3974	Systemic	3974	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3771	3392	10605-21-7	3975	Systemic	3975	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3772	81926	3878-19-1	3976	3976	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3773	45979	148-79-8	3977	3977	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3774	82060	23564-06-9	3978	3978	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3775	35014	23564-05-8	3979	Systemic	3979	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3776	4520	87130-20-9	3980	Systemic	3980	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
3777	82048	156052-68-5	3981	3981	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
3778	82856	162650-77-3	3982	3982	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
3779	7957	66063-05-6	3983	3983	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
3780	81764	239110-15-7	3984	3984	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
3781	82860	130339-07-0	3985	3985	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
3782	38628	129558-76-5	3986	3986	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
3783	82052	15310-01-7	3987	3987	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3784	81792	66332-96-5	3988	3988	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3785	81823	55814-41-0	3989	3989	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3786	83065	875915-78-9	3990	3990	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3787	83070	658066-35-4	3991	3991	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3788	81994	24691-80-3	3992	3992	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3789	3405	5234-68-4	3993	Systemic	3993	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3790	7858	5259-88-1	3994	3994	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3791	81794	130000-40-7	3995	3995	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3792	83092	1072957-71-1	3996	3996	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3793	83106	581809-46-3	3997	3997	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3794	83113	907204-31-3	3998	3998	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3795	81793	123572-88-3	3999	3999	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3796	83126	881685-58-1	4000	4000	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3797	83134	494793-67-8	4001	4001	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3798	81777	183675-82-3	4002	4002	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3799	83173	874967-67-6	4003	4003	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3800	81822	188425-85-6	4004	4004	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
3801	40909	131860-33-8	4005	Preventive, curative, and systemic	4005	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3802	83185	850881-70-8	4006	4006	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3803	83187	238410-11-2	4007	4007	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3804	83194	918162-02-4	4008	4008	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3805	83197	117428-22-5	4009	4009	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3806	83202	862588-11-2	4010	4010	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3807	83205	173662-97-0	4011	4011	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3808	78780	175013-18-0	4012	4012	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3809	83212	915410-70-7	4013	4013	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3810	83213	902760-40-1	4014	4014	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3811	2962	143390-89-0	4015	4015	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3812	81833	141517-21-7	4016	4016	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3813	83218	149961-52-4	4017	4017	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3814	83220	366815-39-6	4018	4018	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3815	81831	133408-50-1	4019	4019	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3816	81832	248593-16-0	4020	4020	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3817	59340	131807-57-3	4021	4021	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3818	83253	361377-29-9	4022	4022	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3819	83258	161326-34-7	4023	4023	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3820	83261	799247-52-2	4024	4024	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
3821	81841	120116-88-3	4025	4025	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
3822	81846	348635-87-0	4026	4026	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
3823	82153	485-31-4	4027	4027	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
3824	83372	131-72-6	4028	4028	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
3825	83379	39300-45-3	4029	4029	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
3826	81843	79622-59-6	4030	4030	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
3827	81844	89269-64-7	4031	4031	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
3828	81918	900-95-8	4032	4032	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
3829	35036	639-58-7	4033	4033	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
3830	30473	76-87-9	4034	4034	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
3831	83393	175217-20-6	4035	4035	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
3832	83398	865318-97-4	4036	4036	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
3833	4045	121552-61-2	4037	4037	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
3834	6751	110235-47-7	4038	4038	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
3835	8674	53112-28-0	4039	4039	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
3836	15353	2079-00-7	4040	4040	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
3837	81419	6980-18-3	4041	4041	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
3838	17076	57-92-1	4042	4042	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
3839	27701	79-57-2	4043	4043	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
3840	82040	124495-18-7	4044	4044	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
3841	83555	189278-12-4	4045	4045	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
3842	34759	74738-17-3	4046	4046	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
3843	81763	131341-86-1	4047	4047	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
3844	3656	84332-86-5	4048	4048	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3845	28909	36734-19-7	4049	Preventive, early curative, and systemic	4049	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3846	8450	32809-16-8	4050	4050	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3847		50471-44-8	4051	4051	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
3848			4052	4052	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
3849		17109-49-8	4053	4053	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3850		26087-47-8	4054	4054	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3851		13457-18-6	4055	4055	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3852		50512-35-1	4056	4056	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
3853	17097	92-52-4	4057	4057	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3854	3628	2675-77-6	4058	4058	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3855	27864	99-30-9	4059	4059	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3856	34908	82-68-8	4060	4060	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3857	82044	117-18-0	4061	4061	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3858	81731	57018-04-9	4062	4062	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3859	81761	2593-15-9	4063	4063	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
3860	83279	55406-53-6	4064	4064	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
3861	82033	24579-73-5	4065	4065	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
3862	82084	19622-08-3	4066	4066	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
3863			4067	4067	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
3864			4068	4068	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3865			4069	4069	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3866			4070	4070	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3867			4071	4071	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
3868	83629		4072	4072	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
3869		26644-46-2	4073	4073	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3870		88283-41-4	4074	4074	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3871		847749-37-5	4075	4075	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3872	4998	60168-88-9	4076	4076	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3873	7645	63284-71-9	4077	4077	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3874		35554-44-0	4078	4078	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3875		134074-64-9	4079	4079	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3876		101903-30-4	4080	4080	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3877		67747-09-5	4081	4081	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3878		68694-11-1	4082	4082	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3879		60207-31-0	4083	4083	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3880		55179-31-2	4084	4084	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3881		116255-48-2	4085	4085	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3882		94361-06-5	4086	4086	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3883		119446-68-3	4087	4087	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4159			4361	4361	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
3884		83657-18-5	4088	4088	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3885		133855-98-8	4089	4089	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3886		60207-93-4	4090	4090	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3887		114369-43-6	4091	4091	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3888		136426-54-5	4092	4092	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3889		85509-19-9	4093	4093	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3890		76674-21-0	4094	4094	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3891		79983-71-4	4095	4095	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3892		86598-92-7	4096	4096	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3893		125225-28-7	4097	4097	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4160		57966-95-7	4362	4362	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
3894		125116-23-6	4098	4098	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3895		88671-89-0	4099	4099	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3896		66246-88-6	4100	4100	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3897		60207-90-1	4101	4101	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3898		149508-90-7	4102	4102	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3899		107534-96-3	4103	4103	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3900		112281-77-3	4104	4104	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3901		43121-43-3	4105	4105	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3902		55219-65-3	4106	4106	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3903		131983-72-7	4107	4107	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3966	81938	2425-06-1	4170	4170	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3904		178928-70-6	4108	4108	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
3905	83295	91315-15-0	4109	Systemic	4109	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3906	81960	1593-77-7	4110	Systemic	4110	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3907	50145	67564-91-4	4111	Systemic	4111	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3908	9700	81412-43-3	4112	Systemic	4112	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3909	81917	67306-00-7	4113	Systemic	4113	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3910	83283	3478-94-2	4114	4114	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3911	9242	118134-30-8	4115	Systemic	4115	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
3912	81853	126833-17-8	4116	Locally systemic	4116	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
3913	83327	473798-59-3	4117	4117	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
3914	81736	88678-67-5	4118	Systemic	4118	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
3915	7451	65472-88-0	4119	Various	4119	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
3916	9448	91161-71-6	4120	Various	4120	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
3917		37248-47-8	4121	4121	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
3918		11113-80-7	4122	4122	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
3919	81848	110488-70-5	4123	4123	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3920	83428	211867-47-9	4124	4124	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3921	83663	868390-90-3	4125	4125	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3922	83601	413615-35-7	4126	4126	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3923	82023	140923-17-7	4127	4127	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3924	83610	283159-90-0	4128	4128	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3925	81802	374726-62-2	4129	4129	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
3929		104030-54-8	4133	4133	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
3930		139920-32-4	4134	4134	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
3931		115852-48-7	4135	4135	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
3932		135158-54-2	4136	4136	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
3933		27605-76-1	4137	4137	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
3934	81825	223580-51-6	4138	4138	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
3935	83657	224049-04-1	4139	4139	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
3936		9008-22-4	4140	4140	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
3937			4141	4141	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
3938		57966-95-7	4142	4142	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
3939		39148-24-8	4143	4143	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
3940		13598-36-2	4144	4144	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
3941	83341	76280-91-6	4145	4145	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
3942	83335	72459-58-6	4146	4146	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
3943	81801	106917-52-6	4147	4147	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
3944	81759	62865-36-5	4148	4148	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
3945	81933	66952-49-6	4149	4149	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
3946	81797	180409-60-3	4150	4150	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
3947	83345	220899-03-6	4151	4151	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
3948	83346	688046-61-9	4152	4152	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
3949	74889	2439-10-3	4153	4153	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
3950	83277	958647-10-4	4154	4154	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
3951	81844	89269-64-7	4155	4155	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
3952	83268	1003318-67-9	4156	4156	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
3953	83266	376645-78-2	4157	4157	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
3954			4158	4158	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
3955		7440-50-8	4159	4159	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3956	17909	7704-34-9	4160	4160	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3957	5015	14484-64-1	4161	4161	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3958	52492	8018-01-7	4162	4162	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3959	52497	12427-38-2	4163	4163	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3960	81539	9006-42-2	4164	4164	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3961	81755	12071-83-9	4165	4165	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3962	9495	137-26-8	4166	4166	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3963	52498	12122-67-7	4167	4167	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3964	79736	137-30-4	4168	4168	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3965	34608	133-06-2	4169	4169	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3967	82019	133-07-3	4171	4171	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3968	3639	1897-45-6	4172	4172	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3969	74875	1085-98-9	4173	4173	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3970	75182	731-27-1	4174	4174	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3971	82843	108173-90-6	4175	4175	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3972	5569	13516-27-3	4176	4176	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3973	82076	101-05-3	4177	4177	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3974	81842	3347-22-6	4178	4178	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3975	34620	2439-01-2	4179	4179	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3976	81826	41205-21-4	4180	4180	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
3979	3009	71626-11-4	4181	4181	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3980	82779	98243-83-5	4182	4182	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3981	5194	57646-30-7	4183	4183	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3982	6790	57837-19-1	4184	4184	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3983	60607	70630-17-0	4185	4185	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3984	81937	77732-09-3	4186	4186	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3985	81969	58810-48-3	4187	4187	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3986	81952	41483-43-6	4188	4188	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3987	81958	5221-53-4	4189	4189	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3988	81989	23947-60-6	4190	4190	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
3989	5827	10004-44-1	4191	4191	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
3990	81936	26530-20-1	4192	4192	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
3991	138856	14698-29-4	4193	4193	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
3992	3015	17804-35-2	4194	Systemic	4194	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3993	3392	10605-21-7	4195	Systemic	4195	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3994	81926	3878-19-1	4196	4196	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3995	45979	148-79-8	4197	4197	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4084	82084	19622-08-3	4286	4286	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
3996	82060	23564-06-9	4198	4198	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3997	35014	23564-05-8	4199	Systemic	4199	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
3998	4520	87130-20-9	4200	Systemic	4200	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
3999	82048	156052-68-5	4201	4201	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
4000	82856	162650-77-3	4202	4202	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
4001	7957	66063-05-6	4203	4203	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
4002	81764	239110-15-7	4204	4204	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
4003	82860	130339-07-0	4205	4205	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
4004	38628	129558-76-5	4206	4206	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
4005	82052	15310-01-7	4207	4207	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4006	81792	66332-96-5	4208	4208	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4007	81823	55814-41-0	4209	4209	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4008	83065	875915-78-9	4210	4210	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4009	83070	658066-35-4	4211	4211	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4010	81994	24691-80-3	4212	4212	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4011	3405	5234-68-4	4213	Systemic	4213	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4012	7858	5259-88-1	4214	4214	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4013	81794	130000-40-7	4215	4215	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4014	83092	1072957-71-1	4216	4216	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4015	83106	581809-46-3	4217	4217	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4016	83113	907204-31-3	4218	4218	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4017	81793	123572-88-3	4219	4219	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4018	83126	881685-58-1	4220	4220	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4019	83134	494793-67-8	4221	4221	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4020	81777	183675-82-3	4222	4222	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4021	83173	874967-67-6	4223	4223	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4022	81822	188425-85-6	4224	4224	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4023	40909	131860-33-8	4225	Preventive, curative, and systemic	4225	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4024	83185	850881-70-8	4226	4226	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4025	83187	238410-11-2	4227	4227	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4026	83194	918162-02-4	4228	4228	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4027	83197	117428-22-5	4229	4229	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4028	83202	862588-11-2	4230	4230	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4029	83205	173662-97-0	4231	4231	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4030	78780	175013-18-0	4232	4232	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4031	83212	915410-70-7	4233	4233	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4032	83213	902760-40-1	4234	4234	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4033	2962	143390-89-0	4235	4235	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4085			4287	4287	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
4034	81833	141517-21-7	4236	4236	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4035	83218	149961-52-4	4237	4237	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4036	83220	366815-39-6	4238	4238	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4037	81831	133408-50-1	4239	4239	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4038	81832	248593-16-0	4240	4240	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4039	59340	131807-57-3	4241	4241	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4040	83253	361377-29-9	4242	4242	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4041	83258	161326-34-7	4243	4243	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4042	83261	799247-52-2	4244	4244	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4043	81841	120116-88-3	4245	4245	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
4044	81846	348635-87-0	4246	4246	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
4045	82153	485-31-4	4247	4247	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
4046	83372	131-72-6	4248	4248	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
4047	83379	39300-45-3	4249	4249	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
4048	81843	79622-59-6	4250	4250	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
4049	81844	89269-64-7	4251	4251	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
4050	81918	900-95-8	4252	4252	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
4051	35036	639-58-7	4253	4253	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
4052	30473	76-87-9	4254	4254	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
4053	83393	175217-20-6	4255	4255	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
4054	83398	865318-97-4	4256	4256	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
4055	4045	121552-61-2	4257	4257	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
4056	6751	110235-47-7	4258	4258	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
4057	8674	53112-28-0	4259	4259	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
4058	15353	2079-00-7	4260	4260	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
4059	81419	6980-18-3	4261	4261	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
4060	17076	57-92-1	4262	4262	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
4061	27701	79-57-2	4263	4263	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
4062	82040	124495-18-7	4264	4264	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
4063	83555	189278-12-4	4265	4265	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
4064	34759	74738-17-3	4266	4266	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
4065	81763	131341-86-1	4267	4267	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
4066	3656	84332-86-5	4268	4268	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4067	28909	36734-19-7	4269	Preventive, early curative, and systemic	4269	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4068	8450	32809-16-8	4270	4270	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4069		50471-44-8	4271	4271	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4070			4272	4272	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
4071		17109-49-8	4273	4273	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4072		26087-47-8	4274	4274	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4073		13457-18-6	4275	4275	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4074		50512-35-1	4276	4276	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4075	17097	92-52-4	4277	4277	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4076	3628	2675-77-6	4278	4278	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4077	27864	99-30-9	4279	4279	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4078	34908	82-68-8	4280	4280	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4079	82044	117-18-0	4281	4281	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4080	81731	57018-04-9	4282	4282	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4081	81761	2593-15-9	4283	4283	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4082	83279	55406-53-6	4284	4284	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
4083	82033	24579-73-5	4285	4285	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
4086			4288	4288	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
4087			4289	4289	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
4088			4290	4290	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
4089			4291	4291	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
4090	83629		4292	4292	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
4091		26644-46-2	4293	4293	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4092		88283-41-4	4294	4294	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4093		847749-37-5	4295	4295	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4094	4998	60168-88-9	4296	4296	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4095	7645	63284-71-9	4297	4297	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4096		35554-44-0	4298	4298	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4097		134074-64-9	4299	4299	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4155		27605-76-1	4357	4357	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
4098		101903-30-4	4300	4300	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4099		67747-09-5	4301	4301	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4100		68694-11-1	4302	4302	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4101		60207-31-0	4303	4303	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4102		55179-31-2	4304	4304	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4103		116255-48-2	4305	4305	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4104		94361-06-5	4306	4306	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4105		119446-68-3	4307	4307	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4106		83657-18-5	4308	4308	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4107		133855-98-8	4309	4309	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4156	81825	223580-51-6	4358	4358	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
4108		60207-93-4	4310	4310	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4109		114369-43-6	4311	4311	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4110		136426-54-5	4312	4312	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4111		85509-19-9	4313	4313	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4112		76674-21-0	4314	4314	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4113		79983-71-4	4315	4315	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4114		86598-92-7	4316	4316	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4115		125225-28-7	4317	4317	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4116		125116-23-6	4318	4318	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4117		88671-89-0	4319	4319	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4157	83657	224049-04-1	4359	4359	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
4118		66246-88-6	4320	4320	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4119		60207-90-1	4321	4321	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4120		149508-90-7	4322	4322	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4121		107534-96-3	4323	4323	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4122		112281-77-3	4324	4324	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4123		43121-43-3	4325	4325	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4124		55219-65-3	4326	4326	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4125		131983-72-7	4327	4327	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4126		178928-70-6	4328	4328	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4127	83295	91315-15-0	4329	Systemic	4329	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4128	81960	1593-77-7	4330	Systemic	4330	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4129	50145	67564-91-4	4331	Systemic	4331	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4130	9700	81412-43-3	4332	Systemic	4332	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4131	81917	67306-00-7	4333	Systemic	4333	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4132	83283	3478-94-2	4334	4334	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4133	9242	118134-30-8	4335	Systemic	4335	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4134	81853	126833-17-8	4336	Locally systemic	4336	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
4135	83327	473798-59-3	4337	4337	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
4136	81736	88678-67-5	4338	Systemic	4338	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
4137	7451	65472-88-0	4339	Various	4339	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
4138	9448	91161-71-6	4340	Various	4340	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
4139		37248-47-8	4341	4341	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
4140		11113-80-7	4342	4342	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
4141	81848	110488-70-5	4343	4343	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4142	83428	211867-47-9	4344	4344	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4143	83663	868390-90-3	4345	4345	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4144	83601	413615-35-7	4346	4346	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4145	82023	140923-17-7	4347	4347	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4146	83610	283159-90-0	4348	4348	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4147	81802	374726-62-2	4349	4349	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4148	47617	27355-22-2	4350	4350	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
4149	45141	57369-32-1	4351	4351	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
4150	81783	41814-78-2	4352	4352	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
4151		104030-54-8	4353	4353	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
4152		139920-32-4	4354	4354	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
4153		115852-48-7	4355	4355	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
4154		135158-54-2	4356	4356	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
4158		9008-22-4	4360	4360	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
4168	81797	180409-60-3	4370	4370	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
4169	83345	220899-03-6	4371	4371	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
4170	83346	688046-61-9	4372	4372	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
4171	74889	2439-10-3	4373	4373	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
4172	83277	958647-10-4	4374	4374	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
4173	81844	89269-64-7	4375	4375	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
4174	83268	1003318-67-9	4376	4376	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
4175	83266	376645-78-2	4377	4377	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
4176			4378	4378	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
4177		7440-50-8	4379	4379	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4178	17909	7704-34-9	4380	4380	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4179	5015	14484-64-1	4381	4381	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4180	52492	8018-01-7	4382	4382	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4181	52497	12427-38-2	4383	4383	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4182	81539	9006-42-2	4384	4384	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4183	81755	12071-83-9	4385	4385	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4184	9495	137-26-8	4386	4386	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4185	52498	12122-67-7	4387	4387	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4186	79736	137-30-4	4388	4388	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4187	34608	133-06-2	4389	4389	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4188	81938	2425-06-1	4390	4390	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4189	82019	133-07-3	4391	4391	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4190	3639	1897-45-6	4392	4392	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4191	74875	1085-98-9	4393	4393	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4192	75182	731-27-1	4394	4394	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4193	82843	108173-90-6	4395	4395	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4194	5569	13516-27-3	4396	4396	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4195	82076	101-05-3	4397	4397	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4196	81842	3347-22-6	4398	4398	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4197	34620	2439-01-2	4399	4399	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4198	81826	41205-21-4	4400	4400	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4201	3009	71626-11-4	4401	4401	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4361		37248-47-8	4561	4561	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
4202	82779	98243-83-5	4402	4402	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4203	5194	57646-30-7	4403	4403	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4204	6790	57837-19-1	4404	4404	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4205	60607	70630-17-0	4405	4405	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4206	81937	77732-09-3	4406	4406	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4207	81969	58810-48-3	4407	4407	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4208	81952	41483-43-6	4408	4408	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
4209	81958	5221-53-4	4409	4409	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
4210	81989	23947-60-6	4410	4410	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
4211	5827	10004-44-1	4411	4411	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
4212	81936	26530-20-1	4412	4412	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
4213	138856	14698-29-4	4413	4413	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
4214	3015	17804-35-2	4414	Systemic	4414	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4215	3392	10605-21-7	4415	Systemic	4415	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4216	81926	3878-19-1	4416	4416	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4217	45979	148-79-8	4417	4417	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4218	82060	23564-06-9	4418	4418	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4219	35014	23564-05-8	4419	Systemic	4419	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4220	4520	87130-20-9	4420	Systemic	4420	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
4221	82048	156052-68-5	4421	4421	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
4222	82856	162650-77-3	4422	4422	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
4223	7957	66063-05-6	4423	4423	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
4224	81764	239110-15-7	4424	4424	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
4225	82860	130339-07-0	4425	4425	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
4226	38628	129558-76-5	4426	4426	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
4227	82052	15310-01-7	4427	4427	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4228	81792	66332-96-5	4428	4428	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4229	81823	55814-41-0	4429	4429	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4230	83065	875915-78-9	4430	4430	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4231	83070	658066-35-4	4431	4431	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4232	81994	24691-80-3	4432	4432	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4233	3405	5234-68-4	4433	Systemic	4433	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4234	7858	5259-88-1	4434	4434	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4235	81794	130000-40-7	4435	4435	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4236	83092	1072957-71-1	4436	4436	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4237	83106	581809-46-3	4437	4437	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4238	83113	907204-31-3	4438	4438	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4239	81793	123572-88-3	4439	4439	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4240	83126	881685-58-1	4440	4440	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4241	83134	494793-67-8	4441	4441	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4242	81777	183675-82-3	4442	4442	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4243	83173	874967-67-6	4443	4443	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4261	59340	131807-57-3	4461	4461	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4244	81822	188425-85-6	4444	4444	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4245	40909	131860-33-8	4445	Preventive, curative, and systemic	4445	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4246	83185	850881-70-8	4446	4446	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4247	83187	238410-11-2	4447	4447	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4248	83194	918162-02-4	4448	4448	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4249	83197	117428-22-5	4449	4449	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4250	83202	862588-11-2	4450	4450	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4251	83205	173662-97-0	4451	4451	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4252	78780	175013-18-0	4452	4452	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4253	83212	915410-70-7	4453	4453	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4254	83213	902760-40-1	4454	4454	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4255	2962	143390-89-0	4455	4455	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4256	81833	141517-21-7	4456	4456	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4257	83218	149961-52-4	4457	4457	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4258	83220	366815-39-6	4458	4458	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4259	81831	133408-50-1	4459	4459	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4260	81832	248593-16-0	4460	4460	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4357	83327	473798-59-3	4557	4557	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
4262	83253	361377-29-9	4462	4462	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4263	83258	161326-34-7	4463	4463	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4264	83261	799247-52-2	4464	4464	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4265	81841	120116-88-3	4465	4465	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
4266	81846	348635-87-0	4466	4466	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
4267	82153	485-31-4	4467	4467	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
4268	83372	131-72-6	4468	4468	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
4269	83379	39300-45-3	4469	4469	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
4270	81843	79622-59-6	4470	4470	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
4271	81844	89269-64-7	4471	4471	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
4272	81918	900-95-8	4472	4472	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
4273	35036	639-58-7	4473	4473	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
4274	30473	76-87-9	4474	4474	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
4275	83393	175217-20-6	4475	4475	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
4276	83398	865318-97-4	4476	4476	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
4277	4045	121552-61-2	4477	4477	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
4278	6751	110235-47-7	4478	4478	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
4279	8674	53112-28-0	4479	4479	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
4280	15353	2079-00-7	4480	4480	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
4281	81419	6980-18-3	4481	4481	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
4282	17076	57-92-1	4482	4482	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
4283	27701	79-57-2	4483	4483	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
4284	82040	124495-18-7	4484	4484	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
4285	83555	189278-12-4	4485	4485	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
4286	34759	74738-17-3	4486	4486	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
4287	81763	131341-86-1	4487	4487	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
4288	3656	84332-86-5	4488	4488	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4289	28909	36734-19-7	4489	Preventive, early curative, and systemic	4489	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4290	8450	32809-16-8	4490	4490	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4291		50471-44-8	4491	4491	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4292			4492	4492	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
4293		17109-49-8	4493	4493	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4294		26087-47-8	4494	4494	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4295		13457-18-6	4495	4495	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4296		50512-35-1	4496	4496	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4297	17097	92-52-4	4497	4497	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4298	3628	2675-77-6	4498	4498	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4299	27864	99-30-9	4499	4499	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4300	34908	82-68-8	4500	4500	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4301	82044	117-18-0	4501	4501	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4302	81731	57018-04-9	4502	4502	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4303	81761	2593-15-9	4503	4503	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4304	83279	55406-53-6	4504	4504	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
4305	82033	24579-73-5	4505	4505	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
4306	82084	19622-08-3	4506	4506	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
4307			4507	4507	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
4308			4508	4508	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
4309			4509	4509	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
4310			4510	4510	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
4311			4511	4511	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
4312	83629		4512	4512	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
4313		26644-46-2	4513	4513	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4314		88283-41-4	4514	4514	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4315		847749-37-5	4515	4515	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4316	4998	60168-88-9	4516	4516	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4317	7645	63284-71-9	4517	4517	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4318		35554-44-0	4518	4518	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4319		134074-64-9	4519	4519	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4320		101903-30-4	4520	4520	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4321		67747-09-5	4521	4521	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4322		68694-11-1	4522	4522	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4358	81736	88678-67-5	4558	Systemic	4558	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
4323		60207-31-0	4523	4523	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4324		55179-31-2	4524	4524	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4325		116255-48-2	4525	4525	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4326		94361-06-5	4526	4526	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4327		119446-68-3	4527	4527	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4328		83657-18-5	4528	4528	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4329		133855-98-8	4529	4529	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4330		60207-93-4	4530	4530	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4331		114369-43-6	4531	4531	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4332		136426-54-5	4532	4532	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4359	7451	65472-88-0	4559	Various	4559	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
4333		85509-19-9	4533	4533	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4334		76674-21-0	4534	4534	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4335		79983-71-4	4535	4535	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4336		86598-92-7	4536	4536	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4337		125225-28-7	4537	4537	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4338		125116-23-6	4538	4538	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4339		88671-89-0	4539	4539	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4340		66246-88-6	4540	4540	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4341		60207-90-1	4541	4541	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4342		149508-90-7	4542	4542	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4360	9448	91161-71-6	4560	Various	4560	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
4343		107534-96-3	4543	4543	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4344		112281-77-3	4544	4544	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4345		43121-43-3	4545	4545	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4346		55219-65-3	4546	4546	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4347		131983-72-7	4547	4547	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4348		178928-70-6	4548	4548	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4349	83295	91315-15-0	4549	Systemic	4549	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4350	81960	1593-77-7	4550	Systemic	4550	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4351	50145	67564-91-4	4551	Systemic	4551	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4352	9700	81412-43-3	4552	Systemic	4552	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4353	81917	67306-00-7	4553	Systemic	4553	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4354	83283	3478-94-2	4554	4554	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4355	9242	118134-30-8	4555	Systemic	4555	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4356	81853	126833-17-8	4556	Locally systemic	4556	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
4362		11113-80-7	4562	4562	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
4363	81848	110488-70-5	4563	4563	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4364	83428	211867-47-9	4564	4564	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4365	83663	868390-90-3	4565	4565	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4366	83601	413615-35-7	4566	4566	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4367	82023	140923-17-7	4567	4567	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4368	83610	283159-90-0	4568	4568	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4369	81802	374726-62-2	4569	4569	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4370	47617	27355-22-2	4570	4570	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
4371	45141	57369-32-1	4571	4571	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
4372	81783	41814-78-2	4572	4572	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
4373		104030-54-8	4573	4573	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
4374		139920-32-4	4574	4574	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
4375		115852-48-7	4575	4575	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
4376		135158-54-2	4576	4576	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
4377		27605-76-1	4577	4577	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
4378	81825	223580-51-6	4578	4578	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
4379	83657	224049-04-1	4579	4579	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
4380		9008-22-4	4580	4580	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
4381			4581	4581	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
4382		57966-95-7	4582	4582	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
4383		39148-24-8	4583	4583	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
4384		13598-36-2	4584	4584	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
4385	83341	76280-91-6	4585	4585	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
4386	83335	72459-58-6	4586	4586	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
4387	81801	106917-52-6	4587	4587	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
4388	81759	62865-36-5	4588	4588	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
4389	81933	66952-49-6	4589	4589	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
4390	81797	180409-60-3	4590	4590	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
4391	83345	220899-03-6	4591	4591	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
4392	83346	688046-61-9	4592	4592	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
4393	74889	2439-10-3	4593	4593	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
4394	83277	958647-10-4	4594	4594	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
4395	81844	89269-64-7	4595	4595	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
4396	83268	1003318-67-9	4596	4596	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
4397	83266	376645-78-2	4597	4597	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
4398			4598	4598	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
4399		7440-50-8	4599	4599	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4400	17909	7704-34-9	4600	4600	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4401	5015	14484-64-1	4601	4601	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4402	52492	8018-01-7	4602	4602	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4403	52497	12427-38-2	4603	4603	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4404	81539	9006-42-2	4604	4604	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4405	81755	12071-83-9	4605	4605	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4406	9495	137-26-8	4606	4606	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4407	52498	12122-67-7	4607	4607	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4408	79736	137-30-4	4608	4608	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4409	34608	133-06-2	4609	4609	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4410	81938	2425-06-1	4610	4610	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4411	82019	133-07-3	4611	4611	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4412	3639	1897-45-6	4612	4612	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4413	74875	1085-98-9	4613	4613	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4414	75182	731-27-1	4614	4614	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4415	82843	108173-90-6	4615	4615	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4416	5569	13516-27-3	4616	4616	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4417	82076	101-05-3	4617	4617	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4418	81842	3347-22-6	4618	4618	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4419	34620	2439-01-2	4619	4619	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4420	81826	41205-21-4	4620	4620	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4423	3009	71626-11-4	4621	4621	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4424	82779	98243-83-5	4622	4622	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4425	5194	57646-30-7	4623	4623	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4426	6790	57837-19-1	4624	4624	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4427	60607	70630-17-0	4625	4625	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4428	81937	77732-09-3	4626	4626	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4429	81969	58810-48-3	4627	4627	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4430	81952	41483-43-6	4628	4628	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
4431	81958	5221-53-4	4629	4629	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
4432	81989	23947-60-6	4630	4630	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
4433	5827	10004-44-1	4631	4631	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
4434	81936	26530-20-1	4632	4632	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
4435	138856	14698-29-4	4633	4633	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
4436	3015	17804-35-2	4634	Systemic	4634	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4437	3392	10605-21-7	4635	Systemic	4635	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4438	81926	3878-19-1	4636	4636	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4439	45979	148-79-8	4637	4637	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4440	82060	23564-06-9	4638	4638	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4441	35014	23564-05-8	4639	Systemic	4639	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
4442	4520	87130-20-9	4640	Systemic	4640	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
4443	82048	156052-68-5	4641	4641	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
4444	82856	162650-77-3	4642	4642	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
4445	7957	66063-05-6	4643	4643	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
4446	81764	239110-15-7	4644	4644	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
4447	82860	130339-07-0	4645	4645	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
4448	38628	129558-76-5	4646	4646	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
4449	82052	15310-01-7	4647	4647	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4450	81792	66332-96-5	4648	4648	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4451	81823	55814-41-0	4649	4649	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4452	83065	875915-78-9	4650	4650	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4621		7440-50-8	4819	4819	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4453	83070	658066-35-4	4651	4651	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4454	81994	24691-80-3	4652	4652	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4455	3405	5234-68-4	4653	Systemic	4653	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4456	7858	5259-88-1	4654	4654	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4457	81794	130000-40-7	4655	4655	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4458	83092	1072957-71-1	4656	4656	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4459	83106	581809-46-3	4657	4657	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4460	83113	907204-31-3	4658	4658	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4461	81793	123572-88-3	4659	4659	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4462	83126	881685-58-1	4660	4660	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4463	83134	494793-67-8	4661	4661	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4464	81777	183675-82-3	4662	4662	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4465	83173	874967-67-6	4663	4663	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4466	81822	188425-85-6	4664	4664	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
4467	40909	131860-33-8	4665	Preventive, curative, and systemic	4665	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4468	83185	850881-70-8	4666	4666	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4469	83187	238410-11-2	4667	4667	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4470	83194	918162-02-4	4668	4668	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4471	83197	117428-22-5	4669	4669	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4472	83202	862588-11-2	4670	4670	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4473	83205	173662-97-0	4671	4671	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4474	78780	175013-18-0	4672	4672	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4475	83212	915410-70-7	4673	4673	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4476	83213	902760-40-1	4674	4674	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4477	2962	143390-89-0	4675	4675	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4478	81833	141517-21-7	4676	4676	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4479	83218	149961-52-4	4677	4677	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4480	83220	366815-39-6	4678	4678	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4481	81831	133408-50-1	4679	4679	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4482	81832	248593-16-0	4680	4680	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4483	59340	131807-57-3	4681	4681	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4484	83253	361377-29-9	4682	4682	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4485	83258	161326-34-7	4683	4683	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4486	83261	799247-52-2	4684	4684	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
4487	81841	120116-88-3	4685	4685	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
4488	81846	348635-87-0	4686	4686	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
4489	82153	485-31-4	4687	4687	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
4490	83372	131-72-6	4688	4688	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
4491	83379	39300-45-3	4689	4689	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
4492	81843	79622-59-6	4690	4690	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
4493	81844	89269-64-7	4691	4691	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
4494	81918	900-95-8	4692	4692	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
4495	35036	639-58-7	4693	4693	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
4496	30473	76-87-9	4694	4694	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
4497	83393	175217-20-6	4695	4695	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
4498	83398	865318-97-4	4696	4696	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
4499	4045	121552-61-2	4697	4697	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
4500	6751	110235-47-7	4698	4698	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
4501	8674	53112-28-0	4699	4699	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
4502	15353	2079-00-7	4700	4700	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
4503	81419	6980-18-3	4701	4701	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
4504	17076	57-92-1	4702	4702	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
4505	27701	79-57-2	4703	4703	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
4506	82040	124495-18-7	4704	4704	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
4507	83555	189278-12-4	4705	4705	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
4508	34759	74738-17-3	4706	4706	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
4509	81763	131341-86-1	4707	4707	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
4510	3656	84332-86-5	4708	4708	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4511	28909	36734-19-7	4709	Preventive, early curative, and systemic	4709	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4512	8450	32809-16-8	4710	4710	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4513		50471-44-8	4711	4711	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
4514			4712	4712	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
4515		17109-49-8	4713	4713	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4516		26087-47-8	4714	4714	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4517		13457-18-6	4715	4715	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4518		50512-35-1	4716	4716	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
4519	17097	92-52-4	4717	4717	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4520	3628	2675-77-6	4718	4718	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4521	27864	99-30-9	4719	4719	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4522	34908	82-68-8	4720	4720	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4523	82044	117-18-0	4721	4721	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4524	81731	57018-04-9	4722	4722	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4525	81761	2593-15-9	4723	4723	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
4526	83279	55406-53-6	4724	4724	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
4527	82033	24579-73-5	4725	4725	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
4528	82084	19622-08-3	4726	4726	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
4529			4727	4727	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
4530			4728	4728	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
4531			4729	4729	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
4532			4730	4730	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
4533			4731	4731	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
4534	83629		4732	4732	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
4535		26644-46-2	4733	4733	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4536		88283-41-4	4734	4734	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4537		847749-37-5	4735	4735	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4538	4998	60168-88-9	4736	4736	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4539	7645	63284-71-9	4737	4737	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4540		35554-44-0	4738	4738	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4541		134074-64-9	4739	4739	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4542		101903-30-4	4740	4740	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4543		67747-09-5	4741	4741	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4544		68694-11-1	4742	4742	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4545		60207-31-0	4743	4743	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4546		55179-31-2	4744	4744	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4622	17909	7704-34-9	4820	4820	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4547		116255-48-2	4745	4745	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4548		94361-06-5	4746	4746	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4549		119446-68-3	4747	4747	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4550		83657-18-5	4748	4748	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4551		133855-98-8	4749	4749	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4552		60207-93-4	4750	4750	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4553		114369-43-6	4751	4751	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4554		136426-54-5	4752	4752	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4555		85509-19-9	4753	4753	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4556		76674-21-0	4754	4754	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4557		79983-71-4	4755	4755	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4558		86598-92-7	4756	4756	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4559		125225-28-7	4757	4757	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4560		125116-23-6	4758	4758	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4561		88671-89-0	4759	4759	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4562		66246-88-6	4760	4760	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4563		60207-90-1	4761	4761	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4564		149508-90-7	4762	4762	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4565		107534-96-3	4763	4763	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4566		112281-77-3	4764	4764	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4567		43121-43-3	4765	4765	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4568		55219-65-3	4766	4766	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4569		131983-72-7	4767	4767	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4570		178928-70-6	4768	4768	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
4571	83295	91315-15-0	4769	Systemic	4769	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4572	81960	1593-77-7	4770	Systemic	4770	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4573	50145	67564-91-4	4771	Systemic	4771	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4574	9700	81412-43-3	4772	Systemic	4772	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4575	81917	67306-00-7	4773	Systemic	4773	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4576	83283	3478-94-2	4774	4774	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4577	9242	118134-30-8	4775	Systemic	4775	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
4578	81853	126833-17-8	4776	Locally systemic	4776	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
4579	83327	473798-59-3	4777	4777	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
4580	81736	88678-67-5	4778	Systemic	4778	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
4581	7451	65472-88-0	4779	Various	4779	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
4582	9448	91161-71-6	4780	Various	4780	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
4583		37248-47-8	4781	4781	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
4584		11113-80-7	4782	4782	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
4585	81848	110488-70-5	4783	4783	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4586	83428	211867-47-9	4784	4784	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4587	83663	868390-90-3	4785	4785	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4588	83601	413615-35-7	4786	4786	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4589	82023	140923-17-7	4787	4787	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4590	83610	283159-90-0	4788	4788	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4591	81802	374726-62-2	4789	4789	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
4592	47617	27355-22-2	4790	4790	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
4593	45141	57369-32-1	4791	4791	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
4594	81783	41814-78-2	4792	4792	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
4595		104030-54-8	4793	4793	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
4596		139920-32-4	4794	4794	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
4597		115852-48-7	4795	4795	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
4598		135158-54-2	4796	4796	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
4599		27605-76-1	4797	4797	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
4600	81825	223580-51-6	4798	4798	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
4601	83657	224049-04-1	4799	4799	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
4602		9008-22-4	4800	4800	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
4603			4801	4801	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
4604		57966-95-7	4802	4802	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
4605		39148-24-8	4803	4803	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
4606		13598-36-2	4804	4804	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
4607	83341	76280-91-6	4805	4805	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
4608	83335	72459-58-6	4806	4806	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
4609	81801	106917-52-6	4807	4807	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
4610	81759	62865-36-5	4808	4808	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
4611	81933	66952-49-6	4809	4809	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
4612	81797	180409-60-3	4810	4810	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
4613	83345	220899-03-6	4811	4811	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
4614	83346	688046-61-9	4812	4812	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
4615	74889	2439-10-3	4813	4813	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
4616	83277	958647-10-4	4814	4814	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
4617	81844	89269-64-7	4815	4815	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
4618	83268	1003318-67-9	4816	4816	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
4619	83266	376645-78-2	4817	4817	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
4620			4818	4818	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
4623	5015	14484-64-1	4821	4821	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4624	52492	8018-01-7	4822	4822	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4625	52497	12427-38-2	4823	4823	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4626	81539	9006-42-2	4824	4824	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4627	81755	12071-83-9	4825	4825	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4628	9495	137-26-8	4826	4826	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4629	52498	12122-67-7	4827	4827	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4630	79736	137-30-4	4828	4828	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4631	34608	133-06-2	4829	4829	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4632	81938	2425-06-1	4830	4830	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4633	82019	133-07-3	4831	4831	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4634	3639	1897-45-6	4832	4832	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4635	74875	1085-98-9	4833	4833	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4636	75182	731-27-1	4834	4834	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4637	82843	108173-90-6	4835	4835	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4638	5569	13516-27-3	4836	4836	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4639	82076	101-05-3	4837	4837	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4640	81842	3347-22-6	4838	4838	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4641	34620	2439-01-2	4839	4839	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
4642	81826	41205-21-4	4840	4840	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
